<SEC-DOCUMENT>0001206774-22-001662.txt : 20220713
<SEC-HEADER>0001206774-22-001662.hdr.sgml : 20220713
<ACCEPTANCE-DATETIME>20220713160535
ACCESSION NUMBER:		0001206774-22-001662
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20220713
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220713
DATE AS OF CHANGE:		20220713

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BORGWARNER INC
		CENTRAL INDEX KEY:			0000908255
		STANDARD INDUSTRIAL CLASSIFICATION:	MOTOR VEHICLE PARTS & ACCESSORIES [3714]
		IRS NUMBER:				133404508
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12162
		FILM NUMBER:		221081134

	BUSINESS ADDRESS:	
		STREET 1:		3850 HAMLIN RD.
		CITY:			AUBURN HILLS
		STATE:			MI
		ZIP:			48326
		BUSINESS PHONE:		2487549200

	MAIL ADDRESS:	
		STREET 1:		3850 HAMLIN RD.
		CITY:			AUBURN HILLS
		STATE:			MI
		ZIP:			48326

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BORG WARNER AUTOMOTIVE INC
		DATE OF NAME CHANGE:	19930628
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bwa4082911-8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:bwa="http://borgwarner.com/20220713">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_bwa_borgwarner.com_20220713 -->
<!-- Field: Set; Name: xdx; ID: xdx_045_20220712_20220713 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000908255 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body>
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-07-12to2022-07-13" name="dei:EntityCentralIndexKey">0000908255</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-12to2022-07-13" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="bwa-20220713.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-07-12to2022-07-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000908255</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-12</xbrli:startDate>
        <xbrli:endDate>2022-07-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-122022-07-13_custom_CommonStockParValue0.01PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000908255</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bwa:CommonStockParValue0.01PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-12</xbrli:startDate>
        <xbrli:endDate>2022-07-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-122022-07-13_custom_Sec1.00SeniorNotesDue2031Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000908255</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bwa:Sec1.00SeniorNotesDue2031Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-12</xbrli:startDate>
        <xbrli:endDate>2022-07-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="text-align: center"><span style="font-size: 13.56pt; font-family: Arial; Font-weight: bold">UNITED STATES SECURITIES AND EXCHANGE COMMISSION<br /></span><span style="font-size: 12pt; font-family: Arial; font-weight: bold">Washington D.C. 20549</span></p>

<p style="text-align: center"><span style="font-size: 18pt; font-family: Arial; font-weight: bold">FORM <span id="xdx_909_edei--DocumentType_c20220712__20220713_zP85OEK4cn44"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" name="dei:DocumentType">8-K</ix:nonNumeric></span></span></p>

<p style="text-align: center"><span style="font-size: 10pt; font-family: Arial; font-weight: bold">CURRENT REPORT</span></p>

<p style="text-align: center"><span style="font-size: 10pt; font-family: Arial; font-weight: bold">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>

<p style="text-align: center"><span style="font-size: 10pt; font-family: Arial">Date of Report (Date of earliest event reported): <span id="xdx_90A_edei--DocumentPeriodEndDate_c20220712__20220713_zVK9KgnUJZUf"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">July 13, 2022</ix:nonNumeric></span></span></p>

<p style="text-align: center"><span style="font-size: 24pt; font-family: Arial; font-weight: bold"><span id="xdx_90D_edei--EntityRegistrantName_c20220712__20220713_zP4ou59waxZg"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" name="dei:EntityRegistrantName">BORGWARNER INC.</ix:nonNumeric></span></span></p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">



<tr style="vertical-align: bottom">

   <td style="width: 31%; white-space: nowrap; text-align: left"></td>

   <td style="border-top: Black 1pt solid; padding-right: 10pt; width: 38%; white-space: nowrap; text-align: center; padding-left: 10pt"><span style="font-size: 10pt; font-family: Arial">(Exact name of registrant as specified in its charter)</span></td>

   <td style="width: 31%; white-space: nowrap; text-align: center"></td></tr></table>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">



<tr style="vertical-align: bottom">

   <td style="width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">&#160;</span></td>

   <td style="width: 1%; white-space: nowrap; text-align: center"></td>

   <td style="width: 32%; white-space: nowrap; text-align: center"></td>

   <td style="width: 1%; white-space: nowrap; text-align: center"></td>

   <td style="width: 33%; white-space: nowrap; text-align: center"></td></tr>

<tr style="vertical-align: bottom">

   <td style="border-bottom: #000000 1pt solid; width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial"><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20220712__20220713_zBjHcenX8Wui"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>

   <td style="width: 1%; white-space: nowrap; text-align: center">&#160;&#160;&#160;&#160;&#160;</td>

   <td style="border-bottom: #000000 1pt solid; width: 32%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial"><span id="xdx_907_edei--EntityFileNumber_c20220712__20220713_zk7FDOXjWOvg"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" name="dei:EntityFileNumber">1-12162</ix:nonNumeric></span></span></td>

   <td style="width: 1%; white-space: nowrap; text-align: center">&#160;&#160;&#160;&#160;&#160;</td>

   <td style="border-bottom: #000000 1pt solid; width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial"><span id="xdx_90A_edei--EntityTaxIdentificationNumber_c20220712__20220713_z8FzZkDSRhyh"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" name="dei:EntityTaxIdentificationNumber">13-3404508</ix:nonNumeric></span></span></td></tr>

<tr style="vertical-align: bottom">

   <td style="width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">(State or other jurisdiction of</span></td>

   <td style="width: 1%; white-space: nowrap; text-align: center"></td>

   <td style="width: 32%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">(Commission File No.)</span></td>

   <td style="width: 1%; white-space: nowrap; text-align: center"></td>

   <td style="width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">(I.R.S. Employer</span></td></tr>

<tr style="vertical-align: bottom">

   <td style="width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">Incorporation or organization)</span></td>

   <td style="width: 1%; white-space: nowrap; text-align: center"></td>

   <td style="width: 32%; white-space: nowrap; text-align: left"></td>

   <td style="width: 1%; white-space: nowrap; text-align: left"></td>

   <td style="width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">Identification No.)</span></td></tr></table>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">



<tr style="vertical-align: bottom">

   <td style="width: 50%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">&#160;</span></td>

   <td style="width: 1%; white-space: nowrap; text-align: left"></td>

   <td style="width: 49%; white-space: nowrap; text-align: center"></td></tr>

<tr style="vertical-align: bottom">

   <td style="border-bottom: #000000 1pt solid; width: 50%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial"><span id="xdx_908_edei--EntityAddressAddressLine1_c20220712__20220713_zW5znPazJ7wf"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" name="dei:EntityAddressAddressLine1">3850 Hamlin Road</ix:nonNumeric></span>,</span> <span style="font-size: 10pt; font-family: Arial"><span id="xdx_904_edei--EntityAddressCityOrTown_c20220712__20220713_zfagSUiRZlze"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" name="dei:EntityAddressCityOrTown">Auburn Hills</ix:nonNumeric></span>,</span> <span style="font-size: 10pt; font-family: Arial"><span id="xdx_90D_edei--EntityAddressStateOrProvince_c20220712__20220713_z9FYDCnTe983"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Michigan</ix:nonNumeric></span></span></td>

   <td style="width: 1%; white-space: nowrap; text-align: left">&#160;&#160;&#160;&#160;&#160;</td>

   <td style="border-bottom: #000000 1pt solid; width: 49%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial"><span id="xdx_907_edei--EntityAddressPostalZipCode_c20220712__20220713_zSP5UhqbFHsf"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" name="dei:EntityAddressPostalZipCode">48326</ix:nonNumeric></span></span></td></tr>

<tr style="vertical-align: bottom">

   <td style="width: 50%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">(Address of principal executive offices)</span> </td>

   <td style="width: 1%; white-space: nowrap; text-align: left"></td>

   <td style="width: 49%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">(Zip Code)</span></td></tr></table>


<p style="text-align: center"><span style="font-size: 10pt; font-family: Arial">Registrant&#8217;s telephone number, including area code: (<span id="xdx_908_edei--CityAreaCode_c20220712__20220713_zjpkInzGtEBa"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" name="dei:CityAreaCode">248</ix:nonNumeric></span>) <span id="xdx_907_edei--LocalPhoneNumber_c20220712__20220713_zhgWFmOz9gK6"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" name="dei:LocalPhoneNumber">754-9200</ix:nonNumeric></span></span></p>

<p style="text-align: center"><span style="font-size: 10pt; font-family: Arial">(Former name or former address, if changed since last report)</span></p>

<p style="text-align: justify"><span style="font-size: 10pt; font-family: Arial">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></p>

<table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Arial; text-align: justify; width: 100%">



<tr>

   <td style="padding-bottom: 4pt; padding-right: 8pt; vertical-align: top; width: 1%"><span style="font-size: 9.5pt"><span id="xdx_90B_edei--WrittenCommunications_c20220712__20220713_z1OhZUdtLj07"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>

   <td style="padding-top: 1pt; vertical-align: top; width: 99%; padding-bottom: 4pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>

<tr>

   <td style="padding-bottom: 4pt; padding-right: 8pt; vertical-align: top; width: 1%"><span style="font-size: 9.5pt"><span id="xdx_90E_edei--SolicitingMaterial_c20220712__20220713_zqSOiGNX4WNd"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>

   <td style="padding-top: 1pt; vertical-align: top; width: 99%; padding-bottom: 4pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>

<tr>

   <td style="padding-bottom: 4pt; padding-right: 8pt; vertical-align: top; width: 1%"><span style="font-size: 9.5pt"><span id="xdx_90D_edei--PreCommencementTenderOffer_c20220712__20220713_zzr5rqlqo4mi"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>

   <td style="padding-top: 1pt; vertical-align: top; width: 99%; padding-bottom: 4pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>

<tr>

   <td style="padding-right: 8pt; vertical-align: top; width: 1%"><span style="font-size: 9.5pt"><span id="xdx_90B_edei--PreCommencementIssuerTenderOffer_c20220712__20220713_zGgsl2rfgiHa"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>

   <td style="vertical-align: top; width: 99%; padding-top: 1pt"><span style="font-size: 10pt; font-family: Arial">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table>

<p style="text-align: left"><span style="font-size: 10pt; font-family: Arial">Securities registered pursuant to Section 12(b) of the Act:</span></p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">



<tr style="vertical-align: bottom">

   <td style="width: 33%; white-space: nowrap; text-align: left"></td>

   <td style="width: 1%; white-space: nowrap; text-align: left"></td>

   <td style="width: 32%; white-space: nowrap; text-align: left"></td>

   <td style="width: 1%; white-space: nowrap; text-align: left"></td>

   <td style="width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">Name of each exchange on</span></td></tr>

<tr style="vertical-align: bottom">

   <td style="border-bottom: #000000 1pt solid; width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">Title of each class</span></td>

   <td style="width: 1%; white-space: nowrap; text-align: center">&#160;&#160;&#160;&#160;&#160;</td>

   <td style="border-bottom: #000000 1pt solid; width: 32%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">Trading Symbol(s)</span></td>

   <td style="width: 1%; white-space: nowrap; text-align: center">&#160;&#160;&#160;&#160;&#160;</td>

   <td style="border-bottom: #000000 1pt solid; width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial">which registered</span></td></tr>

<tr style="vertical-align: bottom; background-color: Silver">

   <td style="width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial"><span id="xdx_90B_edei--Security12bTitle_c20220712__20220713__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.01PerShareMember_z83w0RptQjOh"><ix:nonNumeric contextRef="From2022-07-122022-07-13_custom_CommonStockParValue0.01PerShareMember" name="dei:Security12bTitle">Common Stock, par value $0.01 per share</ix:nonNumeric></span></span></td>

   <td style="width: 1%; white-space: nowrap; text-align: center"></td>

   <td style="width: 32%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial"><span id="xdx_900_edei--TradingSymbol_c20220712__20220713__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.01PerShareMember_zCH8cfLf3ZR3"><ix:nonNumeric contextRef="From2022-07-122022-07-13_custom_CommonStockParValue0.01PerShareMember" name="dei:TradingSymbol">BWA</ix:nonNumeric></span></span></td>

   <td style="width: 1%; white-space: nowrap; text-align: center"></td>

   <td style="width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial"><span id="xdx_905_edei--SecurityExchangeName_c20220712__20220713__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.01PerShareMember_z4ba3qOsroeg"><ix:nonNumeric contextRef="From2022-07-122022-07-13_custom_CommonStockParValue0.01PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr>

<tr style="vertical-align: bottom">

   <td style="width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial"><span id="xdx_902_edei--Security12bTitle_c20220712__20220713__us-gaap--StatementClassOfStockAxis__custom--Sec1.00SeniorNotesDue2031Member_ztZu4WhJRBmb"><ix:nonNumeric contextRef="From2022-07-122022-07-13_custom_Sec1.00SeniorNotesDue2031Member" name="dei:Security12bTitle">1.00% Senior Notes due 2031</ix:nonNumeric></span></span></td>

   <td style="width: 1%; white-space: nowrap; text-align: center"></td>

   <td style="width: 32%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial"><span id="xdx_907_edei--TradingSymbol_c20220712__20220713__us-gaap--StatementClassOfStockAxis__custom--Sec1.00SeniorNotesDue2031Member_zuiY66r1071c"><ix:nonNumeric contextRef="From2022-07-122022-07-13_custom_Sec1.00SeniorNotesDue2031Member" name="dei:TradingSymbol">BWA31</ix:nonNumeric></span></span></td>

   <td style="width: 1%; white-space: nowrap; text-align: center"></td>

   <td style="width: 33%; white-space: nowrap; text-align: center"><span style="font-size: 10pt; font-family: Arial"><span id="xdx_907_edei--SecurityExchangeName_c20220712__20220713__us-gaap--StatementClassOfStockAxis__custom--Sec1.00SeniorNotesDue2031Member_zq76oLb6b5n2"><ix:nonNumeric contextRef="From2022-07-122022-07-13_custom_Sec1.00SeniorNotesDue2031Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr></table>


<p style="text-align: justify"><span style="font-size: 10pt; font-family: Arial">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (</span><span style="font-size: 12pt; font-family: Arial">&#167;</span><span style="font-size: 10pt; font-family: Arial">230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (</span><span style="font-size: 12pt; font-family: Arial">&#167;</span><span style="font-size: 10pt; font-family: Arial">240.12b-2 of this chapter). Emerging growth company </span><span style="font-size: 10pt; font-family: Arial"><span id="xdx_90F_edei--EntityEmergingGrowthCompany_c20220712__20220713_zMZhSNpTF3a9"><ix:nonNumeric contextRef="From2022-07-12to2022-07-13" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="text-align: justify"><span style="font-size: 10pt; font-family: Arial">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size: 10pt; font-family: Arial">&#9744;</span></p>

<hr style="width: 100%; color: Gray; background-color: Gray; height: 2px; border-width: 0" />



<div style="page-break-before: always"></div>







<table cellspacing="0" cellpadding="0" border="0" style="width: 100%">



<tr>

   <td style="width: 1%"></td>

   <td style="width: 1%">&#160;&#160;&#160;&#160;&#160;</td>

   <td style="width: 98%"></td></tr>

<tr>

   <td style="width: 1%; white-space: nowrap"><span style="border-bottom: #000000 1pt solid; font-size: 10pt; font-family: Arial">Item 8.01</span></td>

   <td style="width: 1%"></td>

   <td style="width: 98%"><span style="border-bottom: #000000 1pt solid; font-size: 10pt; font-family: Arial">Other Events</span></td></tr></table>

<p style="text-indent: 15pt; text-align: justify"><span style="font-size: 10pt; font-family: Arial">As BorgWarner Inc. (the &#8220;</span><span style="font-size: 10pt; font-family: Arial"><span style="text-decoration: underline">Company</span></span><span style="font-size: 10pt; font-family: Arial">&#8221;) previously disclosed, a putative derivative lawsuit captioned Nyiradi, et al. v. Michas, et al. was filed on December 15, 2020 with the United States District Court of Delaware against certain current and former directors and former officers of the Company. The lawsuit, which was purportedly brought on the Company&#8217;s behalf, named the Company as a nominal defendant. Plaintiffs alleged, among other things, violations of the federal securities laws and breaches of fiduciary duty relating to the Company&#8217;s past accounting for incurred but not yet asserted asbestos liabilities and its public disclosures. As a nominal defendant, the Company had no direct exposure in connection with the lawsuit. On April 22, 2021, the plaintiffs dismissed the case without prejudice, without any payment by the Company. The dismissal occurred on April 22, 2021. By letter dated June 9, 2021, a different stockholder delivered a litigation demand to the Company&#8217;s Board of Directors (the &#8220;</span><span style="font-size: 10pt; font-family: Arial"><span style="text-decoration: underline">Board</span></span><span style="font-size: 10pt; font-family: Arial">&#8221;) under Delaware law that included similar allegations relating to certain current and former directors and officers. The letter demanded that the Board conduct an investigation and commence a civil action against appropriate directors and officers. On January 20, 2022, the parties agreed to a memorandum of understanding (&#8220;</span><span style="font-size: 10pt; font-family: Arial"><span style="text-decoration: underline">MOU</span></span><span style="font-size: 10pt; font-family: Arial">&#8221;) detailing, among other items, mutually agreed upon corporate governance reforms that the Company would implement.</span></p>

<p style="text-indent: 15pt; text-align: justify"><span style="font-size: 10pt; font-family: Arial">Following the agreement to the MOU by the parties, on May 23, 2022, stockholders Don David Price, Maria Nyiradi, and Peter Wahler (&#8220;Plaintiffs&#8221;) filed a derivative action with the United States District Court for the Eastern District of Michigan captioned Price, et al. v. Michas, et al. (E.D. Mich.). The Company is named as a nominal defendant. On June 2, 2022, the Company and the Plaintiffs filed with the court an agreement to settle the derivative action (the &#8220;</span><span style="font-size: 10pt; font-family: Arial"><span style="text-decoration: underline">Stipulation of Settlement</span></span><span style="font-size: 10pt; font-family: Arial">&#8221;), which remains subject to the court&#8217;s approval. As part of the Stipulation of Settlement, the Company: (i) agreed to adopt certain corporate governance reforms, the terms of which are set forth in Exhibit A to the Stipulation of Settlement, and (ii) agreed to attorneys&#8217; fees of the Plaintiffs&#8217; counsel of up to $625,000. On June 2, 2022, the Plaintiffs filed with the court an unopposed motion for preliminary approval of the proposed Stipulation of Settlement, and on June 22, 2022, the court issued an order (the &#8220;</span><span style="font-size: 10pt; font-family: Arial"><span style="text-decoration: underline">Order</span></span><span style="font-size: 10pt; font-family: Arial">&#8221;) granting preliminary approval of the proposed Stipulation of Settlement and approving the form and manner of delivering of a Notice of Pendency and Proposed Settlement of Shareholder Derivative Action (the &#8220;</span><span style="font-size: 10pt; font-family: Arial"><span style="text-decoration: underline">Notice of Proposed Settlement</span></span><span style="font-size: 10pt; font-family: Arial">&#8221;). The court scheduled a hearing on September 23, 2022 to consider final approval of the proposed Stipulation of Settlement. Until the court issues a final order approving the Stipulation of Settlement, the Company cannot provide assurance that the derivative action will be settled on the terms set forth herein or at all. Pursuant to the Order, no later than September 9, 2022, any objections to the Stipulation of Settlement (together with the other requisite information) must be filed in writing with the court and duly served in each case in accordance with the requirements specified in the Notice of Proposed Settlement.</span></p>

<p style="text-indent: 15pt; text-align: justify"><span style="font-size: 10pt; font-family: Arial">The foregoing descriptions of the Stipulation of Settlement and the Notice of Proposed Settlement do not purport to be complete and are qualified in their entirety by reference to the Stipulation of Settlement and the Notice of Proposed Settlement which, as required by the Order, the Company is filing as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K, and such exhibits are incorporated herein by reference.</span></p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">



<tr>

   <td style="width: 1%"></td>

   <td style="width: 1%">&#160;&#160;&#160;&#160;</td>

   <td style="width: 98%"></td></tr>

<tr style="vertical-align: bottom">

   <td style="white-space: nowrap; text-align: left"><span style="border-bottom: #000000 1pt solid; font-size: 10pt; font-family: Arial">Item 9.01</span></td>

   <td style="white-space: nowrap; text-align: left"></td>

   <td style="white-space: nowrap; text-align: left"><span style="border-bottom: #000000 1pt solid; font-size: 10pt; font-family: Arial">Financial Statements and Exhibits</span></td></tr>

<tr style="vertical-align: bottom">

   <td style="white-space: nowrap; text-align: left">&#160;</td>

   <td style="white-space: nowrap; text-align: left"></td>

   <td style="white-space: nowrap; text-align: left"><span style="border-bottom: #000000 1pt solid; font-size: 10pt; font-family: Arial"></span></td></tr>

<tr style="vertical-align: bottom">

   <td style="white-space: nowrap; text-align: left"><span style="font-size: 10pt; font-family: Arial">(d) Exhibits.</span></td>

   <td style="white-space: nowrap; text-align: left"></td>

   <td style="white-space: nowrap; text-align: left"></td></tr>

<tr style="vertical-align: bottom">

   <td style="white-space: nowrap; text-align: left">&#160;</td>

   <td style="white-space: nowrap; text-align: left"></td>

   <td style="white-space: nowrap; text-align: left"></td></tr>

<tr style="vertical-align: bottom">

   <td style="white-space: nowrap; text-align: left"><span style="border-bottom: #000000 1pt solid; font-size: 10pt; font-family: Arial">Exhibit No.</span></td>

   <td style="white-space: nowrap; text-align: left"></td>

   <td style="white-space: nowrap; text-align: left"><span style="border-bottom: #000000 1pt solid; font-size: 10pt; font-family: Arial">Description of Exhibit</span></td></tr>


<tr style="vertical-align: bottom; background-color: Silver">

   <td style="white-space: nowrap; text-align: left"><a href="bwa4082911-ex991.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-family: Arial">99.1</span></a></td>

   <td style="white-space: nowrap; text-align: left"></td>

   <td style="white-space: nowrap; text-align: left"><a href="bwa4082911-ex991.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-family: Arial">Stipulation of Settlement</span></a></td></tr>

<tr style="vertical-align: bottom">

   <td style="white-space: nowrap; text-align: left"><a href="bwa4082911-ex992.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-family: Arial">99.2</span></a></td>

   <td style="white-space: nowrap; text-align: left"></td>

   <td style="white-space: nowrap; text-align: left"><a href="bwa4082911-ex992.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt; font-family: Arial">Notice of Proposed Settlement</span></a></td></tr>

<tr style="vertical-align: bottom; background-color: Silver">

   <td style="white-space: nowrap; text-align: left"><span style="font-size: 10pt; font-family: Arial">104.1</span></td>

   <td style="white-space: nowrap; text-align: left"></td>

   <td style="white-space: nowrap; text-align: left"><span style="font-size: 10pt; font-family: Arial">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr><tr style="vertical-align: bottom">
   <td style="white-space: nowrap; text-align: left">&#160;</td>
   <td style="white-space: nowrap; text-align: left">&#160;</td>
   <td style="white-space: nowrap; text-align: left">&#160;</td></tr>
                                                               </table>


<hr style="width: 100%; color: Gray; background-color: Gray; height: 2px; border-width: 0" />



<div style="page-break-before: always"></div>



<p style="text-align: center"><span style="font-size: 10pt; font-family: Arial">SIGNATURES</span></p>

<p style="text-indent: 15pt; text-align: left"><span style="font-size: 10pt; font-family: Arial">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>

<table cellspacing="0" cellpadding="0" border="0" style="line-height: 14pt; border-collapse: collapse; width: 100%">



<tr style="vertical-align: bottom">

   <td style="width: 49%; white-space: nowrap; text-align: left"></td>

   <td colspan="2" style="width: 51%; white-space: nowrap; text-align: left"><span style="font-size: 10pt; font-family: Arial">BorgWarner Inc.</span></td></tr>

<tr>

   <td style="width: 49%">&#160;</td>

   <td style="width: 1%">&#160;</td>

   <td style="width: 50%">&#160;</td></tr>

<tr style="vertical-align: bottom">

   <td style="width: 49%; white-space: nowrap; text-align: left"><span style="font-size: 10pt; font-family: Arial">Date: July 13, 2022</span></td>

   <td style="width: 1%; white-space: nowrap; text-align: left"><span style="font-size: 10pt; font-family: Arial">By:&#160;&#160;</span></td>

   <td style="border-bottom: #000000 1pt solid; width: 50%; white-space: nowrap; text-align: left"><span style="font-size: 10pt; font-family: Arial">/s/ Tonit M. Calaway</span></td></tr>

<tr style="vertical-align: bottom">

   <td style="width: 49%; white-space: nowrap; text-align: left"></td>

   <td style="width: 1%; white-space: nowrap; text-align: left"></td>

   <td style="width: 50%; white-space: nowrap; text-align: left"><span style="font-size: 10pt; font-family: Arial">Name: Tonit M. Calaway</span></td></tr>

<tr style="vertical-align: bottom">

   <td style="width: 49%; white-space: nowrap; text-align: left"></td>

   <td style="width: 1%; white-space: nowrap; text-align: left"></td>

   <td style="width: 50%; white-space: nowrap; text-align: left"><span style="font-size: 10pt; font-family: Arial">Title: Executive Vice President and Secretary</span></td></tr>

<tr style="vertical-align: bottom">

   <td style="width: 49%; white-space: nowrap; text-align: left">&#160;</td>

   <td style="width: 1%; white-space: nowrap; text-align: left"></td>

   <td style="width: 50%; white-space: nowrap; text-align: left"></td></tr></table>


<hr style="width: 100%; color: Gray; background-color: Gray; height: 2px; border-width: 0" />



</body>

</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kFFLwzAQxz/BvsNR9G1sSacIfZtVh7iNso7ha2xvGtbmyiWd7iP5LU3SDV80BEK43+/+xyXJOFnQk26Q4fV+s4Qttl2jHMIG98hoKvRE/vySgX83+K6tY2Vc/F7EnLyD3rmdyBvlCxE9aot1BuJuKmfTNAUpspmA+SoZhXpOZq9rNE6rBpSpoWDqWKNTfBo6bNUXGWpPMWqHbDWZDOREDOVvSIVMYU1H9Ul8sLBc5sloHM8oWTD1XYjpraMWHhtsfZYd1N8bR6kik5VY+eaiRKOJ1+TQPvSYiplcYfuG7EEpUp85Pw8Q4GsYcIg81D1CMP7o7nfUkikdVYdC8U41PYqJkAVy+aEY/8kYLIjaGDrFcAwmXAUXOr97G+xL3g9izYUT -->

</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>bwa4082911-ex991.htm
<DESCRIPTION>STIPULATION OF SETTLEMENT
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor="#ffffff">
<DIV>
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.136</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 2 of 85</FONT></TD></TR></TABLE>

<P style="TEXT-ALIGN: center"><B><U><FONT size=2 face=TimesNewRoman>STIPULATION OF SETTLEMENT</FONT></U></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>This Stipulation of Settlement, dated May 19, 2022 (this "Stipulation"), is made and entered into by and among the following Settling Parties, by and through their respective counsel of record: (i) stockholders Don David Price, Maria Nyiradi, and Peter Wahler ("Stockholders"), individually and derivatively on behalf of nominal defendant BorgWarner Inc. ("BorgWarner" or the "Company"); (ii) Alexis P. Michas, Dennis C. Cuneo, Michael S. Hanley, Joseph F. Fadool, Brady D.</FONT><FONT size=2 face=TimesNewRoman> Ericson, and Frederic B. Lissalde (collectively, the "Individual Defendants"); and (iii) nominal defendant BorgWarner (together with the Individual Defendants, "Defendants"). This Stipulation is intended by the Settling Parties<SUP>1 </SUP>to fully, finally, and forever resolve, discharge, and settle the Released Claims, subject to the terms and conditions set forth herein.</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="width: 1%; text-align: left; padding-right: 8pt"><B><FONT size=2 face=TimesNewRoman>I.</FONT></B></TD>

   <TD STYLE="width: 99%; text-align: left"><B><FONT size=2 face=TimesNewRoman>FACTUAL AND PROCEDURAL BACKGROUND</FONT></B></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>BorgWarner is an automotive parts manufacturer. Until the 1980s, BorgWarner manufactured brake pads and clutches alleged to contain asbestos. As a result of the allegations, BorgWarner or an affiliate has been named as a defendant in multiple asbestos-related cases with varying liability (the "Asbestos Liability"). BorgWarner had an obligation to accrue or disclose estimates of the costs of asbestos-related litigation in its filings with the U.S. Securities and Exchange Commission ("SEC").</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; white-space: nowrap; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman><SUP>1</SUP></FONT></TD>

   <TD STYLE="vertical-align: top; width: 99%; text-align: justify"><FONT size=2 face=TimesNewRoman>All capitalized terms not otherwise defined are defined in section IV.1.</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><FONT size=2 face=TimesNewRoman>- 1 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.137</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 3 of 85</FONT></TD></TR></TABLE>




<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>Stockholders allege derivatively that certain of the Company's officers and directors breached their fiduciary duties by, among other things: (i) causing the Company to omit estimates of significant asbestos-related contingent liabilities from its filings with the SEC; and (ii) failing to implement adequate internal controls designed to identify and disclose such liabilities. Stockholders also allege derivatively violations of the securities laws in connection with BorgWarner's repurchase of $113 million in shares of its stock and that BorgWarner's stock price was artificially inflated as a result of the Company's failure to properly disclose the Asbestos Liability. Finally, Stockholder Price alleges derivatively that Company insiders made illicit proceeds by selling certain shares of BorgWarner stock while in possession of inside information and while the Company's stock price was allegedly artificially inflated.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face=TimesNewRoman>A.</FONT></B> <B><FONT size=2 face=TimesNewRoman>Proceedings in the Related Delaware Derivative Action</FONT></B></P>




<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>In December 2018, Stockholders Nyiradi and Wahler each sent BorgWarner an inspection demand pursuant to 8 </FONT><I><FONT size=2 face=TimesNewRoman>Del. C. </FONT></I><FONT size=2 face=TimesNewRoman>&#167;220, requesting the Company's internal books and records relating to the alleged wrongdoing. After reviewing the documents provided, Stockholders Nyiradi and Wahler filed a stockholder derivative action on behalf of BorgWarner, titled </FONT><I><FONT size=2 face=TimesNewRoman>Nyiradi, et al. v. Michas, et al.</FONT></I><FONT size=2 face=TimesNewRoman>, C.A. No. 20-</FONT><FONT size=2 face=TimesNewRoman>1700-RGA (Del.) (the "Delaware Action"). Defendants moved to dismiss the Delaware Action, and Stockholders Nyiradi and Wahler subsequently voluntarily dismissed the Delaware Action without prejudice.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face=TimesNewRoman>- 2 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.138</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 4 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face=TimesNewRoman>B.</FONT></B> <B><FONT size=2 face=TimesNewRoman>Litigation Demand, this Derivative Action, and Settlement Efforts</FONT></B></P>




<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>On January 4, 2021, Stockholder Price sent BorgWarner an inspection demand pursuant to 8 </FONT><I><FONT size=2 face=TimesNewRoman>Del. C. </FONT></I><FONT size=2 face=TimesNewRoman>&#167;220, requesting the Company's internal books and records relating to the alleged wrongdoing. After negotiations, the Company produced over 7,500 pages of internal corporate documents. On June 9, 2021, Stockholder Price sent the Company a litigation demand, requesting that the Company investigate the alleged wrongdoing and take appropriate action ("Litigation Demand"), including a comprehensive review and overhaul of the Company's corporate governance and compliance practices and systems of internal controls and reporting for the purpose of not only preventing a recurrence of the failures detailed in the Litigation Demand, but to optimize them considering current relevant best practices.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>While Stockholder Price was engaged in discussions with the Company and its counsel regarding the pending Litigation Demand, the Settling Parties began discussing a potential settlement of all of the derivative claims.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>On July 22, 2021, Stockholders sent the Company a joint settlement demand, </FONT><FONT size=2 face=TimesNewRoman>which proposed a slate of corporate governance reforms designed to address the </FONT><FONT size=2 face=TimesNewRoman>alleged wrongdoing. The Settling Parties thereafter engaged in extensive arm's-length negotiations regarding the corporate governance reforms, which included numerous phone calls and emails, and several settlement proposals and counterproposals.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face=TimesNewRoman>- 3 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>


<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.139</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 5 of 85</FONT></TD></TR></TABLE>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>After significant arm's-length negotiations, the Settling Parties reached agreement on the substantive terms of the proposed Settlement, which were memorialized in a Memorandum of Understanding ("MOU") dated January 20, 2022.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>After signing the MOU, the Settling Parties commenced negotiations relating to the attorneys' fees and expenses to be paid to Stockholders' Counsel in recognition of the benefits conferred on the Company through the corporate governance reforms set forth in Exhibit A attached hereto ("Reforms"). After lengthy and adversarial negotiations, the Settling Parties agreed that, in recognition of the substantial benefits to be conferred through the proposed Settlement, Stockholders' Counsel should receive attorneys' fees and expenses of $625,000, subject to Court approval.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>Thereafter, Stockholders prepared to file the above-captioned action, styled </FONT><I><FONT size=2 face=TimesNewRoman>Price, et al. v. Michas, et al. </FONT></I><FONT size=2 face=TimesNewRoman>(E.D. Mich.) (the "Action" and, together with the Delaware Action, the "Derivative Actions"), for purposes of obtaining the Court's approval of the Settlement.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face=TimesNewRoman>- 4 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.140</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 6 of 85</FONT></TD></TR></TABLE>

<BR>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: justify; padding-right: 8pt"><B><FONT size=2 face=TimesNewRoman>II.</FONT></B></TD>

   <TD STYLE="vertical-align: top; width: 99%; text-align: justify"><B><FONT size=2 face=TimesNewRoman>STOCKHOLDERS' CLAIMS AND THE BENEFITS OF SETTLEMENT</FONT></B></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>Stockholders believe that the claims asserted in the Litigation Demand and the Derivative Actions have substantial merit, and Stockholders' entry into this Stipulation and Settlement is not intended to be and shall not be construed as an admission or concession concerning the relative strength or merit of those claims. However, Stockholders and Stockholders' Counsel recognize and acknowledge the significant risk, expense, and length of continued proceedings necessary to prosecute the derivative claims against the Individual Defendants through trial and possible appeals. Stockholders' Counsel also have taken into account the uncertain outcome and the risk of any litigation, especially in complex cases such as the Derivative Actions, as well as the difficulties and delays inherent in such litigation. </FONT><FONT size=2 face=TimesNewRoman>Stockholders' Counsel are also mindful of the inherent problems of establishing standing in derivative litigation, and the possible defenses to the claims alleged in the Litigation Demand and Derivative Actions.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>Stockholders' Counsel have conducted extensive investigation and analysis, including, </FONT><I><FONT size=2 face=TimesNewRoman>inter alia</FONT></I><FONT size=2 face=TimesNewRoman>: (i) reviewing BorgWarner's press releases, public statements, SEC filings, and securities analysts' reports and advisories about the Company; (ii) reviewing related media reports about the Company; (iii) reviewing over 7,500 pages of the Company's internal books and records obtained pursuant to 8 </FONT><I><FONT size=2 face=TimesNewRoman>Del. Code </FONT></I><FONT size=2 face=TimesNewRoman>&#167;220; (iv) researching applicable law with respect to the claims alleged in the Action </FONT><FONT size=2 face=TimesNewRoman>and potential defenses thereto; (v) preparing a litigation demand; (vi) preparing and filing derivative complaint(s); (vii) conducting damages analyses; and (viii) negotiating this Settlement with Defendants, including researching corporate governance best practices and negotiating the Reforms.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face=TimesNewRoman>- 5 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>


<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.141</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 7 of 85</FONT></TD></TR></TABLE>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>Based on Stockholders' Counsel's thorough review and analysis of the relevant facts, allegations, defenses, and controlling legal principles, Stockholders' Counsel believe that the Settlement set forth in this Stipulation is fair, reasonable, and adequate, and confers substantial benefits upon BorgWarner. Based upon Stockholders' Counsel's evaluation, Stockholders have determined that the Settlement is in the best interests of BorgWarner and have agreed to settle the Released Claims upon the terms and subject to the conditions set forth herein.</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><B><FONT size=2 face=TimesNewRoman>III.</FONT></B></TD>

   <TD STYLE="vertical-align: top; width: 99%; text-align: left"><B><FONT size=2 face=TimesNewRoman>INDIVIDUAL DEFENDANTS' DENIALS OF WRONGDOING AND LIABILITY</FONT></B></TD></TR></TABLE>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>The Individual Defendants have denied and continue to deny each and every one of the claims, contentions, and allegations made against them or that could have been made against them in the Litigation Demand and Derivative Actions, and expressly deny all charges of wrongdoing or liability against them. The Individual Defendants assert that they have satisfied their fiduciary duties at all relevant times, have acted in good faith and in the best interests of BorgWarner and its stockholders, have meritorious defenses to Stockholders' claims, and that judgment should be entered dismissing all claims against them with prejudice. The Individual </FONT><FONT size=2 face=TimesNewRoman>Defendants also have denied and continue to deny, among other things, the allegations that Stockholders, BorgWarner, or its stockholders have suffered damage, or that Stockholders, BorgWarner, or its stockholders were harmed by the conduct alleged in the Litigation Demand and Derivative Actions. The Individual Defendants have thus entered into the Stipulation solely to avoid the continuing additional expense, inconvenience, and distraction of this litigation and to avoid the risks inherent in the lawsuit, and without admitting any wrongdoing or liability whatsoever.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face=TimesNewRoman>- 6 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.142</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 8 of 85</FONT></TD></TR></TABLE>

<BR>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: justify; padding-right: 8pt"><B><FONT size=2 face=TimesNewRoman>IV.</FONT></B></TD>

   <TD STYLE="vertical-align: top; width: 99%; text-align: justify"><B><FONT size=2 face=TimesNewRoman>TERMS OF STIPULATION AND AGREEMENT OF SETTLEMENT NOW, THEREFORE, IT IS HEREBY STIPULATED AND AGREED</FONT></B></TD></TR></TABLE>

<P style="TEXT-ALIGN: justify"><FONT size=2 face=TimesNewRoman>by and among the undersigned counsel for the Settling Parties herein, that in exchange for the consideration set forth below, the Released Claims shall be, subject to Court approval (and such approval becoming Final), fully, finally, and forever compromised, settled, discharged, relinquished, and released, and the Action shall be dismissed with prejudice, upon and subject to the terms and conditions of this Stipulation, as follows.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face=TimesNewRoman>1.</FONT></B> <B><FONT size=2 face=TimesNewRoman>Definitions</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>As used in this Stipulation, the following terms have the meanings specified</FONT><FONT size=2 face=TimesNewRoman> below:</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face=TimesNewRoman>- 7 -</FONT></P>

<HR align=center width="100%" noShade size="2">
<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<!-- PART 02 -->
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.143</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 9 of 85</FONT></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.1 "Action" means the shareholder derivative action that will be filed in the United States District Court for the Eastern District of Michigan, styled </FONT><I><FONT size=2 face="Times New Roman">Price, et al. v. Michas, et al. </FONT></I><FONT size=2 face="Times New Roman">(E.D. Mich.).</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.2 "BorgWarner" or the "Company" means nominal defendant BorgWarner, a Delaware corporation, and its affiliates, subsidiaries, predecessors, successors, and assigns.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.3 "Court" means United States District Court for the Eastern District of Michigan.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.4 "Current BorgWarner Stockholders" means any Person who owned BorgWarner common stock as of the date of the execution of this Stipulation and continues to hold their BorgWarner common stock as of the date of the Settlement Hearing, excluding the Individual Defendants, the officers and directors of BorgWarner, members of their immediate families, and their legal representatives, heirs, successors, or assigns, and any entity in which Individual Defendants have or had a controlling interest.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.5 "Defendants" means, collectively, nominal defendant BorgWarner and the Individual Defendants.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.6 "Defendants' Counsel" means Simpson Thatcher &amp; Bartlett LLP.</FONT></P>
<P STYLE="text-align: center">
<FONT size=2 face="Times New Roman">- 8 -</FONT></P>
<HR noshade align="center" width="100%" size=2>

<DIV STYLE="page-break-before: always"></DIV>
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.144</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 10 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.7 "Delaware Action" means the shareholder derivative action styled </FONT><I><FONT size=2 face="Times New Roman">Nyiradi, et al. v. Michas, et al.</FONT></I><FONT size=2 face="Times New Roman">, C.A. No. 20-1700-RGA (D. Del.), which was voluntarily dismissed without prejudice.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.8 "Derivative Actions" means the Action and the Delaware Action.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.9 "Effective Date" means the first date by which the events and conditions specified in &para;6.1 of this Stipulation have been met and have occurred.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.10 "Final" means the date upon which the last of the following shall occur with respect to the Judgment approving this Stipulation, substantially in the form of Exhibit E attached hereto: (i) the expiration of the time to file a notice of appeal from the Judgment; (ii) if an appeal has been filed, the appellate court has either affirmed the Judgment or dismissed that appeal and the time for any reconsideration or further appellate review has passed; or (iii) if a higher court has granted further appellate review, that court has either affirmed the underlying Judgment or affirmed the court of appeal's decision affirming the Judgment or dismissing the appeal. For purposes of this paragraph, an "appeal" shall not include any appeal that concerns only the issue of attorneys' fees and expenses or the payment of a service award. Any proceeding or order, or any appeal or petition for a writ of certiorari pertaining solely to the application for attorneys' fees or expenses or the payment of a service award, shall not in any way delay or preclude the Judgment from becoming Final.</FONT></P>
<P STYLE="text-align: center">
<FONT size=2 face="Times New Roman">- 9 -</FONT></P>
<HR noshade align="center" width="100%" size=2><DIV STYLE="page-break-before: always"></DIV>
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.145</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 11 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.11 "Individual Defendants" means Alexis P. Michas, Dennis C. Cuneo, Michael S. Hanley, Joseph F. Fadool, Brady D. Ericson, and Frederic B. Lissalde.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.12 "Judgment" means the Order and Final Judgment to be rendered by the Court, substantially in the form attached hereto as Exhibit E.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.13 "Litigation Demand" means the letter which Stockholder Price sent the Company, dated June 9, 2021, which requested that the Company investigate the alleged wrongdoing and take appropriate action.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.14 "Notice" means the Notice of Pendency and Proposed Settlement of Shareholder Derivative Action, substantially in the form attached hereto as Exhibit C.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.15 "Person" means an individual, corporation, limited liability company, professional corporation, limited liability partnership, partnership, limited partnership, association, joint venture, joint stock company, estate, legal representative, trust, unincorporated association, government or any political subdivision or agency thereof, and any other business or legal entity, and each of their spouses, heirs, predecessors, successors, representatives, or assignees.</FONT></P>

<P STYLE="text-align: center">
<FONT size=2 face="Times New Roman">- 10 -</FONT></P>
<HR noshade align="center" width="100%" size=2><DIV STYLE="page-break-before: always"></DIV>
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.146</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 12 of 85</FONT></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.16 "Preliminary Approval Order" refers to the proposed order substantially in the form of Exhibit B attached hereto, requesting: (i) preliminary approval of the Settlement set forth in this Stipulation; (ii) approval of the form and manner of providing notice of the Settlement to Current BorgWarner Stockholders; and (iii) a date for the Settlement Hearing.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.17 "Related Persons" means each of the Defendants' past or present agents, employees, officers, directors, parents, subsidiaries, divisions, affiliates, attorneys, accountants, auditors, advisors, insurers, co-insurers, reinsurers, spouses, immediate family members, heirs, executors, personal representatives, estates, administrators, trusts, predecessors, successors, and assigns, or other person in which any Defendant has a controlling interest, and each and all of their respective past and present officers, directors, employees, agents, affiliates, parents, subsidiaries, divisions, attorneys, accountants, auditors, advisors, insurers, coinsurers, reinsurers, trusts, predecessors, successors, and assigns.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.18 "Released Claims" shall collectively mean any and all claims for relief (including Unknown Claims), rights, demands, suits, matters, causes of action, or liabilities, known or unknown, asserted or unasserted, that have been or could have been asserted in the Litigation Demand or Derivative Actions by Stockholders, by BorgWarner, or by any Current BorgWarner Stockholder derivatively on behalf of BorgWarner against any Defendant or Released Person, arising out of or based upon the facts, transactions, events, occurrences, acts, disclosures, statements, omissions, or failures to act that were or could have been alleged in the Litigation Demand or Derivative Actions, or any claims in connection with, based upon, arising out of, or relating to the Settlement, but excluding any claims to enforce the Settlement set forth in this Stipulation. Excluded from the term "Released Claims" are all claims, rights, or obligations of BorgWarner or the Individual Defendants regarding indemnification, contribution, or insurance matters, as set forth in &para;5.4.</FONT></P><P STYLE="text-align: center">
<FONT size=2 face="Times New Roman">- 11 -</FONT></P>
<HR noshade align="center" width="100%" size=2><DIV STYLE="page-break-before: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.147</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 13 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.19 "Released Persons" means each of the Defendants and their Related Persons.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.20 "Releasing Parties" means the Stockholders, all other Current BorgWarner Stockholders, Stockholders' Counsel, and BorgWarner. "Releasing Party" means, individually, any of the Releasing Parties.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.21 "Settlement" means the agreement, terms, and conditions contained in this Stipulation, dated May 19, 2022, and its exhibits.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.22 "Settlement Hearing" means any hearing or hearings at which the Court will consider final approval of the Settlement.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.23 "Settling Parties" means, collectively, each of the Stockholders and each of the Defendants.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.24 "Stockholders" means Don David Price, Maria Nyiradi, and Peter Wahler.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.25 "Stockholders' Counsel" means Kahn Swick &amp; Foti, LLC and Robbins LLP.</FONT></P>
<P STYLE="text-align: center">
<FONT size=2 face="Times New Roman">- 12 -</FONT></P>
<HR noshade align="center" width="100%" size=2><DIV STYLE="page-break-before: always"></DIV>
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.148</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 14 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.26 "Summary Notice" means the Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Action, substantially in the form attached hereto as Exhibit D.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">1.27 "Unknown Claims" means any of the Released Claim(s) which Stockholders, BorgWarner, Current BorgWarner Stockholders, or Defendants do not know of or suspect to exist in his, her, or its favor at the time of the release of the Released Persons, including claims which, if known by him, her, or it, might have affected his, her, or its decision not to object to this Settlement. With respect to any and all Released Claims, the Settling Parties stipulate and agree that, upon the Effective Date, the Settling Parties shall expressly waive and each of the Current BorgWarner Stockholders shall be deemed to have, and by operation of the Judgment shall have, expressly waived, the provisions, rights and benefits conferred by or under California Civil Code section 1542, which provides:</FONT></P>
<P style="text-align: justify; PADDING-LEFT: 15PT; PADDING-RIGHT: 15PT">
<FONT size=2 face="Times New Roman">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.</FONT></P>

<P STYLE="text-align: center">
<FONT size=2 face="Times New Roman">- 13 -</FONT></P>
<HR noshade align="center" width="100%" size=2><DIV STYLE="page-break-before: always"></DIV>
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.149</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 15 of 85</FONT></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify">
<FONT size=2 face="Times New Roman">Upon the Effective Date, Stockholders and Defendants shall expressly waive, and each of the Current BorgWarner Stockholders shall be deemed to have, and by operation of the Judgment shall have, expressly waived any and all provisions, rights, and benefits conferred by any law of any jurisdiction or any state or territory of the United States or any foreign jurisdiction, or principle of common law, which is similar, comparable, or equivalent to California Civil Code Section 1542. Stockholders, Defendants, and Current BorgWarner Stockholders may hereafter discover facts in addition to or different from those which he, she, or it now knows or believes to be true with respect to the subject matter of the Released Claims, but, upon the Effective Date, each Stockholder and Defendant shall expressly settle and release, and each Current BorgWarner Stockholder shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever settled and released, any and all Released Claims, known or unknown, suspected or unsuspected, contingent or noncontingent, which now exist, or heretofore have existed upon any theory of law or equity now existing or coming into existence in the future, including, but not limited to, conduct which is negligent, intentional, with or without malice, or a breach of any duty, law, or rule, without regard to the subsequent discovery or existence of such different or additional facts. The Settling Parties acknowledge, and the Current BorgWarner Stockholders shall be deemed by operation of the Judgment to have acknowledged, that the foregoing waiver was separately bargained for and is a key element of the Settlement of which this release is a part.</FONT></P>
<P STYLE="text-align: center">
<FONT size=2 face="Times New Roman">- 14 -</FONT></P>
<HR noshade align="center" width="100%" size=2>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<!-- PART 03 -->
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.150</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 16 of 85</FONT></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face=TimesNewRoman>2.</FONT></B> <B><FONT size=2 face=TimesNewRoman>Terms of the Settlement</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face=TimesNewRoman>2.1 </FONT><U><FONT size=2 face=TimesNewRoman>Corporate Governance Reforms</FONT></U><FONT size=2 face=TimesNewRoman>. BorgWarner shall adopt, implement, and maintain the Reforms upon the terms and conditions set forth in Exhibit A attached hereto within a period of 120 days after the Effective Date. The Reforms set forth in Exhibit A will remain in effect for a period of no less than four (4) years following the Effective Date. The Company may amend or eliminate any one or more of the Reforms set forth in Exhibit A only if the BorgWarner Board of Directors ("Board") determines in a good faith exercise of its business judgment that a policy, procedure, control, or agreement term is not in the Company's best interest or conflicts with any provision of any applicable law, including without limitation, the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, or any rules or regulations promulgated thereunder. If a Reform is eliminated or modified, the Board shall within sixty (60) business days or at the Board's next regularly scheduled meeting, adopt a replacement provision that accomplishes substantially the same objective; provided, however, that no such replacement provision need be adopted if, in the reasonable good faith business judgment of a majority of the Board's independent directors, it is not reasonably possible to do so in a manner consistent with the law, the best interests of the Company, or otherwise. Any changes deemed material to the Company by the Company shall be reported on an annual basis in the Company's Annual Report on Form 10-K or Definitive Proxy Statement on Form DEF14A, or posted on the Company's website.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face=TimesNewRoman>- 15 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>


<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.151</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 17 of 85</FONT></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">2.2 BorgWarner acknowledges and agrees that the Litigation Demand, the Delaware Action, and the litigation and settlement efforts were substantial and material factors in the Company's decision to implement the Reforms for the agreed term.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">2.3 BorgWarner's Board, including each of its independent, non-defendant directors, in a good faith exercise of business judgment, has determined that: (i) the Reforms confer a substantial benefit upon BorgWarner and its stockholders; and (ii) the Settlement, including the Fee and Expense Amount is, in all respects, fair, reasonable, and in the best interests of the Company and its stockholders.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face=TimesNewRoman>3.</FONT></B> <B><FONT size=2 face=TimesNewRoman>Approval and Notice</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">3.1 Within five (5) business days after execution of this Stipulation, Stockholders shall file the Action with the Court. Defendants shall execute waivers of service of the Action promptly thereafter. With the exception of securing service of the filing of the Action, Stockholders shall not engage in any litigation activity in the Action apart from activities related to seeking approval of the Settlement.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">3.2 Within ten (10) business days of filing the Action, Stockholders' Counsel shall submit this Stipulation together with its exhibits to the Court and shall apply for entry of an order (the "Preliminary Approval Order"), substantially in the form of Exhibit B attached hereto, requesting: (i) preliminary approval of the Settlement set forth in this Stipulation; (ii) approval of the form and manner of providing notice of the Settlement to Current BorgWarner Stockholders; and (iii) a date for the Settlement Hearing.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 16 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.152</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 18 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">3.3 Notice to Current BorgWarner Stockholders shall consist of a Notice of Pendency and Proposed Settlement of Shareholder Derivative Action ("Notice"), which includes the general terms of the Settlement set forth in this Stipulation and the date of the Settlement Hearing, substantially in the form attached hereto as Exhibit C, as well as a Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Action ("Summary Notice"), substantially in the form attached hereto as Exhibit D.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">3.4 Within fourteen (14) business days after the entry of the Preliminary Approval Order, BorgWarner, at its own cost, shall cause the Stipulation of Settlement and Notice to be filed with or furnished to the SEC by including a copy as an exhibit to a Current Report on Form 8-K (the "8-K"), and BorgWarner shall publish the Summary Notice one time in the national edition of </FONT><I><FONT size=2 face="Times New Roman">Investors' Business Daily</FONT></I><FONT size=2 face="Times New Roman">. The 8-K and attachments shall also be posted on the Company's website until the Judgment becomes Final. Stockholders' Counsel, at their cost, shall also post the Stipulation of Settlement and Notice on their respective websites. If additional notice is required by the Court, then the cost and administration of such additional notice will be borne by BorgWarner. The Settling Parties believe the content and manner of the notice, as set forth in this paragraph, constitutes adequate and reasonable notice to Current BorgWarner Stockholders pursuant to applicable law and due process. Prior to the Settlement Hearing, Defendants' Counsel shall file with the Court an appropriate affidavit or declaration with respect to filing and posting the Notice and Summary Notice.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 17 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.153</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 19 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">3.5 The Settling Parties agree to request that the Court hold a Settlement Hearing in the Action within forty-five (45) calendar days after Notice is given, during which the Court will consider and determine whether the Judgment, substantially in the form of Exhibit E attached hereto, should be entered: (i) approving the terms of the Settlement as fair, reasonable, and adequate; and (ii) dismissing with prejudice the Action against the Defendants.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face=TimesNewRoman>4.</FONT></B> <B><FONT size=2 face=TimesNewRoman>Stockholders' Counsel's Separately Negotiated Attorneys' Fees and Expenses</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">4.1 After negotiating the principal terms of the Settlement, counsel for the Settling Parties, acting by and through their respective counsel, separately negotiated the attorneys' fees and expenses the Company would cause to be paid to Stockholders' Counsel based on the corporate governance benefits conferred upon BorgWarner by the Settlement. The Company will cause Stockholders' Counsel to be paid up to $625,000 in attorneys' fees and expenses, subject to approval by the Court (the "Fee and Expense Amount").</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 18 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.154</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 20 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">4.2 The Fee and Expense Amount shall be paid into an escrow account controlled by Stockholders' Counsel within fourteen (14) business days of the later of: (i) the entry of an order from the Court preliminarily approving the Settlement; or (ii) the date on which Stockholders' Counsel provides to the Company's Counsel written payment and wire instructions and a signed W-9 reflecting a valid taxpayer identification number for the account into which the Fee and Expense Amount is to be deposited.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">4.3 The Fee and Expense Amount shall be immediately releasable upon the later of: (i) seven (7) days after the Effective Date; or (ii) the date on which the Court enters an order approving the Fee and Expense Amount (or such other amount as may be approved by the Court) that is not subject to further appeal or review. In the event that the Effective Date does not occur or the Court does not approve the Fee and Expense Amount (or approves the Fee and Expense Amount only in part), the Fee and Expense Amount (or the portion thereof in excess of the Court's award) shall be immediately releasable to the payor. In the event that the Fee and Expense Amount is released to Stockholders' Counsel but the Judgment fails to become Final as defined in &#182;1.10 herein, then Stockholders' Counsel shall be severally obligated to make appropriate refunds or repayments to the payor of any attorneys' fees and expenses previously paid within fifteen (15) business days from receiving notice from Defendants' Counsel of written payment instructions and tax information.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 19 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.155</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 21 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">4.4 Stockholders' Counsel may seek service awards of up to $5,000 for each of the Stockholders to be paid out of the Fee and Expense Amount, subject to Court approval, which Defendants shall not oppose ("Service Awards").</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">4.5 The payment of the Fee and Expense Amount pursuant to &#182;&#182;4.1, 4.2, and 4.3 hereof shall constitute final and complete payment for Stockholders' Counsel's attorneys' fees and for the reimbursement of expenses and costs that have been incurred, or will be incurred, in connection with the Litigation Demand and Derivative Actions. Stockholders' Counsel shall allocate the Fee and Expense Amount among themselves. Stockholders' Counsel agree that any disputes regarding the allocation of the Fee and Expense Amount among them shall be presented to and be mediated, and, if necessary, finally decided and resolved by a mutually-agreeable mediator on the terms and subject to the processes and procedures set forth by the mediator. The mediator's fees and costs for any such mediation and/or arbitration shall be borne solely by Stockholders' Counsel and allocated among Stockholders' Counsel by agreement or as finally determined by the mediator.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">4.6 The Fee and Expense Amount, as well as any Service Awards, are subject to the approval of the Court; however, the effectiveness of the Stipulation shall not be conditioned upon the approval, in whole or in part, of the Court of either the Fee and Expense Amount or the Service Awards.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 20 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.156</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 22 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face=TimesNewRoman>5.</FONT></B> <B><FONT size=2 face=TimesNewRoman>Releases</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">5.1 Upon the Effective Date, BorgWarner, Stockholders (acting on their own behalf and derivatively on behalf of BorgWarner), and each of the Current BorgWarner Stockholders (solely in their respective capacities as such) shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished, and discharged the Released Claims against the Released Persons and any and all claims (including Unknown Claims) arising out of, relating to, or in connection with the defense, settlement or resolution of the Litigation Demand or Derivative Actions, provided that nothing herein shall in any way impair or restrict the rights of any of the Settling Parties to enforce the terms of this Stipulation or the Judgment.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">5.2 Upon the Effective Date, BorgWarner, Stockholders (acting on their own behalf and derivatively on behalf of BorgWarner), and each of the Current BorgWarner Stockholders (solely in their respective capacities as such) will be forever barred and enjoined from commencing, instituting, or prosecuting any of the Released Claims or any action or other proceeding against any of the Released Persons based on the Released Claims or any action or proceeding arising out of, related to, or in connection with the settlement or resolution of the Litigation Demand or Derivative Actions, provided that nothing herein shall in any way impair or restrict the rights of any of the Settling Parties to enforce the terms of this Stipulation or the Judgment.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 21 -</FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<!-- PART 04 -->

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.157</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 23 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">5.3 Upon the Effective Date, each of the Released Persons shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished, and discharged each and all of the Stockholders, Stockholders' Counsel, BorgWarner, and all of the Current BorgWarner Stockholders (solely in their capacity as such) from all claims (including Unknown Claims) arising out of, relating to, or in connection with the institution, prosecution, assertion, settlement, or resolution of the Litigation Demand or Derivative Actions or the Released Claims. Nothing herein shall in any way impair or restrict the rights of any Settling Party to enforce the terms of this Stipulation or the Judgment.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">5.4 Notwithstanding anything to the contrary in this Stipulation, nothing herein shall constitute or reflect a waiver or release of any rights or claims of Defendants against their insurers, or their insurers' subsidiaries, predecessors, successors, assigns, affiliates, or representatives, including, but not limited to, any rights or claims by the Defendants under any directors' and officers' liability insurance or other applicable insurance coverage maintained by the Company. Nothing in this Stipulation constitutes or reflects a waiver or release of any rights or claims of the Defendants relating in any way to indemnification or advancement of attorneys' fees relating to any matter, including, but not limited to, the Litigation Demand, Derivative Actions, or the Released Claims, whether under any written indemnification or advancement agreement, or under the Company's certificate of incorporation, by-laws or operating agreement, or under applicable law. The Settlement will not be conditioned upon the obtaining of, or judicial approval of, any releases between or among any settling Defendants, except as set forth in this Stipulation, and/or any third parties and will not be conditioned upon the settlement, or the approval of the settlement, of any other lawsuits or claims.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 22 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.158</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 24 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face=TimesNewRoman>6.</FONT></B> <B><FONT size=2 face=TimesNewRoman>Conditions of Settlement; Effect of Disapproval, Cancellation, or Termination</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">6.1 The Effective Date of this Stipulation shall be conditioned on the occurrence of all of the following events:</FONT></P>

<P STYLE="text-indent: 30pt; text-align: justify"><FONT size=2 face="Times New Roman">a. Court approval of the method of providing Notice, substantially in the forms of Exhibit C and Exhibit D attached hereto;</FONT></P>

<P STYLE="text-indent: 30pt; text-align: justify"><FONT size=2 face="Times New Roman">b. Dissemination of the Notice as set forth in &#182;&#182;3.3 and 3.4;</FONT></P>

<P STYLE="text-indent: 30pt; text-align: justify"><FONT size=2 face="Times New Roman">c. Entry of the Judgment, substantially in the form of Exhibit E attached hereto, approving the Settlement without awarding costs to any party, except as provided herein;</FONT></P>

<P STYLE="text-indent: 30pt; text-align: justify"><FONT size=2 face="Times New Roman">d. The payment into escrow of the Fee and Expense Amount in accordance with &#182;&#182;4.2 and 4.3; and</FONT></P>

<P STYLE="text-indent: 30pt; text-align: justify"><FONT size=2 face="Times New Roman">e. The passing of the date upon which the Judgment becomes Final.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 23 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.159</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 25 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">6.2 If any of the conditions specified above in &#182;6.1 are not met, then this Stipulation shall be canceled and terminated subject to &#182;6.3, unless counsel for the Settling Parties mutually agree in writing to proceed with this Stipulation.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">6.3 If for any reason the Effective Date does not occur or the Judgment does not become Final, or if this Stipulation is canceled or terminated in accordance with its terms: (i) all Settling Parties shall be restored to their respective positions in the Action that existed immediately prior to the date of execution of this Stipulation; (ii) the Stockholders shall seek dismissal of the Action; (iii) all releases delivered in connection with this Stipulation shall be null and void; (iv) the Fee and Expense Amount shall be immediately releasable to the payor; (v) the terms and provisions of this Stipulation (other than those set forth in &#182;&#182;1.1-1.27, 6.2-6.3, and 7.3-7.4 hereof) shall have no further force or effect with respect to the Settling Parties and shall not be used in connection with the Litigation Demand, the Action, or in any other proceeding for any purpose; and (vi) all negotiations, proceedings, documents prepared, and statements made in connection herewith shall be without prejudice to the Settling Parties, shall not be deemed or construed to be an admission by a Settling Party of any act, matter, or proposition, and shall not be used in any manner for any purpose (other than to enforce the terms remaining in force) in connection with the Litigation Demand, the Action, or in any other action or proceeding.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 24 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.160</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 26 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">6.4 No order of the Court concerning the Fee and Expense Amount or the Service Awards or any interest awarded by the Court to Stockholders' Counsel, nor any modification or reversal on appeal of any such order of the Court, shall constitute grounds for cancellation or termination of the Stipulation, affect the enforceability of the Stipulation, or delay or preclude the Judgment from becoming Final.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face=TimesNewRoman>7.</FONT></B> <B><FONT size=2 face=TimesNewRoman>Miscellaneous Provisions</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.1 The Settling Parties: (a) acknowledge that it is their intent to consummate this Stipulation; and (b) agree to act in good faith and cooperate to take all reasonable and necessary steps to expeditiously implement the terms and conditions of this Stipulation to the extent reasonably necessary to effectuate and implement all terms and conditions of the Stipulation and to exercise their best efforts to accomplish the foregoing terms and conditions of the Stipulation expeditiously.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.2 The Settling Parties intend this Settlement to be a final and complete resolution of all disputes between Stockholders and BorgWarner and its stockholders, on the one hand, and the Released Persons, on the other hand, arising out of, based upon, or related to the Released Claims. The Settlement compromises claims that are contested and shall not be deemed an admission by any Settling Party or Released Person as to the merits of any claim, allegation, or defense. The Judgment shall contain a finding that (a) the Individual Defendants and BorgWarner agree that the Litigation Demand and Derivative Actions were served and/or filed in good faith and were not frivolous, and that the Litigation Demand, Action, and the Released Claims are being settled voluntarily by the Defendants; and (b) the Settling Parties agree that, throughout the course of the litigation, all parties and their counsel complied with the provisions of Federal Rule of Civil Procedure 11. No Settling Party or Related Person of a Settling Party shall assert any claims for violation of Rule 11 of the Federal Rules of Civil Procedure or any other similar laws relating to the institution, prosecution, defense, and/or settlement of the Litigation Demand or Derivative Actions. The Settling Parties agree that the Released Claims are being settled voluntarily after consultation with legal counsel who could assess the strengths and weaknesses of their respective clients' claims or defenses.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 25 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.161</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 27 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.3 None of the Settlement, this Stipulation (including any exhibits attached hereto), or any act performed or document executed pursuant to, or in furtherance of, the Stipulation or the Settlement: (i) is, may be deemed to be, or may be offered, attempted to be offered, or used in any way as a concession, admission, or evidence of the validity of any Released Claims, or of any fault, wrongdoing, or liability of the Released Persons or BorgWarner; or (ii) is, may be deemed to be, or may be used as a presumption, admission, or evidence of, any liability, fault, or omission of any of the Released Persons in any civil, criminal, administrative, or other proceeding in any court, administrative agency, tribunal, or other forum. Neither this Stipulation nor the Settlement shall be admissible in any proceeding for any purpose, except to enforce the terms of the Settlement, and except that the Released Persons may file or use the Stipulation and/or the Judgment in any action that may be brought against them in order to support a defense or counterclaim based on principles of res judicata, collateral estoppel, full faith and credit, release, good faith settlement, standing, judgment bar or reduction, or any other theory of claim preclusion or issue preclusion, or similar defense or counterclaim.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 26 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.162</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 28 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.4 All designations and agreements made and orders entered during the course of the Litigation Demand and Derivative Actions relating to the confidentiality of documents or information shall survive this Settlement.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.5 Within thirty (30) days of the Effective Date, Stockholders shall each certify that they have destroyed or returned any documents obtained from Defendants that were marked Confidential in connection with the Litigation Demand or Derivative Actions. However, Stockholders' Counsel may each retain a file copy of any court filings and any confidential attorney work-product that attaches, cites, or refers to any such documents.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.6 All exhibits to this Stipulation are material and integral parts hereof and </FONT><FONT size=2 face="Times New Roman">are fully incorporated herein by this reference.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 27 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.163</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 29 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.7 In the event that there exists a conflict or inconsistency between the terms of this Stipulation and the terms of any exhibit hereto, the terms of this Stipulation shall prevail.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.8 This Stipulation may be amended or modified only by a written instrument signed by, or on behalf of, all Settling Parties or their respective successors-in-interest.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.9 This Stipulation shall be deemed drafted equally by all parties hereto.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.10 This Stipulation and the exhibits attached hereto constitute the entire agreement among the Settling Parties and no representations, warranties, or inducements have been made to any Settling Party concerning the Stipulation and/or any of its exhibits, other than the representations, warranties, and covenants contained and memorialized in such documents.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.11 The Stipulation supersedes and replaces any prior or contemporaneous writing, statement, or understanding pertaining to the Settlement of the Litigation Demand and Derivative Actions.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.12 Defendants confirm receipt of confirmation that each of the Stockholders has owned stock in BorgWarner during all relevant periods described in the Litigation Demand and Derivative Actions, that they continue to own such stock as of the date of this Stipulation, and that they have standing to pursue the claims they have asserted in each of the Litigation Demand and Derivative Actions.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 28 -</FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<!-- PART 05 -->

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.164</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 30 of 85</FONT></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.13 It is understood by the Settling Parties that, except for matters expressly represented herein, the facts or law with respect to which this Stipulation is entered into may turn out to be other than, or different from, the facts or law now known to each party or believed by such party to be true; each party therefore expressly assumes the risk of facts or law turning out to be different and agrees that this Stipulation shall be in all respects effective, and not subject to termination by reason of any such different facts or law.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.14 Except as otherwise expressly provided herein, all parties, including all Individual Defendants, BorgWarner, Defendants' Counsel, Stockholders, and Stockholders' Counsel, shall bear their own fees, costs, and expenses.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.15 Counsel for the Settling Parties are expressly authorized by their respective clients to take all appropriate actions required or permitted to be taken pursuant to the Stipulation to effectuate its terms and conditions.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.16 Stockholders represent and warrant they have not assigned or transferred, or attempted to assign or transfer, to any Person any Released Claim or any portion thereof or interest therein.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.17 Each counsel or other Person executing this Stipulation or any of its exhibits on behalf of any party hereto hereby warrants that such Person has the full authority to do so.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 29 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.165</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 31 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.18 This Stipulation shall be binding upon, and inure to the benefit of, the Settling Parties and the Released Persons, and their respective successors, assigns, heirs, spouses, marital communities, executors, administrators, trustees in bankruptcy, and legal representatives, and any corporation or other entity into or with which any Settling Party merges, consolidates, or reorganizes.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.19 Any failure by any party to this Stipulation to insist upon the strict performance by any other party of any of the provisions of the Stipulation shall not be deemed a waiver of any of the provisions, and such party, notwithstanding such failure, shall have the right thereafter to insist upon the strict performance of any and all of the provisions of the Stipulation to be performed by such other party.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.20 The Stipulation and the exhibits attached hereto may be executed in one or more counterparts. A facsimile or PDF signature shall be deemed an original signature for purposes of this Stipulation. All executed counterparts, including facsimile and/or PDF counterparts, shall be deemed to be one and the same instrument. A complete set of counterparts, either originally executed or copies thereof, shall be filed with the Court.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.21 Without affecting the finality of the Judgment entered in accordance with this Stipulation, the Court shall retain jurisdiction with respect to interpretation, implementation, and enforcement of the terms of the Stipulation and the Judgment, and the Settling Parties hereto submit to the jurisdiction of the Court for purposes of implementing and enforcing the Settlement embodied in the Stipulation, and the Judgment, and for matters arising out of, concerning, or relating thereto.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 30 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.166</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 32 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.22 This Stipulation and the exhibits attached hereto shall be governed by, construed, performed, and enforced in accordance with the laws of the State of Delaware, without regard to any state's principles, policies, or provisions governing choice of law. The Settling Parties agree that the Settlement, and all matters relating to its enforcement, will be subject to the continuing jurisdiction of the Court.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.23 The headings herein are used for the purpose of convenience only and </FONT><FONT size=2 face="Times New Roman">are not meant to have legal effect.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.24 Nothing in this Stipulation, or the negotiations relating thereto, is intended to or shall be deemed to constitute a waiver of any applicable privilege or immunity, including, without limitation, the attorney-client privilege, the joint defense privilege, or work product protection.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.25 Without further order of the Court, the Settling Parties may agree to </FONT><FONT size=2 face="Times New Roman">reasonable extensions of time to carry out any of the provisions of this Stipulation.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7.26 The Settling Parties and their counsel respectively agree not to issue any disparaging statements about the other Settling Parties to this Agreement or their Related Persons.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">IN WITNESS WHEREOF, the Settling Parties have caused this Stipulation </FONT><FONT size=2 face="Times New Roman">to be executed by their duly authorized attorneys.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 31 -</FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.167</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 33 of 85</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Dated: May 19, 2022</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="line-height: normal; border-collapse: collapse; width: 100%">



<TR vAlign=bottom>

   <TD STYLE="width: 25%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">KAHN SWICK &amp; FOTI, LLC</FONT></TD>

   <TD STYLE="width: 15%; white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD STYLE="width: 35%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">SIMPSON THACHER</FONT></TD>
    <TD STYLE="width: 25%">&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="padding-left: 15pt; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">&amp; BARTLETT LLP</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><img src="bwa4082911-ex9915x4x1.jpg" border=0></TD>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD STYLE="white-space: nowrap; text-align: left"><img src="bwa4082911-ex9915x4x3.jpg" border=0></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="border-top: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Melinda A. Nicholson</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="border-top: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Jonathan Youngwood</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">1100 Poydras Street, Suite 3200</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">425 Lexington Avenue</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">New Orleans, LA 70163</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">New York, NY 10017</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">
   <FONT size=2 face="Times New Roman">melinda.nicholson@ksfcounsel.com</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left">
   <FONT size=2 face="Times New Roman">jyoungwood@stblaw.com</FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"><B><i>Attorneys for Don David Price</I></B></FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"><B><i>Attorneys for Defendants</i></B></FONT></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">ROBBINS LLP</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>
    <TD>&nbsp;</TD></TR>

<TR STYLE="vertical-align: bottom">
   <TD STYLE="white-space: nowrap; text-align: left"><img src="bwa4082911-ex9915x4x2.jpg" border=0></TD>
   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
   <TD STYLE="white-space: nowrap; text-align: left"></TD>
    <TD>&nbsp;</TD></TR>
<TR vAlign=bottom>

   <TD STYLE="border-top: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Ashley R. Rifkin</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">5040 Shoreham Place</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">San Diego, CA 92122</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">
   <FONT size=2 face="Times New Roman">arifkin@robbinsllp.com</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD colspan="2" STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"><B><i>Attorneys for Maria Nyiradi and Peter Wahler</i></B></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD>
    <TD>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>
    <TD>&nbsp;</TD></TR></TABLE>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 32 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.168</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 34  of 85</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">EXHIBIT A</FONT></B></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>


<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.169</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 35 of 85</FONT></TD></TR></TABLE>

<P style="TEXT-ALIGN: center"><B><U><FONT size=2 face="Times New Roman">PROPOSED CORPORATE GOVERNANCE MODIFICATIONS</FONT></U></B></P>

<P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman">The corporate governance reforms described herein shall remain in effect for a period of not less </FONT><FONT size=2 face="Times New Roman">than four (4) years following the Effective Date (&#8220;Implementation Period&#8221;). The Company may </FONT><FONT size=2 face="Times New Roman">amend or eliminate any one or more of the corporate governance reforms during the Implementation Period if the Board determines in a good faith exercise of its business judgment </FONT><FONT size=2 face="Times New Roman">that a policy, procedure, control, or agreement term is not in the Company&#8217;s best interest or </FONT><FONT size=2 face="Times New Roman">conflicts with any provision of any applicable law, including without limitation, the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, or any rules or regulations promulgated thereunder. If a corporate governance provision is eliminated or modified, the Board shall within sixty (60) </FONT><FONT size=2 face="Times New Roman">business days or at the Board&#8217;s next regularly </FONT><FONT size=2 face="Times New Roman">scheduled meeting, adopt a replacement provision that accomplishes substantially the same objective; provided, however, that no such replacement provision need be adopted if, in the reasonabl</FONT><FONT size=2 face="Times New Roman">e good faith business judgment of a majority of the Board&#8217;s independent directors, it is </FONT><FONT size=2 face="Times New Roman">not reasonably possible to do so in a manner consistent with the law, the best interests of the Company or otherwise. Any changes deemed material to the Company that are made pursuant to </FONT><FONT size=2 face="Times New Roman">the above shall be reported on an annual basis either in the Company&#8217;s SEC Form 10</FONT><FONT size=2 face="Times New Roman">-K, SEC </FONT><FONT size=2 face="Times New Roman">Form 14(a) Proxy Statement, or posted on the Company&#8217;s website.</FONT></P>

<P style="TEXT-ALIGN: justify"><B><U><FONT size=2 face="Times New Roman">Disclosure Committee Reforms</FONT></U></B></P>

<P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman">The Disclosure Committee Charter will be amended to include the following:</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman">1.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">&#8220;</FONT><FONT size=2 face="Times New Roman">Any </FONT><FONT size=2 face="Times New Roman">changes to the Disclosure Committee&#8217;s Charter must be approved by the Certifying Officers or their designee(s), which may be the Company&#8217;s Policy Committee.&#8221;</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman">2.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">&#8220;Additional committee members may be appointed and/or removed by the </FONT><FONT size=2 face="Times New Roman">CEO and/or CFO (the &#8220;Certifying Officers&#8221;) or their designee(s) at any time.&#8221;</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman">3.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">&#8220;One member of the Disclosure Committee will be designated the Committee&#8217;s Chairperson by the Certifying Officers. The Chairperson shall schedule and preside over meetings and ensure the timely preparation of agendas for meetings. Any interpretation of the Charter or the Disclosure Committee&#8217;s procedures shall be made by the Disclosure Committee Chairperson.&#8221;</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman">4.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">&#8220;</FONT><FONT size=2 face="Times New Roman">The Chairperson or the Disclosure Committee may retain outside consultants or advisors, including independent auditors, and other personnel of the Company as appropriate.&#8221;</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman">5.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">&#8220;A designee of the Disclosure Committee will report at least quarterly to the Audit Committee of the Board or the Chair of the Audit Committee. Such reports shall include, among other things, any material updates regarding: (i) the Company&#8217;s compliance with respect to reporting requirements and standards under the FASB ASC, GAAP, and Exchange Act; and (ii) material changes, trends, and statistics of the actual and potential liabilities of the Company.&#8221;</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">1</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.170</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 36 of 85</FONT></TD></TR></TABLE>


<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR STYLE="vertical-align: bottom">
   <TD STYLE="padding-right: 8pt; vertical-align: top; text-align: left"></TD>
   <TD STYLE="vertical-align: top; text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman">6.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">The responsibilities of the Disclos</FONT><FONT size=2 face="Times New Roman">ure Committee will include: &#8220;</FONT><FONT size=2 face="Times New Roman">Providing a sub-certification to the Certifying Officers before filing each SEC Periodic Report as to (i) the Disclosure Committee&#8217;s compliance with the Company&#8217;s Disclosure Policy and this Charter, and (ii) the Disclosure Committee&#8217;s conclusions resulting from its evaluation of the effectiveness of the Disclosure Controls.&#8221;</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman">7.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">The Disclosure Committee is also responsible for</FONT><FONT size=2 face="Times New Roman">: &#8220;</FONT><FONT size=2 face="Times New Roman">Ensuring the timely and accurate public disclosure of material information concerning, among other things: (i) the Company&#8217;s compliance with respect to reporting requirements and standards under the FASB ASC, GAAP, and Exchange Act; and (ii) material changes, trends, and statistics of the actual and potential liabilities of the Company.&#8221;</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: justify"><B><U><FONT size=2 face="Times New Roman">Chief Compliance Officer Reforms</FONT></U></B></P>

<P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman">The Company shall adopt and memorialize in a job description for the CCO the following:</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman">1.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">The responsibilitie</FONT><FONT size=2 face="Times New Roman">s of the CCO shall include,</FONT> <FONT size=2 face="Times New Roman">&#8220;managing and overseeing the Company&#8217;s ethics and compliance program, and assisting the Governance Committee, Audit Committee and the Board in fulfilling their oversight duties regarding the Company&#8217;s compliance with applicable laws and regulations.&#8221;</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman">2.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">The responsibilitie</FONT><FONT size=2 face="Times New Roman">s of the CCO shall include,</FONT> <FONT size=2 face="Times New Roman">&#8220;o</FONT><FONT size=2 face="Times New Roman">verseeing employee training in risk assessment and compliance.&#8221;</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman">3.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">The responsibilities of the CCO shall include,</FONT> <FONT size=2 face="Times New Roman">&#8220;</FONT><FONT size=2 face="Times New Roman">timely reporting material risks relating to compliance issues to the Governance Committee, the Audit Committee or the Chairs of those Committees and making written recommendations for further evaluation and/or remedial action within deadlines established by the Governance Committee or the Audit Committee.&#8221;</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman">4.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">The responsibilities of the CCO shall include,</FONT> <FONT size=2 face="Times New Roman">&#8220;</FONT><FONT size=2 face="Times New Roman">communicating with and informing the Audit Committee, Governance Committee or the Chairs of those Committees at least twice per year and the entire Board at least annually regarding the Company&#8217;s ethics and compliance program, as well as progress toward meeting program goals, and where necessary recommending remedial action within the Committee and/or the Board&#8217;s purview.&#8221;</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: justify"><B><U><FONT size=2 face="Times New Roman">Employee Compliance Training Reforms</FONT></U></B></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: right; padding-right: 8pt"><FONT size=2 face="Times New Roman">1.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">&#8220;The Company shall mandate a Compliance Management Progra</FONT><FONT size=2 face="Times New Roman">m to be headed by the CCO.&#8221;</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: right; padding-right: 8pt"><FONT size=2 face="Times New Roman">2.</FONT></TD>

   <TD VALIGN="TOP" WIDTH="99%" ALIGN="LEFT" STYLE="text-align: justify"><FONT size=2 face="Times New Roman">&#8220;Appropriate employee training shall be conducted annually.&#8221;</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: justify"><B><U><FONT size=2 face="Times New Roman">Insider Trading Policy Reforms</FONT></U></B></P>

<P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman">The Insider Trading Policy will be amended to include the following:</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman">1.</FONT></TD>

   <TD STYLE="width: 99%; text-align: left; vertical-align: top; text-align: justify"><FONT size=2 face="Times New Roman">&#8220;</FONT><FONT size=2 face="Times New Roman">The
   Insider Trading Policy will be disseminated annually</FONT> <FONT size=2 face="Times New Roman">to all applicable</FONT> <FONT size=2 face="Times New Roman">BWA
   employees (including non-employee directors).&rdquo;</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">2</FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<!-- PART 06 -->
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.171</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 37 of 85</FONT></TD></TR></TABLE>

<BR>

<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="border-collapse: collapse; width: 100%">

<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; width: 1%; white-space: nowrap"><FONT size=2 face="Times New Roman">2.</FONT></TD>

   <TD STYLE="width: 99%">

   <P align=justify><FONT size=2 face="Times New Roman">&#8220;The CCO in conjunction with the General Counsel, will </FONT><FONT size=2 face="Times New Roman">conduct a periodic review as necessary to ensure that the Insider Trading Policy is amended as necessary to remain up-to-date with insider trading laws and regulati</FONT><FONT size=2 face="Times New Roman">ons.&#8221;</FONT></P></TD></TR>

<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; white-space: nowrap"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD>

   <P align=justify><FONT size=2 face="Times New Roman">&nbsp;</FONT></P></TD></TR>

<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; white-space: nowrap"><FONT size=2 face="Times New Roman">3.</FONT></TD>

   <TD>

   <P align=justify><FONT size=2 face="Times New Roman">The prohibition on trading (or Blackout period) will begin no later than the fifteenth (15<SUP>th</SUP>) day of the last month of each quarter.</FONT></P></TD></TR>

<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; white-space: nowrap"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD>

   <P align=justify><FONT size=2 face="Times New Roman">&nbsp;</FONT></P></TD></TR>

<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; white-space: nowrap"><FONT size=2 face="Times New Roman">4.</FONT></TD>

   <TD>

   <P align=justify><FONT size=2 face="Times New Roman">The Company will adopt separate guidelines governing 10b5-1 plan administration which shall include, but not be limi</FONT><FONT size=2 face="Times New Roman">ted to, requirements that &#8220;a</FONT><FONT size=2 face="Times New Roman">ny proposed Rule 10b5-1 plan or any amendments made to an approved Rule 10b5-1 plan be: (i) approved by the General Counsel at least forty-five (45) days in advance of any trades thereunder; and (ii) submitted to the CCO fo</FONT><FONT size=2 face="Times New Roman">r review when no blackout period is in effect.&#8221;</FONT></P></TD></TR>

<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; white-space: nowrap"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD>

   <P align=justify><FONT size=2 face="Times New Roman">&nbsp;</FONT></P></TD></TR>

<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; white-space: nowrap"><FONT size=2 face="Times New Roman">5.</FONT></TD>

   <TD>

   <P align=justify><FONT size=2 face="Times New Roman">&#8220;The CCO shall maintain a record of all complaints, including, but not limited to: (i) </FONT><FONT size=2 face="Times New Roman">substance of complaint; (ii) date of receipt of the complaint; (iii) actions taken to investigate the complaint and the dates on which such actions were taken; (iv) recommendations made in response to the complaint and the date such recommendations were made; and (v) outcome of the investigation into the complaint and the date such determination was made (collectively, the &#8216;CCO&#8217;s Log&#8217;).&#8221;</FONT></P></TD></TR>

<TR>

   <TD STYLE="padding-right: 8pt"></TD>

   <TD>

   <P align=justify>&nbsp;</P></TD></TR>

<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; white-space: nowrap"><FONT size=2 face="Times New Roman">6.</FONT></TD>

   <TD>

   <P align=justify><FONT size=2 face="Times New Roman">&#8220;The Company will not take any inappropriate retaliatory action against any BorgWarner </FONT><FONT size=2 face="Times New Roman">employee with respect to good faith reporting of complaints relating to or arising out of the Policy.&#8221;</FONT></P></TD></TR>

<TR>

   <TD STYLE="padding-right: 8pt"></TD>

   <TD>

   <P align=justify>&nbsp;</P></TD></TR>

<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; white-space: nowrap"><FONT size=2 face="Times New Roman">7.</FONT></TD>

   <TD>

   <P align=justify><FONT size=2 face="Times New Roman">&#8220;Copies of complaints and the CCO&#8217;s Log will be main</FONT><FONT size=2 face="Times New Roman">tained for seven (7) years from the </FONT><FONT size=2 face="Times New Roman">date made.&#8221;</FONT></P></TD></TR>

<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; white-space: nowrap"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD>

   <P align=justify><FONT size=2 face="Times New Roman">&nbsp;</FONT></P></TD></TR>

<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; white-space: nowrap"><FONT size=2 face="Times New Roman">8.</FONT></TD>

   <TD>

   <P align=justify><FONT size=2 face="Times New Roman">&#8220;The Insider Trading Policy shall continue to be published on the Investor Relations section of the Company&#8217;s website</FONT><FONT size=2 face="Times New Roman">,</FONT><FONT size=2 face="Times New Roman">&#8221; and &#8220;the Company will publish the most recent Insider Trading </FONT><FONT size=2 face="Times New Roman">Policy within a reasonable </FONT><FONT size=2 face="Times New Roman">time after any changes are adopted.&#8221;</FONT></P></TD></TR></TABLE>

<P style="TEXT-ALIGN: justify"><B><U><FONT size=2 face="Times New Roman">Enhanced Board Oversight of Stock Repurchases</FONT></U></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="border-collapse: collapse; width: 100%">



<TR>

   <TD STYLE="vertical-align: top; width: 1%; white-space: nowrap; padding-right: 8pt"><FONT size=2 face="Times New Roman">1.</FONT></TD>

   <TD STYLE="width: 99%">

   <P align=justify><FONT size=2 face="Times New Roman">The Company shall implement a procedure for approving and overseeing stock repurchases, which shall include the following measure:</FONT></P></TD></TR>

<TR>

   <TD STYLE="vertical-align: top; white-space: nowrap; padding-right: 8pt"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD>

   <P align=justify><FONT size=2 face="Times New Roman">&nbsp;</FONT></P></TD></TR>

<TR>

   <TD STYLE="vertical-align: top; white-space: nowrap; padding-right: 8pt"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="padding-left: 15pt">

   <P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman">Before authorizing any program to re purchase BorgWarner stock, the Board shall </FONT><FONT size=2 face="Times New Roman">evaluate management&#8217;s recommendation and determine independently whether such a </FONT><FONT size=2 face="Times New Roman">repurchase program is in the best interests of the Company. Following authorization of a stock repurchase program, the Audit Committee shall quarterly evaluate the program to </FONT><FONT size=2 face="Times New Roman">confirm that the program remains in the Company&#8217;s best interest.</FONT></P></TD></TR></TABLE>

<P style="TEXT-ALIGN: justify"><B><U><FONT size=2 face="Times New Roman">Enhanced Director Training and Continuing Education</FONT></U></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="border-collapse: collapse; width: 100%">



<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; width: 1%; white-space: nowrap"><FONT size=2 face="Times New Roman">1.</FONT></TD>

   <TD STYLE="width: 99%">

   <P align=justify><FONT size=2 face="Times New Roman">The Company will update Paragraph 21 of the Corporate Governance Guidelines as indicated with additions in bold and with strike outs as applicable:</FONT></P></TD></TR>


</TABLE>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">3</FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.172</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 38 of 85</FONT></TD></TR></TABLE>

<BR>

<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="border-collapse: collapse; width: 100%">





<TR>

   <TD STYLE="padding-right: 8pt; vertical-align: top; white-space: nowrap; width: 1%"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;</FONT></TD>

   <TD STYLE="padding-left: 15pt; width: 99%">



   <P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman">An orientation presentation is provided to each new director to acquaint new directors with the business, to familiarize them with finance, audit and human resources, compliance and other policies, and to acquaint them with other issues relevant to directors. On a periodic</FONT><B><FONT size=2 face="Times New Roman">, but no less than annual, </FONT></B><FONT size=2 face="Times New Roman">basis, continuing education is provided on relevant topics </FONT><B><FONT size=2 face="Times New Roman">which may include, for example, education or training regarding Cybersecurity, GAAP, revenue recognition, corporate governance principles and best practices, SOX, assessment of risk, compliance auditing, and reporting requirements for publicly-traded companies</FONT></B><FONT size=2 face="Times New Roman">, at Board </FONT><FONT size=2 face="Times New Roman">meetings. At a director&#8217;s </FONT><FONT size=2 face="Times New Roman">discretion, he or she may, with Corporate Governance Committee approval, attend certified continuing education programs </FONT><B><STRIKE><FONT size=2 face="Times New Roman">at the Company&#8217;s expense</FONT></STRIKE></B><B><FONT size=2 face="Times New Roman">. The Company shall pay the reasonable costs of such programs up to an amount of at least $15,000 per program for each Director.</FONT></B></P></TD></TR></TABLE>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">4</FONT></P>
<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.173</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 39 of 85</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">EXHIBIT B</FONT></B></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.174</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 40 of 85</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">IN THE UNITED STATES DISTRICT COURT<BR></FONT></B><B><FONT size=2 face="Times New Roman">FOR THE EASTERN DISTRICT OF MICHIGAN</FONT></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="border-collapse: collapse; width: 100%">



<TR vAlign=bottom>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">DON DAVID PRICE, MARIA</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; width: 1%; white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>



   <TD STYLE="width: 49%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Case No.</FONT></TD></TR>


<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">NYIRADI and PETER WAHLER</FONT><FONT size=2 face="Times New Roman">,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Derivatively on Behalf of</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">BORGWARNER INC.,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="padding-left: 200pt; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Plaintiffs,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">v.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">ALEXIS P. MICHAS, DENNIS C.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">CUNEO, MICHAEL S. HANLEY,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>


<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">JOSEPH F. FADOOL, BRADY D.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">ERICSON, AND FREDERIC B.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">LISSALDE</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; padding-left: 200pt; text-align: left"><FONT size=2 face="Times New Roman">Defendants,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">-and-</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">BORGWARNER INC., a Delaware</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Corporation,</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR>

   <TD>&nbsp;</TD>
   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD>
   </TR>

<TR>

   <TD>&nbsp;</TD>
   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD>
   </TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: right"><FONT size=2 face="Times New Roman">Nominal Defendant.</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR></TABLE>

<P style="TEXT-ALIGN: center"><B><U><FONT size=2 face="Times New Roman">[PROPOSED] PRELIMINARY APPROVAL ORDER</FONT></U></B></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.175</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 41 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Stockholders have made an unopposed motion, pursuant to Rule 23.1 of the Federal Rules of Civil Procedure, for an order: (i) preliminarily approving the proposed settlement (&#8220;Settlement&#8221;) of shareholder derivative claims, in accordance with the Stipulation of Settlement dated May 19, 2022 (the &#8220;Stipulation&#8221;); and (ii) approving the form and manner of the Notice of the Settlement.<SUP>1</SUP></FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">WHEREAS, the Stipulation sets forth the terms and conditions for the Settlement, including, but not limited to a proposed Settlement and dismissal of the above-captioned action, titled </FONT><I><FONT size=2 face="Times New Roman">Price, et al. v. Michas, et al. </FONT></I><FONT size=2 face="Times New Roman">(E.D. Mich.) (the &#8220;Action&#8221;);</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">WHEREAS, the Court having: (i) read and considered Stockholders&rsquo; Unopposed Motion for Preliminary Approval of Shareholder Derivative Settlement together with the accompanying Memorandum of Points and Authorities; (ii) read and considered the Stipulation, as well as all the exhibits attached thereto; and (iii) heard and considered arguments by counsel for the Settling Parties in favor of preliminary approval of the Settlement;</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">WHEREAS, the Court finds, upon a preliminary evaluation, that the proposed Settlement falls within the range of possible approval criteria, as it provides a beneficial result for BorgWarner Inc. (&#8220;BorgWarner&#8221;) and appears to be the product of serious, informed, non-collusive negotiations; and</FONT></P>

<div>____________________</div><BR>


<P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman"><SUP>1 </SUP>Except as otherwise expressly provided below or as the context otherwise requires, all capitalized terms contained herein shall have the same meanings and/or definitions as set forth in the Stipulation.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 1 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.176</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 42 of 85</FONT></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">WHEREAS, the Court also finds, upon a preliminary evaluation, that BorgWarner shareholders should be apprised of the Settlement through the proposed form of notice, allowed to file objections, if any, thereto, and appear at the Settlement Hearing.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">NOW, THEREFORE, IT IS HEREBY ORDERED, ADJUDGED, AND </FONT><FONT size=2 face="Times New Roman">DECREED AS FOLLOWS:</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">1. This Court, for purposes of this Preliminary Approval Order, adopts the definitions set forth in the Stipulation.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">2. This Court preliminarily approves, subject to further consideration at the Settlement Hearing described below, the Settlement as set forth in the Stipulation as being fair, reasonable, and adequate.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">3. A hearing shall be held on _______________, 2022 at ____ _.m., before the Honorable _________________, either remotely or in person, and if in person at the U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. Courthouse, 231 W. Lafayette Blvd., Room __, Detroit, Michigan 48226 (the &#8220;Settlement Hearing&#8221;), at which time the Court will determine: (i) whether the terms of the Stipulation should be approved as fair, reasonable, and adequate; (ii) whether the Notice fully satisfied the requirements of Rule 23.1 of the Federal Rule of Civil Procedure and the requirements of due process; (iii) whether all Released Claims against the Released Persons should be fully and finally released; (iv) whether the agreed-to Fee and Expense Amount should be approved; and (v) such other matters as the Court may deem appropriate.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 2 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.177</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 43  of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">4. The Court finds that the form, substance, and dissemination of information regarding the proposed Settlement in the manner set out in this Preliminary Approval Order constitute the best notice practicable under the circumstances and comply fully with Rule 23.1 of the Federal Rules of Civil Procedure and due process.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">5. Within fourteen (14) business days after the entry of this Preliminary Approval Order, BorgWarner, at its own cost, shall cause the Stipulation of Settlement and Notice to be filed with or furnished to the SEC by including a copy as an exhibit to a Current Report on Form 8-K (the &#8220;8-K&#8221;), and shall publish the Summary Notice one time in the national edition of </FONT><I><FONT size=2 face="Times New Roman">Investors&rsquo; Business Daily</FONT></I><FONT size=2 face="Times New Roman">. The 8-K and attachments shall also be posted on the Company&rsquo;s website until the Judgment becomes Final. Stockholders' Counsel, at their cost, shall also post the Stipulation of Settlement and Notice on their respective websites.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">6. At least twenty-four (24) calendar days prior to the Settlement Hearing, Defendants&rsquo; Counsel shall file with the Court an appropriate affidavit or declaration with respect to filing, publishing, and posting the Notice and Summary Notice as provided for in paragraph 5 of this Preliminary Approval Order.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 3 -</FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<!-- PART 07 -->

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.178</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page  44 of 85</FONT></TD></TR></TABLE>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times new Roman">7. All Current BorgWarner Stockholders shall be subject to and bound by the provisions of the Stipulation and the releases contained therein, and by all orders, determinations, and judgments in the Action concerning the Settlement, whether favorable or unfavorable to Current BorgWarner Stockholders.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times new Roman">8. Pending final determination of whether the Settlement should be approved, neither Stockholders nor any other Current BorgWarner Stockholders shall commence or prosecute against any of the Released Persons any action or proceeding in any court or tribunal asserting any of the Released Claims.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times new Roman">9. Any shareholder of BorgWarner common stock may appear and show cause, if he, she, or it has any reason why the Settlement embodied in the Stipulation should not be approved as fair, reasonable, and adequate, or why a judgment should or should not be entered hereon, or why the Fee and Expense Amount or Service Awards should not be awarded. However, no BorgWarner shareholder shall be heard or entitled to contest the approval of the proposed Settlement, or, if approved, the Judgment to be entered hereon, unless that BorgWarner shareholder has caused to be filed, and served on counsel as noted below, written objections stating all supporting bases and reasons for the objection, and setting forth proof of current beneficial ownership of BorgWarner stock and beneficial ownership of BorgWarner stock as of May 19, 2022, as well as documentary evidence of when such beneficial ownership of BorgWarner stock was acquired.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times new Roman">- 4 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.179</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 45 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">10. At least fourteen (14) calendar days prior to the Settlement Hearing set for _____________, 2022, any such person must file the written objection(s) and corresponding materials with the Clerk of the Court, U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. Courthouse, 231 W. Lafayette Blvd., Room 599, Detroit, Michigan 48226 and serve such materials by that date, to each of the following Settling Parties' counsel:</FONT></P>

<TABLE style="BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD width="50%" noWrap align=left><I><FONT size=2 face="Times New Roman">Counsel for Stockholders:</FONT></I></TD>

   <TD width="50%" noWrap align=left><I><FONT size=2 face="Times New Roman">Counsel for Defendants:</FONT></I></TD></TR>

<TR>

   <TD width="100%" colSpan=2>&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">Melinda A. Nicholson</FONT></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">Jonathan Youngwood</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">KAHN SWICK &amp; FOTI, LLC</FONT></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">SIMPSON THACHER</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">1100 Poydras Street, Suite 3200</FONT></TD>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">&amp; BARTLETT LLP</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">New Orleans, LA 70163</FONT></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">425 Lexington Avenue</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">Melinda.nicholson@ksfcounsel.com</FONT></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">New York, NY 10017</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">jyoungwood@stblaw.com</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">Ashley R. Rifkin</FONT></TD>

   <TD width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">ROBBINS LLP</FONT></TD>

   <TD width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">5040 Shoreham Place</FONT></TD>

   <TD width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">San Diego, CA 92122</FONT></TD>

   <TD width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">arifkin@robbinsllp.com</FONT></TD>

   <TD width="50%" noWrap align=left></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">11. Only shareholders who have filed with the Court and sent to the Settling Parties' counsel valid and timely written notices of objection will be entitled to be heard at the hearing unless the Court orders otherwise.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">12. Any Person or entity who fails to appear or object in the manner provided herein shall be deemed to have waived such objection and shall forever be foreclosed from making any objection to the fairness, reasonableness, or adequacy of the Settlement and to the Fee and Expense Amount and Service Awards, unless otherwise ordered by the Court, but shall be forever bound by the Judgment to be entered and the releases to be given as set forth in the Stipulation.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 5 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.180</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 46 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">13. Stockholders shall file their motion for final approval of the Settlement at least twenty-one (21) calendar days prior to the Settlement Hearing. If there is any objection to the Settlement, Stockholders shall file a response to the objection(s) at least seven (7) calendar days prior to the Settlement Hearing.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">14. All proceedings in the Action are stayed until further order of the Court, except as may be necessary to implement the Settlement or comply with the terms of this Stipulation.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">15. This Court may, for good cause, extend any of the deadlines set forth in this Preliminary Approval Order without further notice to BorgWarner shareholders.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">16. Neither the Stipulation nor the Settlement, nor any act performed or document executed pursuant to or in furtherance of the Stipulation or the Settlement: (i) is or may be deemed to be or may be offered, attempted to be offered or used in any way by the Settling Parties or any other Person as a presumption, a concession or an admission of, or evidence of, any fault, wrongdoing or liability of the Settling Parties or Released Persons, or of the validity of any Released Claims; or (ii) is intended by the Settling Parties to be offered or received as evidence or used by any other person in any other actions or proceedings, whether civil, criminal, or administrative, other than to enforce the terms therein.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 6 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.181</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 47 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">17. The Court reserves: (i) the right to approve the Settlement, with such modifications as may be agreed to by counsel for the Settling Parties consistent with such Settlement, without further notice to BorgWarner shareholders; and (ii) the right to continue or adjourn the Settlement Hearing from time to time or by oral announcement at the hearing or at any adjournment thereof, without further notice to BorgWarner shareholders.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face="Times New Roman">IT IS SO ORDERED.</FONT></B></P>

<TABLE style="BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD width="70%" noWrap align=left><FONT size=2 face="Times New Roman">DATED:</FONT></TD>

   <TD STYLE="width: 30%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD></TR>

<TR vAlign=bottom>

   <TD width="70%" noWrap align=left></TD>

   <TD width="30%" noWrap align=center><FONT size=2 face="Times New Roman">UNITED STATES DISTRICT JUDGE</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 7 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.182</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 48 of 85</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">EXHIBIT C</FONT></B></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.183</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 49 of 85</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">IN THE UNITED STATES DISTRICT COURT<BR></FONT></B><B><FONT size=2 face="Times New Roman">FOR THE EASTERN DISTRICT OF MICHIGAN</FONT></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="border-collapse: collapse; width: 100%">



<TR vAlign=bottom>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">DON DAVID PRICE, MARIA</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; width: 1%; white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>



   <TD STYLE="width: 49%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Case No.</FONT></TD></TR>


<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">NYIRADI and PETER WAHLER</FONT><FONT size=2 face="Times New Roman">,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Derivatively on Behalf of</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">BORGWARNER INC.,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="padding-left: 200pt; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Plaintiffs,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">v.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">ALEXIS P. MICHAS, DENNIS C.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">CUNEO, MICHAEL S. HANLEY,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>


<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">JOSEPH F. FADOOL, BRADY D.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">ERICSON, AND FREDERIC B.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">LISSALDE</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; padding-left: 200pt; text-align: left"><FONT size=2 face="Times New Roman">Defendants,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">-and-</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">BORGWARNER INC., a Delaware</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Corporation,</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR>

   <TD>&nbsp;</TD>
   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD>
   </TR>

<TR>

   <TD>&nbsp;</TD>
   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD>
   </TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: right"><FONT size=2 face="Times New Roman">Nominal Defendant.</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">NOTICE OF PENDENCY AND PROPOSED SETTLEMENT<BR></FONT></B><B><U><FONT size=2 face="Times New Roman">OF SHAREHOLDER DERIVATIVE ACTION</FONT></U></B></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.184</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 50 of 85</FONT></TD></TR></TABLE>

<BR>
<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="border-collapse: collapse; width: 100%">



<TR vAlign=bottom>

   <TD STYLE="padding-right: 5pt; vertical-align: top; width: 1%; text-align: left"><B><FONT size=2 face="Times New Roman">TO:</FONT></B></TD>


   <TD STYLE="vertical-align: top; width: 99%; text-align: justify">



   <P STYLE="text-align: justify"><B><FONT size=2 face="Times New Roman">ALL OWNERS OF THE COMMON STOCK OF BORGWARNER INC. ("BORGWARNER" OR THE "COMPANY") CURRENTLY AND AS OF MAY 19, 2022 ("CURRENT BORGWARNER STOCKHOLDERS"):</FONT></B></P>

   <P STYLE="text-align: justify"><B><FONT size=2 face="Times New Roman">THIS NOTICE RELATES TO THE PENDENCY AND PROPOSED SETTLEMENT OF SHAREHOLDER DERIVATIVE LITIGATION. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. IF YOU ARE A BORGWARNER SHAREHOLDER, THIS NOTICE CONTAINS IMPORTANT INFORMATION ABOUT YOUR RIGHTS.</FONT></B></P></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face="Times New Roman">YOU ARE HEREBY NOTIFIED</FONT></B><FONT size=2 face="Times New Roman">, pursuant to an Order of the U.S. District Court for the Eastern District of Michigan (the "Court"), that a proposed settlement has been reached by the parties to the following shareholder derivative action brought on behalf and for the benefit of BorgWarner: </FONT><I><FONT size=2 face="Times New Roman">Price, et al. v. Michas, et al.</FONT></I><FONT size=2 face="Times New Roman">, Case No. _______ (E.D. Mich.) (the "Action").<SUP>1 </SUP></FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">As explained below, a hearing will be held on _______________, 2022 at ____ _.m., before the Honorable ______________, either remotely or in person, and if in person at the U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. Courthouse, 231 W. Lafayette Blvd., Room __, Detroit, Michigan 48226 (the "Settlement Hearing"). You have an opportunity to be heard at the Settlement Hearing.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">At the Settlement Hearing, the Court will determine: (i) whether the terms of </FONT><FONT size=2 face="Times New Roman">the Stipulation should be approved as fair, reasonable, and adequate; (ii) whether the Notice fully satisfied the requirements of Rule 23.1 of the Federal Rule of Civil Procedure and the requirements of due process; (iii) whether all Released Claims against the Released Persons should be fully and finally released; (iv) whether the agreed-to Fee and Expense Amount should be approved; and (v) such other matters as the Court may deem appropriate.</FONT></P>


<DIV>____________________</DIV><BR>

<TABLE style="BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face="Times New Roman"><SUP>1</SUP></FONT></TD>

   <TD vAlign=top width="99%" align=left>



   <P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman">All capitalized terms herein have the same meanings as set forth Settling Parties' Stipulation of Settlement dated May 19, 2022 (the "Stipulation").</FONT></P></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 1 -</FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<!-- PART 08 -->

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.185</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 51 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">The terms of the settlement are set forth in the Stipulation and summarized in this Notice. If approved by the Court, the Settlement will fully resolve the Action, including the dismissal of the Action with prejudice. For a more detailed statement of the matters involved in the Action, the Settlement, and the terms discussed in this Notice, the Stipulation may be inspected at the Clerk of Court's office, U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. Courthouse, 231 W. Lafayette Blvd., Room 599, Detroit, Michigan 48226. The Stipulation is also available for viewing on the Investor Relations page of the website of BorgWarner at www._____________.com, and the website of Stockholders' Counsel at www._______________.com. For a fee, all papers filed in the Action are available at www.pacer.gov.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">This Notice is not intended to be an expression of any opinion by the Court with respect to the merits of the claims made in the Action, but is merely to advise you of the pendency and settlement of the Action.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 2 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.186</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 52 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face="Times New Roman">THERE IS NO CLAIMS PROCEDURE. </FONT></B><FONT size=2 face="Times New Roman">This case was brought to protect the interests of BorgWarner. The Settlement will result in changes to the Company's corporate governance, not in payment to individuals, and accordingly, there will be no claims procedure.</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="width: 1%; text-align: left; padding-right: 8pt"><B><FONT size=2 face=TimesNewRoman>I.</FONT></B></TD>

   <TD STYLE="width: 99%; text-align: left"><B><FONT size=2 face=TimesNewRoman>FACTUAL AND PROCEDURAL BACKGROUND</FONT></B></TD></TR></TABLE>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">The Action is brought by Stockholders solely on behalf of and for the benefit </FONT><FONT size=2 face="Times New Roman">of BorgWarner and against the Individual Defendants.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face="Times New Roman">A. Factual Allegations</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">BorgWarner is an automotive parts manufacturer. Until the 1980s, BorgWarner manufactured brake pads and clutches alleged to contain asbestos. As a result of the allegations, BorgWarner or an affiliate has been named as a defendant in multiple asbestos-related cases with varying liability (the "Asbestos Liability"). BorgWarner had an obligation to accrue or disclose estimates of the costs of asbestos-related litigation in its filings with the U.S. Securities and Exchange Commission ("SEC").</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Stockholders allege that certain of the Company's officers and directors breached their fiduciary duties by, among other things: (i) causing the Company to omit estimates of significant asbestos-related contingent liabilities from its filings with the SEC; and (ii) failing to implement adequate internal controls designed to identify and disclose such liabilities. Stockholders also allege violations of the securities laws in connection with BorgWarner's repurchase of $113 million in shares of its stock and that BorgWarner's stock price was artificially inflated as a result of the Company's failure to properly disclose the Asbestos Liability. Finally, Stockholders allege that Company insiders made illicit proceeds by selling certain shares of BorgWarner stock while in possession of inside information and while the Company's stock price was allegedly artificially inflated.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 3 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.187</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 53 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face="Times New Roman">B. Proceedings in the Related Delaware Derivative Action</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">In December 2018, stockholders Nyiradi and Wahler each sent BorgWarner an inspection demand pursuant to 8 </FONT><I><FONT size=2 face="Times New Roman">Del. C. </FONT></I><FONT size=2 face="Times New Roman">&#167;220, requesting the Company's internal books and records relating to the alleged wrongdoing. After reviewing the documents provided, Stockholders Nyiradi and Wahler filed a stockholder derivative action on behalf of BorgWarner, titled </FONT><I><FONT size=2 face="Times New Roman">Nyiradi et al. v. Michas, et al.</FONT></I><FONT size=2 face="Times New Roman">, C.A. No. 20-1700-RGA (Del.) (the "Delaware Action," together with this Action, the "Derivative Actions"). Defendants moved to dismiss the Delaware Action, and Stockholders Nyiradi and Wahler subsequently voluntarily dismissed the Delaware Action without prejudice.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face="Times New Roman">C. Litigation Demand, this Derivative Action, and Settlement Efforts</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">On January 4, 2021, Stockholder Price sent BorgWarner an inspection demand pursuant to 8 </FONT><I><FONT size=2 face="Times New Roman">Del. C. </FONT></I><FONT size=2 face="Times New Roman">&#167;220, requesting the Company's internal books and records relating to the alleged wrongdoing. After negotiations, the Company produced over 7,500 pages of internal corporate documents. On June 9, 2021, Stockholder Price sent the Company a litigation demand, requesting that the Company investigate the alleged wrongdoing and take appropriate action ("Litigation Demand").</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 4 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.188</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 54 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">While Stockholder Price was engaged in discussions with the Company and its counsel regarding the pending Litigation Demand, the Settling Parties began discussing a potential settlement of all of the derivative claims.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">On July 22, 2021, Stockholders sent the Company a joint settlement demand, which proposed a slate of corporate governance reforms designed to address the alleged wrongdoing. The Settling Parties thereafter engaged in extensive arm's-length negotiations regarding the corporate governance reforms, which included numerous phone calls and emails, and several settlement proposals and counterproposals.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">After significant arm's-length negotiations, the Settling Parties reached agreement on the substantive terms of the proposed Settlement, which were memorialized in a Memorandum of Understanding ("MOU") dated January 20, 2022.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">After signing the MOU, the Settling Parties commenced negotiations relating to the attorneys' fees and expenses to be paid to Stockholders' Counsel in recognition of the benefits to be conferred on the Company through the corporate governance reforms set forth in Exhibit A to the Stipulation ("Reforms"). After lengthy and adversarial negotiations, the Settling Parties agreed that Stockholders' Counsel would seek the agreed upon amount of $625,000 for attorneys' fees and expenses and Defendants would not oppose this application.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 5 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.189</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 55 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Thereafter, the Stockholders prepared to file the above-captioned Action, for purposes of obtaining the Court's approval of the Settlement.</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: justify; padding-right: 8pt"><B><FONT size=2 face=TimesNewRoman>II.</FONT></B></TD>

   <TD STYLE="vertical-align: top; width: 99%; text-align: justify"><B><FONT size=2 face=TimesNewRoman>STOCKHOLDERS' CLAIMS AND THE BENEFITS OF SETTLEMENT</FONT></B></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Stockholders believe that the claims asserted in the Litigation Demand and the Derivative Actions have substantial merit, and Stockholders' entry into this Stipulation and Settlement is not intended to be and shall not be construed as an admission or concession concerning the relative strength or merit of those claims. </FONT><FONT size=2 face="Times New Roman">However, Stockholders and Stockholders' Counsel recognize and acknowledge the significant risk, expense, and length of continued proceedings necessary to prosecute the derivative claims against the Individual Defendants through trial and possible appeals. Stockholders' Counsel also have taken into account the uncertain outcome and the risk of any litigation, especially in complex cases such as the Derivative Actions, as well as the difficulties and delays inherent in such litigation. Stockholders' Counsel are also mindful of the inherent problems of establishing standing in derivative litigation, and the possible defenses to the claims alleged in the Litigation Demand and Derivative Actions.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 6 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.190</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 56 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Stockholders' Counsel have conducted extensive investigation and analysis, including, </FONT><I><FONT size=2 face="Times New Roman">inter alia</FONT></I><FONT size=2 face="Times New Roman">: (i) reviewing BorgWarner's press releases, public statements, SEC filings, and securities analysts' reports and advisories about the Company; (ii) reviewing related media reports about the Company; (iii) reviewing the Company's internal books and records obtained pursuant to 8 </FONT><I><FONT size=2 face="Times New Roman">Del. Code </FONT></I><FONT size=2 face="Times New Roman">&#167;220; (iv) researching applicable law with respect to the claims alleged in the Action and potential defenses thereto; (v) preparing a litigation demand; (vi) preparing and filing derivative complaint(s); (vii) conducting damages analyses; and (viii) negotiating this Settlement with Defendants, including researching corporate governance best practices and negotiating the corporate governance reforms.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Based on Stockholders' Counsel's thorough review and analysis of the relevant facts, allegations, defenses, and controlling legal principles, Stockholders' Counsel believe that the Settlement set forth in this Stipulation is fair, reasonable, and adequate, and confers substantial benefits upon BorgWarner. Based upon Stockholders' Counsel's evaluation, Stockholders have determined that the Settlement is in the best interests of BorgWarner and have agreed to settle the Released Claims upon the terms and subject to the conditions set forth herein.</FONT></P>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 7 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.191</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 57 of 85</FONT></TD></TR></TABLE>


<BR>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="width: 1%; text-align: left; padding-right: 8pt"><B><FONT size=2 face=TimesNewRoman>III.</FONT></B></TD>

   <TD STYLE="width: 99%; text-align: left"><B><FONT size=2 face=TimesNewRoman>DEFENDANTS' DENIALS OF WRONGDOING AND LIABILITY</FONT></B></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">The Individual Defendants have denied and continue to deny each and every </FONT><FONT size=2 face="Times New Roman">one of the claims, contentions, and allegations made against them or that could have been made against them in the Litigation Demand and Derivative Actions, and expressly deny all charges of wrongdoing or liability against them. The Individual Defendants assert that they have satisfied their fiduciary duties at all relevant times, have acted in good faith and in the best interests of BorgWarner and its stockholders, have meritorious defenses to Stockholders' claims, and that judgment should be entered dismissing all claims against them with prejudice. The Individual Defendants also have denied and continue to deny, among other things, the allegations that Stockholders, BorgWarner, or its stockholders have suffered damage, or that Stockholders, BorgWarner, or its stockholders were harmed by the conduct alleged in the Litigation Demand and Derivative Actions. The Individual Defendants have thus entered into the Stipulation solely to avoid the continuing additional expense, inconvenience, and distraction of this litigation and to avoid the risks inherent in the lawsuit, and without admitting any wrongdoing or liability whatsoever.</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="width: 1%; text-align: left; padding-right: 8pt"><B><FONT size=2 face=TimesNewRoman>IV.</FONT></B></TD>

   <TD STYLE="width: 99%; text-align: left"><B><FONT size=2 face=TimesNewRoman>TERMS OF THE SETTLEMENT</FONT></B></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">The terms and conditions of the proposed Settlement are set forth in the Stipulation, which has been filed with the Court and is available for viewing on the Investor Relations page of BorgWarner's website at www.____________.com, and Stockholders' Counsel's website at www._______________.com. The following is only a summary of its terms.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 8 -</FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<!-- PART 09 -->

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.192</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 58 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">As consideration for the Settlement, BorgWarner has agreed to implement and maintain the Reforms. The Reforms shall be maintained by BorgWarner for a period of not less than four (4) years. The Company may amend or eliminate any one or more of the Reforms prior to the end of the four (4) year period if the Company's Board of Directors (the "Board") determines in a good faith exercise of its business judgment that a policy, procedure, control, or agreement term is not in the Company's best interest or conflicts with any provision of applicable law. If a Reform is eliminated or modified, the Board shall adopt a replacement provision, provided, however, that no such replacement provision need be adopted if, in the reasonable good faith business judgment of a majority of the Board's independent directors, it is not reasonably possible to do so in a manner consistent with the law, the best interests of the Company, or otherwise.</FONT></P>



<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 9 -</FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.193</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 59 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">The Reforms provide for, among other things:</FONT></P>

<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR>

   <TD style="PADDING-LEFT: 15pt; PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>

   <TD vAlign=top width="99%">



   <P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman">Amendments to the Disclosure Committee Charter, which shall now provide that, among other things: (i) "Any changes to the Disclosure Committee's Charter must be approved by the Certifying Officers or their designee(s), which may be the Company's Policy Committee," (ii) "Additional committee members may be appointed and/or removed by the CEO and/or CFO (the "Certifying Officers") or their designee(s) at any time," (iii) "One member of the Disclosure Committee will be designated the Committee's Chairperson by the Certifying Officers. The Chairperson shall schedule and preside over meetings and ensure the timely preparation of agendas for meetings. Any interpretation of the Charter or the Disclosure Committee's procedures shall be made by the Disclosure Committee Chairperson," (iv) "The Chairperson or the Disclosure Committee may retain outside consultants or advisors, including independent auditors, and other personnel of the Company as appropriate," (v) "A designee of the Disclosure Committee will report at least quarterly to the Audit Committee of the Board or the Chair of the Audit Committee. Such reports shall include, among other things, any material updates regarding: (a) the Company's compliance with respect to reporting requirements and standards under the FASB ASC, GAAP, and Exchange Act; and (b) material changes, trends, and statistics of the actual and potential liabilities of the Company," (vi) the responsibilities of the Disclosure Committee will include: "Providing a sub-certification to the Certifying Officers before filing each SEC Periodic Report as to (i) the Disclosure Committee's compliance with the Company's Disclosure Policy and this Charter, and (ii) the Disclosure Committee's conclusions resulting from its evaluation of the effectiveness of the Disclosure Controls," and (vii) the Disclosure Committee is also responsible for: "Ensuring the timely and accurate public disclosure of material information concerning, among other things: (i) the Company's compliance with respect to reporting requirements and standards under the FASB ASC, GAAP, and Exchange Act; and (ii) material changes, trends, and statistics of the actual and potential liabilities of the Company."</FONT></P></TD></TR></TABLE>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 10 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.194</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 60 of 85</FONT></TD></TR></TABLE>

<BR>

<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR>

   <TD style="PADDING-LEFT: 15pt; PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>

   <TD vAlign=top width="99%">



   <P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman"><FONT size=2 face="Times New Roman"><FONT size=2 face="Times New Roman">The adoption and memorialization in a job description that the responsibilities of the Chief Compliance Officer ("CCO"), which shall now include: (i) "managing and overseeing the Company's ethics and compliance program, and assisting the Governance Committee, Audit Committee and the Board in fulfilling their oversight duties regarding the Company's compliance with applicable laws and regulations," (ii) "overseeing employee training in risk assessment and compliance," (iii) "timely reporting material risks relating to compliance issues to the Governance Committee, the Audit Committee or the Chairs of those Committees and making written recommendations for further evaluation and/or remedial action within deadlines established by the Governance Committee or the Audit Committee," and (iv) "communicating with and informing the Audit Committee, Governance Committee or the Chairs of those Committees at least twice per year and the entire Board at least annually regarding the Company's ethics and compliance program, as well as progress toward meeting program goals, and where necessary recommending remedial action within the Committee and/or the Board's purview."</FONT></FONT></FONT></P></TD></TR>

<TR>
   <TD STYLE="padding-left: 15pt; padding-right: 8pt; vertical-align: top">&nbsp;</TD>
   <TD STYLE="vertical-align: top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR>

   <TD style="PADDING-LEFT: 15pt; PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>

   <TD vAlign=top width="99%">



   <P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman">Enhancements to the Company's Employee Compliance Training, </FONT><FONT size=2 face="Times New Roman">including that the Company shall mandate a Compliance Management Program to be headed by the CCO, and appropriate employee training shall be conducted at least annually.</FONT></P></TD></TR></TABLE>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 11 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.195</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 61 of 85</FONT></TD></TR></TABLE>

<BR>

<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR>

   <TD style="PADDING-LEFT: 15pt; PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>

   <TD vAlign=top width="99%">



   <P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman">Amendments to the Company's Insider Trading Policy, including that: (i) "The Insider Trading Policy will be disseminated annually to all applicable BWA employees (including non-employee directors)," (ii) "The CCO in conjunction with the General Counsel, will conduct a periodic review as necessary to ensure that the Insider Trading Policy is amended as necessary to remain up-to-date with insider trading laws and regulations," (iii) the prohibition on trading (or Blackout period) will begin no later than the fifteenth (15th) day of the last month of each quarter, (iv) the Company will adopt separate guidelines governing 10b5-1 plan administration which shall include, but not be limited to, requirements that "any proposed Rule 10b5-1 plan or any amendments made to an approved Rule 10b5-1 plan be: (a) approved by the General Counsel at least forty-five (45) days in advance of any trades thereunder; and (b) submitted to the CCO for review when no blackout period is in effect," (v) "The CCO shall maintain a record of all complaints, including, but not limited to: (i) substance of complaint; (ii) date of receipt of the complaint; (iii) actions taken to investigate the complaint and the dates on which such actions were taken; (iv) recommendations made in response to the complaint and the date such recommendations were made; and (v) outcome of the investigation into the complaint and the date such determination was made (collectively, the 'CCO's Log')," (vi) "The Company will not take any inappropriate retaliatory action against any BorgWarner employee with respect to good faith reporting of complaints relating to or arising out of the Policy," (vii) "Copies of complaints and the CCO's Log will be maintained for seven (7) years from the date made," and (viii) "The Insider Trading Policy shall continue to be published on the Investor Relations section of the Company's website," and "the Company will publish the most recent Insider Trading Policy within a reasonable time after any changes are adopted."</FONT></P></TD></TR></TABLE>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 12 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.196</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 62 of 85</FONT></TD></TR></TABLE>

<BR>

<TABLE style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TEXT-ALIGN: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR>

   <TD style="PADDING-LEFT: 15pt; PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>

   <TD vAlign=top width="99%">



   <P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman">Enhancements to the Board's oversight over stock repurchases by the Company's implementation of a procedure for approving and overseeing stock repurchases, which shall include the following measures: (i) before authorizing any program to repurchase BorgWarner stock, the Board shall evaluate management's recommendation and determine independently whether such a repurchase program is in the best interests of the Company, and (ii) following authorization of a stock repurchase program, the Audit Committee shall quarterly evaluate the program to confirm that the program remains in the Company's best interest.</FONT></P></TD></TR>

<TR>
   <TD STYLE="padding-left: 15pt; padding-right: 8pt; vertical-align: top">&nbsp;</TD>
   <TD STYLE="vertical-align: top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR>

   <TD style="PADDING-LEFT: 15pt; PADDING-RIGHT: 8pt" vAlign=top width="1%"><FONT style="FONT-SIZE: 9.5pt">&#9679;</FONT></TD>

   <TD vAlign=top width="99%">



   <P style="TEXT-ALIGN: justify"><FONT size=2 face="Times New Roman">Enhancements to the Company's policies regarding director training and continuing education, which shall provide that on a periodic, but no less than annual, basis, continuing education is provided on relevant topics, which may include, for example, Cybersecurity, GAAP, revenue recognition, corporate governance principles and best practices, SOX, assessment of risk, compliance auditing, and reporting requirements for publicly-traded companies, at Board meetings.</FONT></P></TD></TR></TABLE>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 13 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.197</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 63 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">This Notice provides a summary of the Reforms that BorgWarner has agreed to adopt as consideration for the Settlement. For a list of all of the Reforms, please see Exhibit A to the Stipulation.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">As set forth in the Stipulation, BorgWarner acknowledges and agrees that the Litigation Demand, the Delaware Action, and the litigation and settlement efforts were substantial and material factors in the Company's decision to implement the Reforms for the agreed term. Additionally, BorgWarner's Board, including each of its independent, non-defendant directors, in a good faith exercise of business judgment, has determined that: (i) the Reforms confer a substantial benefit upon BorgWarner and its stockholders; and (ii) the Settlement, including the Fee and Expense Amount, is, in all respects, fair, reasonable, and in the best interests of the Company and its stockholders.</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; padding-right: 8pt"><B><FONT size=2 face="Times New Roman">V.</FONT></B></TD>

   <TD width="99%" noWrap align=left><B><FONT size=2 face="Times New Roman">DISMISSAL AND RELEASES</FONT></B></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">The Settlement is conditioned upon the occurrence of certain events, which include, among other things: (i) final approval of the Settlement by the Court following notice to Current BorgWarner Stockholders and the Settlement Hearing contemplated by the Stipulation; (ii) Court entry of the Judgment, approving the Settlement and dismissing with prejudice the Action, without awarding costs to any Settling Party, except as provided in the Stipulation; (iii) payment of the Fee and Expense Amount awarded by the Court; and (iv) the passing of the date upon which the Judgment becomes Final (the "Effective Date").</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 14 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.198</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 64 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Upon the Effective Date, BorgWarner, Stockholders (acting on their own behalf and derivatively on behalf of BorgWarner), and each of the Current BorgWarner Stockholders (solely in their respective capacities as such) shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished, and discharged the Released Claims against the Released Persons and any and all claims (including Unknown Claims) arising out of, relating to, or in connection with the defense, settlement or resolution of the Litigation Demand or Derivative Actions against the Released Persons.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Upon the Effective Date, each of the Released Persons shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished, and discharged each and all of the Stockholders, Stockholders' Counsel, BorgWarner, and all of the Current BorgWarner Stockholders (solely in their respective capacities as such) from all claims (including Unknown Claims) arising out of, relating to, or in connection with the institution, prosecution, assertion, settlement, or resolution of the Litigation Demand or Derivative Actions or the Released Claims.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 15 -</FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<!-- PART 10 -->

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.199</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 65 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Nothing within these releases shall in any way impair or restrict the rights of </FONT><FONT size=2 face="Times New Roman">any Settling Party to enforce the terms of this Stipulation or the Judgment.</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="width: 1%; text-align: left; padding-right: 8pt"><B><FONT size=2 face=TimesNewRoman>VI.</FONT></B></TD>

   <TD STYLE="width: 99%; text-align: left"><B><FONT size=2 face=TimesNewRoman>STOCKHOLDERS' COUNSEL'S ATTORNEYS' FEES AND EXPENSES</FONT></B></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">After negotiating the substantive terms of the Settlement, the Settling Parties, acting by and through their respective counsel, separately negotiated the attorneys' fees and expenses the Individual Defendants would cause to be paid to Stockholders' Counsel based on the corporate governance benefits conferred upon BorgWarner by the Settlement. The Company will cause Stockholders' Counsel to be paid up to $625,000 in attorneys' fees and expenses, subject to approval by the Court (the "Fee and Expense Amount"). To date, Stockholders' Counsel has not received any payment for their services in conducting the Litigation Demand or Derivative Actions nor have counsel been reimbursed for their out-of-pocket expenses incurred. The Settling Parties believe that the sum agreed to is within the range of attorneys' fees and expenses approved by courts under similar circumstances in litigation of this type. BorgWarner shareholders are not personally liable for the payment of any award of attorneys' fees and expenses.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">The Settling Parties' agreement on the Fee and Expense Amount (i) was reached only after all other material terms of the Settlement were agreed and (ii) was reached following good-faith negotiations.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 16 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.200</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 66 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Stockholders' Counsel may apply to the Court for service awards of up to $5,000 for each of the Stockholders, only to be paid upon Court approval, and to be paid from the Fee and Expense Amount in recognition of Stockholders' participation and effort in the prosecution of the Litigation Demand and Derivative Actions. Neither BorgWarner nor any of the Individual Defendants shall be liable for any portion of any service awards.</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; padding-right: 8pt"><B><FONT size=2 face=TimesNewRoman>VII.</FONT></B></TD>

   <TD width="99%" noWrap align=left><B><FONT size=2 face=TimesNewRoman>THE SETTLEMENT HEARING</FONT></B></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">The Settlement Hearing will be held before the Honorable _____________, either remotely or in person, and if in person at the U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. Courthouse, 231 W. Lafayette Blvd., Room __, Detroit, Michigan 48226 (the "Settlement Hearing"), at which the Court will determine: (i) whether the terms of the Stipulation should be approved as fair, reasonable, and adequate; (ii) whether the Notice fully satisfied the requirements of Rule 23.1 of the Federal Rule of Civil Procedure and the requirements of due process; (iii) whether all Released Claims against the Released Persons should be fully and finally released; (iv) whether the agreed-to Fee and Expense Amount and Service Awards should be approved; and (v) such other matters as the Court may deem appropriate. The Settlement Hearing may be continued by the Court at the Settlement Hearing, or at any adjourned session thereof without further notice.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 17 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.201</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 67 of 85</FONT></TD></TR></TABLE>

<BR>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="width: 1%; text-align: left; padding-right: 8pt"><B><FONT size=2 face=TimesNewRoman>VIII.</FONT></B></TD>

   <TD STYLE="width: 99%; text-align: left"><B><FONT size=2 face=TimesNewRoman>THE RIGHT TO OBJECT AND/OR BE HEARD AT THE HEARING</FONT></B></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Any Current BorgWarner Stockholder may object and/or appear and show cause if he, she, or it has any reason why the Settlement should not be approved as fair, reasonable, and adequate, or why the Judgment should not be entered thereon, or why the amount of attorneys' fees and reimbursement of expenses should not be approved. However, unless otherwise ordered by the Court, you shall only be heard or entitled to contest the approval of the terms and conditions of the Settlement, or, if approved, the Judgment to be entered thereon approving the same, or the amount of attorneys' fees and reimbursement of expenses to Stockholders' Counsel, unless you have, </FONT><B><I><FONT size=2 face="Times New Roman">at least fourteen (14) calendar days prior to the Settlement Hearing</FONT></I></B><FONT size=2 face="Times New Roman">, filed with the Court a written notice of objection containing the following information:</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">1. Your name, legal address, and telephone number;</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">2. The case name and number (</FONT><I><FONT size=2 face="Times New Roman">Price, et al. v. Michas, et al. </FONT></I><FONT size=2 face="Times New Roman">(E.D. Mich.) Case No. _________);</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">3. Proof that you beneficially owned BorgWarner stock as of the date of the execution of the Stipulation on May 19, 2022, and continue to hold such shares;</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">4. A statement of each of each objection being made;</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">5. Notice of whether you intend to appear at the Settlement Hearing (you are not required to appear); and</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 18 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.202</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 68 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">6. Copies of any papers you intend to submit to the Court, along with the names of any witness(es) you intend to call to testify at the Settlement Hearing and the subject(s) of their testimony.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">If you wish to object to the proposed Settlement, you must file the written objection described above with the Court on or before ______, 2022. All written objections and supporting papers must be filed with the Clerk of the Court, U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. </FONT><FONT size=2 face="Times New Roman">Courthouse, 231 W. Lafayette Blvd., Room 599, Detroit, Michigan 48226, and serve </FONT><FONT size=2 face="Times New Roman">such materials by that date, to each of the following Settling Parties' counsel:</FONT></P>

<TABLE style="LINE-HEIGHT: Normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><I><FONT size=2 face="Times New Roman">Counsel for Stockholders:</FONT></I></TD>

   <TD width="1%" noWrap align=left><I><FONT size=2 face="Times New Roman"></FONT></I></TD>

   <TD width="50%" noWrap align=left><I><FONT size=2 face="Times New Roman">Counsel for Defendants:</FONT></I></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><I><FONT size=2 face="Times New Roman"></FONT></I></TD>

   <TD width="1%" noWrap align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD width="50%" noWrap align=left><I><FONT size=2 face="Times New Roman"></FONT></I></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">Melinda A. Nicholson</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">Jonathan Youngwood</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">KAHN SWICK &amp; FOTI, LLC</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">SIMPSON THACHER</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">1100 Poydras Street, Suite 3200</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="padding-left: 15pt; width: 50%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">&amp; BARTLETT LLP</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">New Orleans, LA 70163</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">425 Lexington Avenue</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">Melinda.nicholson@ksfcounsel.com</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">New York, NY 10017</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">jyoungwood@stblaw.com</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">Ashley R. Rifkin</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">ROBBINS LLP</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">5040 Shoreham Place</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">San Diego, CA 92122</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">arifkin@robbinsllp.com</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="50%" noWrap align=left></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">YOUR WRITTEN OBJECTIONS MUST BE POSTMARKED OR ON FILE WITH THE CLERK OF THE COURT NO LATER THAN ____________, 2022. Only shareholders who have filed and delivered valid and timely written notices of objection will be entitled to be heard at the Settlement Hearing unless the Court orders otherwise.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 19 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.203</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 69 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Unless otherwise ordered by the Court, any Current BorgWarner Stockholder who does not make his, her, or its objection in the manner provided herein shall be deemed to have waived such objection and shall forever be barred and foreclosed from making any objection to the fairness, reasonableness, or adequacy of the Settlement, or to otherwise be heard, and shall otherwise be bound by the Judgment to be entered and the releases to be given.</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; padding-right: 8pt"><B><FONT size=2 face=TimesNewRoman>IX.</FONT></B></TD>

   <TD width="99%" noWrap align=left><B><FONT size=2 face=TimesNewRoman>EXAMINATION OF PAPERS AND INQUIRIES</FONT></B></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">There is additional information concerning the Settlement available in the Stipulation, which is available for viewing on BorgWarner's website at www.____________.com, and on Stockholders' Counsel's website at www.____________.com. You may also inspect the Stipulation during business hours at the office of the Clerk of the Court, U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. Courthouse, 231 W. Lafayette Blvd., Room 599, Detroit, Michigan 48226. Or you may call the Stockholders' Counsel listed above from Robbins LLP or Kahn Swick &amp; Foti, LLC, for additional information concerning the settlement.</FONT></P>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">PLEASE DO NOT CONTACT THE COURT OR<BR></FONT></B><B><FONT size=2 face="Times New Roman">BORGWARNER REGARDING THIS NOTICE.</FONT></B></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 20 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.204</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 70 of 85</FONT></TD></TR></TABLE>


<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="line-height: normal; border-collapse: collapse; width: 100%">



<TR STYLE="vertical-align: bottom">
   <TD STYLE="vertical-align: top; white-space: nowrap; text-align: left"></TD>
   <TD STYLE="vertical-align: top; white-space: nowrap; text-align: left"></TD>
   <TD STYLE="vertical-align: top; white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR vAlign=bottom>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; vertical-align: top"><FONT size=2 face="Times New Roman">DATED:</FONT></TD>

   <TD STYLE="width: 58%; white-space: nowrap; text-align: left; vertical-align: top">&nbsp;</TD>

   <TD STYLE="width: 41%; white-space: nowrap; text-align: left; vertical-align: top"><FONT size=2 face="Times New Roman"></FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left; vertical-align: top"></TD>

   <TD STYLE="white-space: nowrap; text-align: left; vertical-align: top"></TD>

   <TD STYLE="vertical-align: top; text-align: justify"><FONT size=2 face="Times New Roman">BY ORDER OF THE COURT UNITED STATES DISTRICT COURT OF THE EASTERN DISTRICT OF MICHIGAN</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 21 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.205</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 71 of 85</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">EXHIBIT D</FONT></B></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.206</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 72 of 85</FONT></TD></TR></TABLE>


<!-- PART 11 -->
<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">IN THE UNITED STATES DISTRICT COURT<BR></FONT></B><B><FONT size=2 face="Times New Roman">FOR THE EASTERN DISTRICT OF MICHIGAN</FONT></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="border-collapse: collapse; width: 100%">



<TR vAlign=bottom>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">DON DAVID PRICE, MARIA</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; width: 1%; white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>



   <TD STYLE="width: 49%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Case No.</FONT></TD></TR>


<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">NYIRADI and PETER WAHLER</FONT><FONT size=2 face="Times New Roman">,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Derivatively on Behalf of</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">BORGWARNER INC.,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="padding-left: 200pt; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Plaintiffs,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">v.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">ALEXIS P. MICHAS, DENNIS C.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">CUNEO, MICHAEL S. HANLEY,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>


<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">JOSEPH F. FADOOL, BRADY D.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">ERICSON, AND FREDERIC B.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">LISSALDE</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; padding-left: 200pt; text-align: left"><FONT size=2 face="Times New Roman">Defendants,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">-and-</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">BORGWARNER INC., a Delaware</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Corporation,</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR>

   <TD>&nbsp;</TD>
   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD>
   </TR>

<TR>

   <TD>&nbsp;</TD>
   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD>
   </TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: right"><FONT size=2 face="Times New Roman">Nominal Defendant.</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">SUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT<BR></FONT></B><B><U><FONT size=2 face="Times New Roman">OF SHAREHOLDER DERIVATIVE ACTION</FONT></U></B></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.207</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 73 of 85</FONT></TD></TR></TABLE>


<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE; text-align: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR STYLE="vertical-align: bottom">
   <TD STYLE="vertical-align: top; text-align: left; padding-right: 8pt"></TD>
   <TD STYLE="vertical-align: top; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><B><FONT size=2 face="Times New Roman">TO:</FONT></B></TD>

   <TD vAlign=top width="99%" align=justify><B><FONT size=2 face="Times New Roman">ALL OWNERS OF THE COMMON STOCK OF BORGWARNER INC. ("BORGWARNER" OR THE "COMPANY") CURRENTLY AND AS OF MAY 19, 2022:</FONT></B></TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="1%" align=left></TD>

   <TD vAlign=top width="99%" align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="1%" align=justify></TD>

   <TD vAlign=top width="99%" align=justify><FONT size=2 face="Times New Roman">THIS NOTICE RELATES TO THE PENDENCY AND PROPOSED SETTLEMENT OF SHAREHOLDER DERIVATIVE LITIGATION. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. IF YOU ARE A BORGWARNER SHAREHOLDER, THIS NOTICE CONTAINS IMPORTANT INFORMATION ABOUT YOUR RIGHTS.</FONT></TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="1%" align=left></TD>

   <TD vAlign=top width="99%" align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD vAlign=top width="1%" align=left></TD>

   <TD vAlign=top width="99%" align=justify><FONT size=2 face="Times New Roman">THIS ACTION IS NOT A "CLASS ACTION." THUS, THERE IS NO COMMON FUND UPON WHICH YOU CAN MAKE A CLAIM FOR MONETARY PAYMENT. IF YOU DO NOT OBJECT TO THE TERMS&nbsp;&nbsp;OF THE PROPOSED SETTLEMENT OR THE AMOUNT OF ATTORNEYS' FEES AND EXPENSES DESCRIBED IN THIS NOTICE, YOU ARE NOT OBLIGATED TO TAKE ANY ACTION.</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">PLEASE TAKE NOTICE that the parties to the above-captioned shareholder derivative action, titled </FONT><I><FONT size=2 face="Times New Roman">Price, et al. v. Michas, et al. </FONT></I><FONT size=2 face="Times New Roman">(E.D. Mich.) (the "Action"), have reached an agreement to settle the derivative claims brought on behalf of and for the benefit of BorgWarner.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">The terms of the settlement are set forth in a Stipulation of Settlement dated May 19, 2022 (the "Stipulation").<SUP>1 </SUP>This notice should be read in conjunction with, and is qualified in its entirety by reference to, the text of the Stipulation, which has been filed with the U.S. District Court for the Eastern District of Michigan. A link to the text of the Stipulation and the full-length Notice of Pendency and Proposed Settlement of Shareholder Derivative Action may be found on the Investor Relations page of BorgWarner's website at www._______________.com, and on the website of Stockholders' Counsel at www._______________.com.</FONT></P>

<P style="TEXT-ALIGN: left">____________________</P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE; text-align: justify" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD STYLE="vertical-align: top; width: 1%; text-align: left; padding-right: 8pt"><SUP><FONT size=2 face="Times New Roman">1</FONT></SUP></TD>

   <TD vAlign=top width="99%" align=left><FONT size=2 face="Times New Roman">All capitalized terms herein have the same meanings as set forth in the Stipulation. </FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 1 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.208</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 74 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Under the terms of the Stipulation, as a part of the proposed Settlement, BorgWarner will adopt and/or implement corporate governance reforms ("Reforms"), which all parties agree confer substantial benefits upon BorgWarner. BorgWarner acknowledges and agrees that the Litigation Demand, the Delaware Action, and the litigation and settlement efforts were substantial and material factors in the Company's decision to implement the Reforms for the agreed term.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">In light of the substantial benefits conferred upon BorgWarner by Stockholders' Counsel's efforts, the Company shall cause Stockholders' Counsel to be paid $625,000 in attorney's fees and expenses, subject to Court approval.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">BorgWarner's Board, including each of its independent, non-defendant directors, in a good faith exercise of business judgment, has determined that: (i) the Reforms confer a substantial benefit upon BorgWarner and its stockholders, and the Settlement is in the best interests of the Company and its stockholders; and (ii) the Settlement, including the Fee and Expense Amount, is, in all respects, fair, reasonable, and in the best interests of the Company and its stockholders.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">A hearing will be held on _______________, 2022 at ____ _.m., before the Honorable ________________, either remotely or in person, and if in person at the U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. Courthouse, 231 W. Lafayette Blvd., Room__, Detroit, Michigan 48226 (the "Settlement Hearing"), at which the Court will determine whether to approve the settlement.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 2 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.209</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 75 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Any BorgWarner shareholder has a right, but is not required, to appear and to be heard at the Settlement Hearing providing that he, she, or it is a shareholder of record or beneficial owner of BorgWarner common stock and was a shareholder of record or beneficial owner of BorgWarner common stock as of May 19, 2022. Any BorgWarner shareholder who satisfies this requirement may enter an appearance through counsel of such shareholder's own choosing and at such shareholder's own expense, or may appear on their own. However, you shall not be heard at the Settlement Hearing unless, no later than _____, 2022, you have filed with the Court a written notice of objection containing the following information:</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">1. Your name, legal address, and telephone number;</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">2. The case name and number (</FONT><I><FONT size=2 face="Times New Roman">Price, et al. v. Michas, et al. </FONT></I><FONT size=2 face="Times New Roman">(E.D. Mich.) Case No. _________);</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">3. Proof that you beneficially owned BorgWarner stock as of the date of the execution of the Stipulation on May 19, 2022, and continue to hold such shares;</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">4. A statement of each of each objection being made;</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">5. Notice of whether you intend to appear at the Settlement Hearing (you are not required to appear); and</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 3 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.210</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 76 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">6. Copies of any papers you intend to submit to the Court, along with the names of any witness(es) you intend to call to testify at the Settlement Hearing and the subject(s) of their testimony.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">If you wish to object to the proposed Settlement, you must file written objections with the Court on or before ______, 2022. All written objections and supporting papers must be filed with the Clerk of the Court, U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. Courthouse, 231 W. </FONT><FONT size=2 face="Times New Roman">Lafayette Blvd., Room 559, Detroit, Michigan 48226, and served upon each of the </FONT><FONT size=2 face="Times New Roman">following Settling Parties' counsel:</FONT></P>

<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><I><FONT size=2 face="Times New Roman">Counsel for Stockholders:</FONT></I></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left><I><FONT size=2 face="Times New Roman">Counsel for Defendants:</FONT></I></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><I></I></TD>

   <TD width="1%" noWrap align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD width="50%" noWrap align=left><I></I></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">Melinda A. Nicholson</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">Jonathan Youngwood</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">KAHN SWICK &amp; FOTI, LLC</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">SIMPSON THACHER</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">1100 Poydras Street, Suite 3200</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">&amp; BARTLETT LLP</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">New Orleans, LA 70163</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">425 Lexington Avenue</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">Melinda.nicholson@ksfcounsel.com</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">New York, NY 10017</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">jyoungwood@stblaw.com</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">Ashley R. Rifkin</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">ROBBINS LLP</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">5040 Shoreham Place</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">San Diego, CA 92122</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">arifkin@robbinsllp.com</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">YOUR WRITTEN OBJECTIONS MUST BE POSTMARKED OR ON FILE WITH THE CLERK OF THE COURT NO LATER THAN ____________, 2022. Only shareholders who have filed and delivered valid and timely written notices of objection will be entitled to be heard at the Settlement Hearing unless the Court orders otherwise. If you fail to object in the manner and within the time prescribed above you shall be deemed to have waived your right to object (including the right to appeal) and shall forever be barred, in this proceeding or in any other proceeding, from raising such objection(s).</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 4 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.211</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 77 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Inquiries may be made to the Stockholders' Counsel at Robbins LLP or Kahn, </FONT><FONT size=2 face="Times New Roman">Swick &amp; Foti, LLC, as listed above.</FONT></P>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">PLEASE DO NOT CONTACT THE COURT OR<BR></FONT></B><B><FONT size=2 face="Times New Roman">BORGWARNER REGARDING THIS NOTICE</FONT></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="line-height: normal; border-collapse: collapse; width: 100%">



<TR vAlign=bottom>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">DATED:</FONT></TD>

   <TD STYLE="width: 58%; white-space: nowrap; text-align: left"></TD>

   <TD STYLE="width: 41%; white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="vertical-align: top; text-align: justify"><FONT size=2 face="Times New Roman">BY ORDER OF THE COURT UNITED STATES DISTRICT COURT OF THE EASTERN DISTRICT OF MICHIGAN</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 5 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.212</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 78 of 85</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">EXHIBIT E</FONT></B></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>
<!-- PART 12 -->

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.213</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 79 of 85</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">IN THE UNITED STATES DISTRICT COURT<BR></FONT></B><B><FONT size=2 face="Times New Roman">FOR THE EASTERN DISTRICT OF MICHIGAN</FONT></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="border-collapse: collapse; width: 100%">



<TR vAlign=bottom>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">DON DAVID PRICE, MARIA</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; width: 1%; white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>



   <TD STYLE="width: 49%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Case No.</FONT></TD></TR>


<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">NYIRADI and PETER WAHLER</FONT><FONT size=2 face="Times New Roman">,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Derivatively on Behalf of</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">BORGWARNER INC.,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="padding-left: 200pt; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Plaintiffs,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">v.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">ALEXIS P. MICHAS, DENNIS C.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">CUNEO, MICHAEL S. HANLEY,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>


<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">JOSEPH F. FADOOL, BRADY D.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">ERICSON, AND FREDERIC B.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">LISSALDE</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; padding-left: 200pt; text-align: left"><FONT size=2 face="Times New Roman">Defendants,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">-and-</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">BORGWARNER INC., a Delaware</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Corporation,</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR>

   <TD>&nbsp;</TD>
   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD>
   </TR>

<TR>

   <TD>&nbsp;</TD>
   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD>
   </TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: right"><FONT size=2 face="Times New Roman">Nominal Defendant.</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR></TABLE>

<P style="TEXT-ALIGN: center"><B><U><FONT size=2 face="Times New Roman">[PROPOSED] ORDER AND FINAL JUDGEMENT</FONT></U></B></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.214</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 80 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">This matter came before the Court for hearing on ____________, 2022, to consider approval of the proposed settlement ("Settlement") set forth in the Stipulation of Settlement dated May 19, 2022, and the exhibits thereto (the "Stipulation"). The Court has reviewed and considered all documents, evidence, objections (if any), and arguments presented in support of or against the Settlement. Good cause appearing therefore, the Court enters this Judgment.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">IT IS HEREBY ORDERED, ADJUDGED, AND DECREED that:</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">1. This Final Judgment incorporates and makes a part hereof: (a) the Stipulation; (b) the Notice; and (c) the Preliminary Approval Order.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">2. All capitalized terms used herein shall have the same meanings as set forth in the Stipulation.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">3. This Court has jurisdiction over the subject matter of the Action, including all matters necessary to effectuate the Settlement, and over all Settling Parties to the Action.</FONT></P>
<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">4. The Court finds that the Notice provided to BorgWarner Inc. shareholders constituted the best notice practicable under the circumstances. The Notice fully satisfied the requirements of Rule 23.1 of the Federal Rules of Civil Procedure and the requirements of due process.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">5. The Court hereby approves the Settlement set forth in the Stipulation and finds that the Settlement is, in all respects, fair, reasonable, and adequate to each of the Settling Parties, and further finds that the Settlement is in the best interests of BorgWarner and its shareholders.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 1 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.215</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 81 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">6. The Action and all claims contained therein, as well as all of the Released Claims against Released Persons, are dismissed with prejudice. The Settling Parties are to bear their own costs, except as otherwise provided below.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">7. Upon the Effective Date, BorgWarner, Stockholders (acting on their own behalf and derivatively on behalf of BorgWarner), and each of the Current BorgWarner Stockholders (solely in their capacity as such) shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished, and discharged the Released Claims against the Released Persons and any and all claims (including Unknown Claims) arising out of, relating to, or in connection with the defense, settlement, or resolution of the Litigation Demand or Derivative Actions against the Released Persons, provided that nothing herein shall in any way impair or restrict the rights of any of the Settling Parties to enforce the terms of the Stipulation or the Judgment.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">8. Upon the Effective Date, each of the Released Persons shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished, and discharged each and all of the Stockholders, Stockholders' Counsel, BorgWarner, and all of the Current BorgWarner Stockholders (solely in their capacity as such) from all claims (including Unknown Claims) arising out of, relating to, or in connection with the institution, prosecution, assertion, settlement, or resolution of the Litigation Demand or Derivative Actions or the Released Claims. Nothing herein shall in any way impair or restrict the rights of any Settling Party to enforce the terms of this Stipulation or the Judgment.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 2 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.216</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 82 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">9. During the course of the litigation, all parties and their respective counsel at all times complied with the requirements of Rule 11 of the Federal Rules of Civil Procedure, and all other similar laws or statutes.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">10. The Court hereby approves the sum of $________________ for the payment of Stockholders' Counsel's attorneys' fees and expenses in the Action ("Fee and Expense Amount"), and finds that the Fee and Expense Amount is fair and reasonable. No other fees, costs, or expenses may be awarded to Stockholders' Counsel in connection with the Settlement. The Fee and Expense Amount shall be distributed in accordance with the terms of the Stipulation.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">11. The Court hereby approves the service awards of $_________ for each of the Stockholders to be paid from Stockholders' Counsel's Fee and Expense Amount in recognition of Stockholders' participation and effort in the prosecution of the Litigation Demand and the Derivative Actions.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">12. Neither the Stipulation nor the Settlement, nor any act performed or document executed pursuant to or in furtherance of the Stipulation or the Settlement: (a) is or may be deemed to be or may be offered, attempted to be offered, or used in any way by the Settling Parties or any other Person as a presumption, a concession, or an admission of, or evidence of, any fault, wrongdoing, or liability of the Settling Parties or Released Persons, or of the validity of any Released Claims; or (b) is intended by the Settling Parties to be offered or received as evidence or used by any other person in any other actions or proceedings, whether civil, criminal, or administrative, other than to enforce the terms therein.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 3 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.217</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 83 of 85</FONT></TD></TR></TABLE>


<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">13. The Released Persons may file the Stipulation and/or the Judgment, and file or reference acts performed or documents executed pursuant to or in furtherance of the Stipulation and/or the Judgment: (i) in any action that may be brought against them in order to support a defense or counterclaim based on principles of </FONT><I><FONT size=2 face="Times New Roman">res judicata</FONT></I><FONT size=2 face="Times New Roman">, collateral estoppel, full faith and credit, release, good faith settlement, judgment bar or reduction, or any other theory of claim preclusion or issue preclusion or similar defense or counterclaim; (ii) in furtherance of the Settlement contemplated in the Stipulation; and (iii) in any action to enforce the Settlement.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">14. Without affecting the finality of this Judgment in any way, this Court hereby retains continuing jurisdiction with respect to implementation and enforcement of the terms of the Stipulation. If for any reason the Effective Date does not occur, or if the Stipulation is in any way canceled, terminated or fails to become Final in accordance with its terms, then: (a) all Settling Parties shall be restored to their respective positions in the Action that existed immediately prior to the date of execution of this Stipulation; (b) the Stockholders shall seek dismissal of the Action; (c) all releases delivered in connection with the Stipulation shall be null and void; (d) the Fee and Expense Amount paid to Stockholders' Counsel shall be refunded and returned within fifteen (15) business days; (d) the terms and provisions of this Stipulation (other than those set forth in &#182;&#182;1.1-1.27, 6.2-6.3, and 7.3-7.4) shall have no further force or effect with respect to the Settling Parties and shall not be used in connection with the Litigation Demand, the Action, or in any other proceeding for any purpose; and (e) all negotiations, proceedings, documents prepared, and statements made in connection herewith shall be without prejudice to the Settling Parties, shall not be deemed or construed to be an admission by a Settling Party of any act, matter, or proposition, and shall not be used in any manner for any purpose (other than to enforce the terms remaining in) in connection with the Litigation Demand, the Action, or in any other action or proceeding.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 4 -</FONT></P>

<HR align=center width="100%" noShade size="2">

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.218</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 84 of 85</FONT></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">15. Pursuant to Rule 23.1 of the Federal Rules of Civil Procedure, this Court hereby finally approves the Stipulation and Settlement in all respects, and orders the Settling Parties to perform its terms to the extent the Settling Parties have not already done so.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">16. This Judgment is a final judgment, and the Court finds that no just reason exists for delay in entering the Judgment in accordance with the Stipulation. Accordingly, the Clerk is hereby directed to enter this Judgment forthwith in accordance with Rule 58 of the Federal Rules of Civil Procedure.</FONT></P>
<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 5 -</FONT></P>
<HR align=center width="100%" noShade size="2">
<DIV style="PAGE-BREAK-BEFORE: always"></DIV>

<BR>
<TABLE style="LINE-HEIGHT: normal; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: left; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Case 2:22-cv-11131-LJM-JJCG</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>ECF No. 13-2, PageID.219</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: center; padding-right: 8pt"><FONT size=2 face=TimesNewRoman color=blue>Filed 06/02/22</FONT></TD>

   <TD STYLE="white-space: nowrap; width: 1%; text-align: right"><FONT size=2 face=TimesNewRoman color=blue>Page 85 of 85</FONT></TD></TR></TABLE>

<P STYLE="text-indent: 15pt; text-align: justify"><B><FONT size=2 face="Times New Roman">IT IS SO ORDERED.</FONT></B></P>

<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD width="70%" noWrap align=left><FONT size=2 face="Times New Roman">DATED:</FONT></TD>

   <TD STYLE="width: 30%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD></TR>

<TR vAlign=bottom>

   <TD width="70%" noWrap align=left></TD>

   <TD width="30%" noWrap align=center><FONT size=2 face="Times New Roman">UNITED STATES DISTRICT JUDGE</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 6 -</FONT></P>

<HR align=center width="100%" noShade size="2">
</DIV>
</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>bwa4082911-ex992.htm
<DESCRIPTION>NOTICE OF PROPOSED SETTLEMENT
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor="#ffffff">

<DIV>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">IN THE UNITED STATES DISTRICT COURT<BR></FONT></B><B><FONT size=2 face="Times New Roman">FOR THE EASTERN DISTRICT OF MICHIGAN</FONT></B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="border-collapse: collapse; width: 100%">



<TR vAlign=bottom>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">DON DAVID PRICE, MARIA</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; width: 1%; white-space: nowrap; text-align: left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>



   <TD STYLE="width: 49%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Case No. 2:22-cv-11131-LJM</FONT></TD></TR>


<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">NYIRADI and PETER WAHLER</FONT><FONT size=2 face="Times New Roman">,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Derivatively on Behalf of</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">BORGWARNER INC.,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="padding-left: 200pt; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Plaintiffs,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">v.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">ALEXIS P. MICHAS, DENNIS C.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">CUNEO, MICHAEL S. HANLEY,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>


<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">JOSEPH F. FADOOL, BRADY D.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">ERICSON, AND FREDERIC B.</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">LISSALDE</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; padding-left: 200pt; text-align: left"><FONT size=2 face="Times New Roman">Defendants,</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">-and-</FONT></TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left">&nbsp;</TD>

   <TD STYLE="border-left: Black 1pt solid; white-space: nowrap; text-align: left"></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">BORGWARNER INC., a Delaware</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Corporation,</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR>

   <TD>&nbsp;</TD>
   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD>
   </TR>

<TR>

   <TD>&nbsp;</TD>
   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD>
   </TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: right"><FONT size=2 face="Times New Roman">Nominal Defendant.</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman"></FONT></TD>



   <TD STYLE="white-space: nowrap; text-align: left"></TD></TR></TABLE>
<BR>


<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">NOTICE OF PENDENCY AND PROPOSED SETTLEMENT<BR></FONT></B><B><U><FONT size=2 face="Times New Roman">OF SHAREHOLDER DERIVATIVE ACTION</FONT></U></B></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>


<br>
<DIV>

<TABLE style="WIDTH: 100%" cellSpacing=0 cellPadding=0 border=0>



<TR>

   <TD WIDTH="1%" STYLE="text-align: left; vertical-align: top">



   <P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">TO:</FONT></B></P></TD>

   <TD WIDTH="1%" STYLE="text-align: left; vertical-align: top">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD WIDTH="98%" STYLE="text-align: justify; vertical-align: top">



   <P STYLE="text-align: justify"><B><FONT size=2 face="Times New Roman">ALL OWNERS OF THE COMMON STOCK OF BORGWARNER INC. ("BORGWARNER" OR THE "COMPANY") CURRENTLY AND AS <B><FONT size=2 face="Times New Roman">OF MAY 19, 2022 ("CURRENT BORGWARNER STOCKHOLDERS"): </FONT></B></FONT></B></P>

   <P STYLE="text-align: justify"><B><FONT size=2 face="Times New Roman"><B><FONT size=2 face="Times New Roman">THIS NOTICE RELATES TO THE PENDENCY AND PROPOSED SETTLEMENT OF SHAREHOLDER DERIVATIVE LITIGATION. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. IF YOU ARE A BORGWARNER SHAREHOLDER, THIS NOTICE CONTAINS IMPORTANT INFORMATION ABOUT YOUR RIGHTS.</FONT></B></FONT></B></P></TD></TR></TABLE></DIV>

<P STYLE="text-align: justify; text-indent: 20px"><B><FONT size=2 face="Times New Roman">YOU ARE HEREBY NOTIFIED</FONT></B><FONT size=2 face="Times New Roman">, pursuant to an Order of the U.S. District Court for the Eastern District of Michigan (the "Court"), that a proposed settlement has been reached by the parties to the following shareholder derivative action brought on behalf and for the benefit of BorgWarner: </FONT><I><FONT size=2 face="Times New Roman">Price, et al. v. Michas, et al.</FONT></I><FONT size=2 face="Times New Roman">, Case No. 2:22-cv-11131-LJM (E.D. Mich.) (the "Action").<SUP>1 </SUP></FONT></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">As explained below, a hearing will be held on September 23, 2022 at 3:30 p.m., before the Honorable Laurie J. Michelson, either remotely or in person, and if in person at the U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. Courthouse, 231 W. Lafayette Blvd., Room 599, Detroit, Michigan 48226 (the "Settlement Hearing"). You have an opportunity to be heard at the Settlement Hearing.</FONT></P>



<DIV>____________________</DIV>

<P STYLE="text-align: justify"><FONT size=2 face="Times New Roman"><SUP>1</SUP>&nbsp;&nbsp;&nbsp;All capitalized terms herein have the same meanings as set forth Settling Parties' Stipulation of Settlement dated May 19, 2022 (the "Stipulation").</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 1 -</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>


<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">At the Settlement Hearing, the Court will determine: (i) whether the terms of </FONT><FONT size=2 face="Times New Roman">the Stipulation should be approved as fair, reasonable, and adequate; (ii) whether the </FONT><FONT size=2 face="Times New Roman">Notice fully satisfied the requirements of Rule 23.1 of the Federal Rule of Civil Procedure and the requirements of due process; (iii) whether all Released Claims against the Released Persons should be fully and finally released; (iv) whether the agreed-to Fee and Expense Amount should be approved; and (v) such other matters as the Court may deem appropriate.</FONT></P>



<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">The terms of the settlement are set forth in the Stipulation and summarized in this Notice. If approved by the Court, the Settlement will fully resolve the Action, including the dismissal of the Action with prejudice. For a more detailed statement of the matters involved in the Action, the Settlement, and the terms discussed in this Notice, the Stipulation may be inspected at the Clerk of Court's office, U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. Courthouse, 231 W. Lafayette Blvd., Room 599, Detroit, Michigan 48226. The Stipulation is also available for viewing on the Investor Relations page of the website of BorgWarner at www.borgwarner.com/investors, and the websites of Stockholders' Counsel at https://www.ksfcounsel.com/settlements/borgwarner/ and https://robbinsllp.com/borgwarner-settlement. For a fee, all papers filed in the Action are available at www.pacer.gov.
</FONT></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">This Notice is not intended to be an expression of any opinion by the Court with respect to the merits of the claims made in the Action, but is merely to advise you of the pendency and settlement of the Action.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 2 -</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P STYLE="text-align: justify; text-indent: 20px"><B><FONT size=2 face="Times New Roman">THERE IS NO CLAIMS PROCEDURE. </FONT></B><FONT size=2 face="Times New Roman">This case was brought to protect the interests of BorgWarner. The Settlement will result in changes to the Company's corporate governance, not in payment to individuals, and accordingly, there will be no claims procedure.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">I. &nbsp;FACTUAL AND PROCEDURAL BACKGROUND</FONT></B></P>

<P style="TEXT-ALIGN: left; TEXT-INDENT: 20px"><FONT size=2 face="Times New Roman">The Action is brought by
Stockholders solely on behalf of and for the benefit of BorgWarner and against the Individual Defendants.</FONT></P>

<P style="TEXT-ALIGN: left; TEXT-INDENT: 20px"><B><FONT size=2 face="Times New Roman">A. Factual Allegations</FONT></B></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">BorgWarner is an automotive parts manufacturer. Until the 1980s, BorgWarner manufactured brake pads and clutches alleged to contain asbestos. As a result of the allegations, BorgWarner or an affiliate has been named as a defendant in multiple asbestos-related cases with varying liability (the "Asbestos Liability"). BorgWarner had an obligation to accrue or disclose estimates of the costs of asbestos-related litigation in its filings with the U.S. Securities and Exchange Commission ("SEC").</FONT></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">Stockholders allege that certain of the Company's
officers and directors breached their fiduciary duties by, among other things: (i) causing the Company to omit estimates of
significant asbestos-related contingent liabilities from its filings with the SEC; and (ii) failing to implement adequate internal
controls designed to identify and disclose such liabilities. Stockholders also allege violations of the securities laws in connection with BorgWarner's repurchase of $113 million in shares of its stock and that BorgWarner's stock price was artificially inflated as a result of the Company's failure to properly disclose the Asbestos Liability. Finally, Stockholders allege that Company insiders made illicit proceeds by selling certain shares of BorgWarner stock while in possession of inside information and while the Company's stock price was allegedly artificially inflated.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 3 -</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>




<P style="TEXT-ALIGN: left; TEXT-INDENT: 20px"><B><FONT size=2 face="Times New Roman">B. Proceedings in the Related Delaware Derivative Action</FONT></B></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">In December 2018, stockholders Nyiradi and Wahler each sent BorgWarner an inspection demand pursuant to 8 </FONT><I><FONT size=2 face="Times New Roman">Del. C. </FONT></I><FONT size=2 face="Times New Roman">&#167;220, requesting the Company's internal books and records relating to the alleged wrongdoing. After reviewing the documents provided, Stockholders Nyiradi and Wahler filed a stockholder derivative action on behalf of BorgWarner, titled </FONT><I><FONT size=2 face="Times New Roman">Nyiradi et al. v. Michas, et al.</FONT></I><FONT size=2 face="Times New Roman">, C.A. No. 20-1700-RGA (Del.) (the "Delaware Action," together with this Action, the "Derivative Actions"). Defendants moved to dismiss the Delaware Action, and Stockholders Nyiradi and Wahler subsequently voluntarily dismissed the Delaware Action without prejudice.</FONT></P>

<P style="TEXT-ALIGN: left; TEXT-INDENT: 20px"><B><FONT size=2 face="Times New Roman">C. Litigation Demand, this Derivative Action, and Settlement Efforts</FONT></B></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">On January 4, 2021, Stockholder Price sent
BorgWarner an inspection demand pursuant to 8 </FONT><I><FONT size=2 face="Times New Roman">Del. C. </FONT></I><FONT size=2 face="Times New Roman">&#167;220,
requesting the Company's internal books and records relating to the alleged wrongdoing. After negotiations, the Company </font><FONT SIZE="2" FACE="Times New Roman">produced over 7,500 pages of internal corporate documents. On June 9, 2021, Stockholder Price sent the Company a litigation demand, requesting that the Company investigate the alleged wrongdoing and take appropriate action ("Litigation Demand").</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 4 -</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P style="TEXT-ALIGN: left"></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">While Stockholder Price was engaged in discussions with the Company and its counsel regarding the pending Litigation Demand, the Settling Parties began discussing a potential settlement of all of the derivative claims.</FONT></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">On July 22, 2021, Stockholders sent the Company a joint settlement demand, which proposed a slate of corporate governance reforms designed to address the alleged wrongdoing. The Settling Parties thereafter engaged in extensive arm's-length negotiations regarding the corporate governance reforms, which included numerous phone calls and emails, and several settlement proposals and counterproposals.</FONT></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">After significant arm's-length negotiations, the Settling Parties reached agreement on the substantive terms of the proposed Settlement, which were memorialized in a Memorandum of Understanding ("MOU") dated January 20, 2022.</FONT></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">After signing the MOU, the Settling Parties
commenced negotiations relating to the attorneys' fees and expenses to be paid to Stockholders' Counsel in recognition of the
benefits to be conferred on the Company through the corporate governance reforms set forth in Exhibit A to the Stipulation ("Reforms"). After lengthy and adversarial negotiations, the Settling Parties agreed that Stockholders' Counsel would seek the agreed upon amount of $625,000 for attorneys' fees and expenses and Defendants would not oppose this application.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 5 -</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>





<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">Thereafter, the Stockholders prepared to file the above-captioned Action, for </FONT><FONT size=2 face="Times New Roman">purposes of obtaining the Court's approval of the Settlement.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">II. STOCKHOLDERS' CLAIMS AND THE BENEFITS OF SETTLEMENT</FONT></B></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">Stockholders believe that the claims asserted in the Litigation Demand and the Derivative Actions have substantial merit, and Stockholders' entry into this Stipulation and Settlement is not intended to be and shall not be construed as an admission or concession concerning the relative strength or merit of those claims. However, Stockholders and Stockholders' Counsel recognize and acknowledge the significant risk, expense, and length of continued proceedings necessary to prosecute the derivative claims against the Individual Defendants through trial and possible appeals. Stockholders' Counsel also have taken into account the uncertain outcome and the risk of any litigation, especially in complex cases such as the Derivative Actions, as well as the difficulties and delays inherent in such litigation. Stockholders' Counsel are also mindful of the inherent problems of establishing standing in derivative litigation, and the possible defenses to the claims alleged in the Litigation Demand and Derivative Actions.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 6 -</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">Stockholders' Counsel have conducted extensive investigation and analysis, including, </FONT><I><FONT size=2 face="Times New Roman">inter alia</FONT></I><FONT size=2 face="Times New Roman">: (i) reviewing BorgWarner's press releases, public statements, SEC filings, and securities analysts' reports and advisories about the Company; (ii) reviewing related media reports about the Company; (iii) reviewing the Company's internal books and records obtained pursuant to 8 </FONT><I><FONT size=2 face="Times New Roman">Del. Code </FONT></I><FONT size=2 face="Times New Roman">&#167;220; (iv) researching applicable law with respect to the claims alleged in the Action and potential defenses thereto; (v) preparing a litigation demand; (vi) preparing and filing derivative complaint(s); (vii) conducting damages analyses; and (viii) negotiating this Settlement with Defendants, including researching corporate governance best practices and negotiating the corporate governance reforms.</FONT></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">Based on Stockholders' Counsel's thorough review and analysis of the relevant facts, allegations, defenses, and controlling legal principles, Stockholders' Counsel believe that the Settlement set forth in this Stipulation is fair, reasonable, and adequate, and confers substantial benefits upon BorgWarner. Based upon Stockholders' Counsel's evaluation, Stockholders have determined that the Settlement is in the best interests of BorgWarner and have agreed to settle the Released Claims upon the terms and subject to the conditions set forth herein.</FONT></P>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 7 -</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>


<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">III. DEFENDANTS' DENIALS OF WRONGDOING AND LIABILITY</FONT></B></P>

<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">The Individual Defendants have denied and continue to deny each and every </FONT><FONT size=2 face="Times New Roman">one of the claims, contentions, and allegations made against them or that could have been made against them in the Litigation Demand and Derivative Actions, and expressly deny all charges of wrongdoing or liability against them. The Individual Defendants assert that they have satisfied their fiduciary duties at all relevant times, have acted in good faith and in the best interests of BorgWarner and its stockholders, have meritorious defenses to Stockholders' claims, and that judgment should be entered dismissing all claims against them with prejudice. The Individual Defendants also have denied and continue to deny, among other things, the allegations that Stockholders, BorgWarner, or its stockholders have suffered damage, or that Stockholders, BorgWarner, or its stockholders were harmed by the conduct alleged in the Litigation Demand and Derivative Actions. The Individual Defendants have thus entered into the Stipulation solely to avoid the continuing additional expense, inconvenience, and distraction of this litigation and to avoid the risks inherent in the lawsuit, and without admitting any wrongdoing or liability whatsoever.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">IV. TERMS OF THE SETTLEMENT</FONT></B></P>

<P STYLE="text-align: justify"><FONT size=2 face="Times New Roman">The terms and conditions of the proposed Settlement are set forth in the Stipulation, which has been filed with the Court and is available for viewing on the Investor Relations page of BorgWarner's website at www.borgwarner.com/investors and Stockholders' Counsel's websites at https://www.ksfcounsel.com/settlements/borgwarner/ and https://robbinsllp.com/borgwarner-settlement. The following is </FONT><FONT SIZE="2" FACE="Times New Roman">only a summary of its terms.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 8 -</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>




<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">As consideration for the Settlement, BorgWarner has agreed to implement and maintain the Reforms. The Reforms shall be maintained by BorgWarner for a period of not less than four (4) years. The Company may amend or eliminate any one or more of the Reforms prior to the end of the four (4) year period if the Company's Board of Directors (the "Board") determines in a good faith exercise of its business judgment that a policy, procedure, control, or agreement term is not in the Company's best interest or conflicts with any provision of applicable law. If a Reform is eliminated or modified, the Board shall adopt a replacement provision, provided, however, that no such replacement provision need be adopted if, in the reasonable good faith business judgment of a majority of the Board's independent directors, it is not reasonably possible to do so in a manner consistent with the law, the best interests of the Company, or otherwise.</FONT></P>

<P style="TEXT-ALIGN: left; TEXT-INDENT: 20px"><FONT size=2 face="Times New Roman">The Reforms provide for, among other things:</FONT></P>



<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 9 -</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P STYLE="text-align: justify; text-indent: 20px"><FONT size=2 face="Times New Roman">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amendments to the Disclosure Committee Charter, which shall now provide that, among other things: (i) "Any changes to the Disclosure Committee's Charter must be approved by the Certifying Officers or their designee(s), which may be the Company's Policy Committee," (ii) "Additional committee members may be appointed and/or removed by the CEO and/or CFO (the "Certifying Officers") or their designee(s) at any time," (iii) "One member of the Disclosure Committee will be designated the Committee's Chairperson by the Certifying Officers. The Chairperson shall schedule and preside over meetings and ensure the timely preparation of agendas for meetings. Any interpretation of the Charter or the Disclosure Committee's procedures shall be made by the Disclosure Committee Chairperson," (iv) "The Chairperson or the Disclosure Committee may retain outside consultants or advisors, including independent auditors, and other personnel of the Company as appropriate," (v) "A designee of the Disclosure Committee will report at least quarterly to the Audit Committee of the Board or the Chair of the Audit Committee. Such reports shall include, among other things, any material updates regarding: (a) the Company's compliance with respect to reporting requirements and standards under the FASB ASC, GAAP, and Exchange Act; and (b) material changes, trends, and statistics of the actual and potential liabilities of the Company," (vi) the responsibilities of the Disclosure Committee will include: "Providing a sub-certification to the Certifying Officers before filing each SEC Periodic Report as to (i) the Disclosure Committee's compliance with the Company's Disclosure Policy and this Charter, and (ii) the Disclosure Committee's conclusions resulting from its evaluation of the effectiveness of the Disclosure Controls," and (vii) the Disclosure Committee is also responsible for: "Ensuring the timely and accurate public disclosure of material information concerning, among other things: (i) the </FONT><FONT size=2 face="Times New Roman">Company's compliance with respect to reporting requirements and standards under the FASB ASC, GAAP, and Exchange Act; and (ii) material changes, trends, and statistics of the actual and potential liabilities of the Company."</FONT></P>
<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 10 -</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>

<DIV style="PAGE-BREAK-BEFORE: always"></DIV>


<!--Part 2-->



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT size=2 face="Times New Roman">The adoption and memorialization in a job description that the responsibilities of the Chief Compliance Officer ("CCO"), which shall now include: (i) "managing and overseeing the Company's ethics and compliance program, and assisting the Governance Committee, Audit Committee and the Board in fulfilling their oversight duties regarding the Company's compliance with applicable laws and regulations," (ii) "overseeing employee training in risk assessment and compliance," (iii) "timely reporting material risks relating to compliance issues to the Governance Committee, the Audit Committee or the Chairs of those Committees and making written recommendations for further evaluation and/or remedial action within deadlines established by the Governance Committee or the Audit Committee," and (iv) "communicating with and informing the Audit Committee, Governance Committee or the Chairs of those Committees at least twice per year and the entire Board at least annually regarding the Company's ethics and compliance program, as well as progress toward meeting program goals, and where necessary recommending remedial action within the Committee and/or the Board's purview."</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT size=2 face="Times New Roman">Enhancements to the Company's Employee Compliance Training, including that the Company shall mandate a Compliance Management Program to be headed by the CCO, and appropriate employee training shall be conducted at least annually.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 11 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT size=2 face="Times New Roman">Amendments to the Company's Insider Trading Policy, including that: (i) "The Insider Trading Policy will be disseminated annually to all applicable BWA employees (including non-employee directors)," (ii) "The CCO in conjunction with the General Counsel, will conduct a periodic review as necessary to ensure that the Insider Trading Policy is amended as necessary to remain up-to-date with insider trading laws and regulations," (iii) the prohibition on trading (or Blackout period) will begin no later than the fifteenth (15th) day of the last month of each quarter, (iv) the Company will adopt separate guidelines governing 10b5-1 plan administration which shall include, but not be limited to, requirements that "any proposed Rule 10b5-1 plan or any amendments made to an approved Rule 10b5-1 plan be: (a) approved by the General Counsel at least forty-five (45) days in advance of any trades thereunder; and (b) submitted to the CCO for review when no blackout period is in effect," (v) "The CCO shall maintain a record of all complaints, including, but not limited to: (i) substance of complaint; (ii) date of receipt of the complaint; (iii) actions taken to investigate the complaint and the dates on which such actions were taken; (iv) recommendations made in response to the complaint and the date such recommendations were made; and (v) outcome of the investigation into the complaint and the date such determination was made (collectively, the 'CCO's Log')," (vi) "The Company will not take any inappropriate retaliatory action against any BorgWarner employee with respect to good faith reporting of complaints relating to or arising out of the Policy," (vii) "Copies of complaints and the CCO's Log will be maintained for seven (7) years from the date made," and (viii) "The Insider Trading Policy shall continue to be published on the Investor Relations section of the Company's website," and "the Company will publish the most recent Insider Trading Policy within a reasonable time after any changes are adopted."</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 12 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT size=2 face="Times New Roman">Enhancements to the Board's oversight over stock repurchases by the Company's implementation of a procedure for approving and overseeing stock repurchases, which shall include the following measures: (i) before authorizing any program to repurchase BorgWarner stock, the Board shall evaluate management's recommendation and determine independently whether such a repurchase program is in the best interests of the Company, and (ii) following authorization of a stock repurchase program, the Audit Committee shall quarterly evaluate the program to confirm that the program remains in the Company's best interest.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT size=2 face="Times New Roman">Enhancements to the Company's policies regarding director training and continuing education, which shall provide that on a periodic, but no less than annual, basis, continuing education is provided on relevant topics, which may include, for example, Cybersecurity, GAAP, revenue recognition, corporate governance principles and best practices, SOX, assessment of risk, compliance auditing, and reporting requirements for publicly-traded companies, at Board meetings.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 13 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">This Notice provides a summary of the Reforms that BorgWarner has agreed to adopt as consideration for the Settlement. For a list of all of the Reforms, please see Exhibit A to the Stipulation.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">As set forth in the Stipulation, BorgWarner acknowledges and agrees that the Litigation Demand, the Delaware Action, and the litigation and settlement efforts were substantial and material factors in the Company's decision to implement the Reforms for the agreed term. Additionally, BorgWarner's Board, including each of its independent, non-defendant directors, in a good faith exercise of business judgment, has determined that: (i) the Reforms confer a substantial benefit upon BorgWarner and its stockholders; and (ii) the Settlement, including the Fee and Expense Amount, is, in all respects, fair, reasonable, and in the best interests of the Company and its stockholders.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">V. DISMISSAL AND RELEASES</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">The Settlement is conditioned upon the occurrence of certain events, which include, among other things: (i) final approval of the Settlement by the Court following notice to Current BorgWarner Stockholders and the Settlement Hearing contemplated by the Stipulation; (ii) Court entry of the Judgment, approving the Settlement and dismissing with prejudice the Action, without awarding costs to any Settling Party, except as provided in the Stipulation; (iii) payment of the Fee and Expense Amount awarded by the Court; and (iv) the passing of the date upon which the Judgment becomes Final (the "Effective Date").</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 14 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Upon the Effective Date, BorgWarner, Stockholders (acting on their own behalf and derivatively on behalf of BorgWarner), and each of the Current BorgWarner Stockholders (solely in their respective capacities as such) shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished, and discharged the Released Claims against the Released Persons and any and all claims (including Unknown Claims) arising out of, relating to, or in connection with the defense, settlement or resolution of the Litigation Demand or Derivative Actions against the Released Persons.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Upon the Effective Date, each of the Released Persons shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished, and discharged each and all of the Stockholders, Stockholders' Counsel, BorgWarner, and all of the Current BorgWarner Stockholders (solely in their respective capacities as such) from all claims (including Unknown Claims) arising out of, relating to, or in connection with the institution, prosecution, assertion, settlement, or resolution of the Litigation Demand or Derivative Actions or the Released Claims.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 15 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Nothing within these releases shall in any way impair or restrict the rights of any Settling Party to enforce the terms of this Stipulation or the Judgment.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">VI. STOCKHOLDERS' COUNSEL'S ATTORNEYS' FEES AND EXPENSES</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">After negotiating the substantive terms of the Settlement, the Settling Parties, acting by and through their respective counsel, separately negotiated the attorneys' fees and expenses the Individual Defendants would cause to be paid to Stockholders' Counsel based on the corporate governance benefits conferred upon BorgWarner by the Settlement. The Company will cause Stockholders' Counsel to be paid up to $625,000 in attorneys' fees and expenses, subject to approval by the Court (the "Fee and Expense Amount"). To date, Stockholders' Counsel has not received any payment for their services in conducting the Litigation Demand or Derivative Actions nor have counsel been reimbursed for their out-of-pocket expenses incurred. The Settling Parties believe that the sum agreed to is within the range of attorneys' fees and expenses approved by courts under similar circumstances in litigation of this type. BorgWarner shareholders are not personally liable for the payment of any award of attorneys' fees and expenses.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">The Settling Parties' agreement on the Fee and Expense Amount (i) was reached only after all other material terms of the Settlement were agreed and (ii) was reached following good-faith negotiations.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 16 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Stockholders' Counsel may apply to the Court for service awards of up to $5,000 for each of the Stockholders, only to be paid upon Court approval, and to be paid from the Fee and Expense Amount in recognition of Stockholders' participation and effort in the prosecution of the Litigation Demand and Derivative Actions. Neither BorgWarner nor any of the Individual Defendants shall be liable for any portion of any service awards.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">VII. THE SETTLEMENT HEARING</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">The Settlement Hearing will be held before the Honorable Laurie J. Michelson, either remotely or in person, and if in person at the U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. Courthouse, 231 W. Lafayette Blvd., Room 599, Detroit, Michigan 48226 (the "Settlement Hearing"), at which the Court will determine: (i) whether the terms of the Stipulation should be approved as fair, reasonable, and adequate; (ii) whether the Notice fully satisfied the requirements of Rule 23.1 of the Federal Rule of Civil Procedure and the requirements of due process; (iii) whether all Released Claims against the Released Persons should be fully and finally released; (iv) whether the agreed-to Fee and Expense Amount and Service Awards should be approved; and (v) such other matters as the Court may deem appropriate. The Settlement Hearing may be continued by the Court at the Settlement Hearing, or at any adjourned session thereof without further notice.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 17 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">VIII. THE RIGHT TO OBJECT AND/OR BE HEARD AT THE HEARING</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Any Current BorgWarner Stockholder may object and/or appear and show cause if he, she, or it has any reason why the Settlement should not be approved as fair, reasonable, and adequate, or why the Judgment should not be entered thereon, or why the amount of attorneys' fees and reimbursement of expenses should not be approved. However, unless otherwise ordered by the Court, you shall only be heard or entitled to contest the approval of the terms and conditions of the Settlement, or, if approved, the Judgment to be entered thereon approving the same, or the amount of attorneys' fees and reimbursement of expenses to Stockholders' Counsel, unless you have, </FONT><B><I><FONT size=2 face="Times New Roman">at least fourteen (14) calendar days prior to the Settlement Hearing</FONT></I></B><FONT size=2 face="Times New Roman">, filed with the Court a written notice of objection containing the following information:</FONT></P>

<P STYLE="text-indent: 15pt; text-align: left"><FONT size=2 face="Times New Roman">1. Your name, legal address, and telephone number;</FONT></P>

<P STYLE="text-indent: 15pt; text-align: left"><FONT size=2 face="Times New Roman">2. The case name and number (</FONT><I><FONT size=2 face="Times New Roman">Price, et al. v. Michas, et al. </FONT></I><FONT size=2 face="Times New Roman">(E.D. Mich.) Case No. 2:22-cv-11131-LJM);</FONT></P>

<P STYLE="text-indent: 15pt; text-align: left"><FONT size=2 face="Times New Roman">3. Proof that you beneficially owned BorgWarner stock as of the date of the execution of the Stipulation on May 19, 2022, and continue to hold such shares;</FONT></P>

<P STYLE="text-indent: 15pt; text-align: left"><FONT size=2 face="Times New Roman">4. A statement of each of each objection being made;</FONT></P>

<P STYLE="text-indent: 15pt; text-align: left"><FONT size=2 face="Times New Roman">5. Notice of whether you intend to appear at the Settlement Hearing (you are not required to appear); and</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 18 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">6. Copies of any papers you intend to submit to the Court, along with the names of any witness(es) you intend to call to testify at the Settlement Hearing and the subject(s) of their testimony.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">If you wish to object to the proposed Settlement, you must file the written objection described above with the Court on or before September 9, 2022. All written objections and supporting papers must be filed with the Clerk of the Court, U.S. District Court for the Eastern District of Michigan, Theodore Levin U.S. Courthouse, 231 W. Lafayette Blvd., Room 599, Detroit, Michigan 48226, and serve such materials by that date, to each of the following Settling Parties' counsel:</FONT></P>

<TABLE style="LINE-HEIGHT: 14pt" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left; padding-left: 15pt"><I><FONT size=2 face="Times New Roman">Counsel for Stockholders:</FONT></I></TD>

   <TD width="1%" noWrap align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD width="49%" noWrap align=left><I><FONT size=2 face="Times New Roman">Counsel for Defendants:</FONT></I></TD></TR>

<TR>

   <TD STYLE="width: 50%; padding-left: 15pt">&nbsp;</TD>

   <TD width="1%"></TD>

   <TD width="49%">&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">Melinda A. Nicholson</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">Jonathan Youngwood</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">KAHN SWICK &amp; FOTI, LLC</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">SIMPSON THACHER</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">1100 Poydras Street, Suite 3200</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&amp; BARTLETT LLP</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">New Orleans, LA 70163</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">425 Lexington Avenue</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">melinda.nicholson@ksfcounsel.com</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">New York, NY 10017</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 50%; white-space: nowrap; text-align: left; padding-left: 15pt">&nbsp;</TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">jyoungwood@stblaw.com</FONT></TD></TR></TABLE>


<P STYLE="margin-left: 15pt; text-align: left"><FONT size=2 face="Times New Roman">Ashley R. Rifkin<BR>ROBBINS LLP<BR></FONT><FONT size=2 face="Times New Roman">5040 Shoreham Place<BR>San Diego, CA 92122<BR>arifkin@robbinsllp.com</FONT></P>

<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">YOUR WRITTEN OBJECTIONS MUST BE POSTMARKED OR ON FILE WITH THE CLERK OF THE COURT NO LATER THAN SEPTEMBER 9, 2022. Only shareholders who have filed and delivered valid and timely written notices of objection will be entitled to be heard at the Settlement Hearing unless the Court orders otherwise.</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 19 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">Unless otherwise ordered by the Court, any Current BorgWarner Stockholder who does not make his, her, or its objection in the manner provided herein shall be deemed to have waived such objection and shall forever be barred and foreclosed from making any objection to the fairness, reasonableness, or adequacy of the Settlement, or to otherwise be heard, and shall otherwise be bound by the Judgment to be entered and the releases to be given.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">IX. EXAMINATION OF PAPERS AND INQUIRIES</FONT></B></P>



<P STYLE="text-indent: 15pt; text-align: justify"><FONT size=2 face="Times New Roman">There is additional information concerning the Settlement available in the
Stipulation, which is available for viewing on BorgWarner's website at www.borgwarner.com/investors, and on Stockholders' Counsel's websites at
https://www.ksfcounsel.com/settlements/borgwarner/ and https://robbinsllp.com/borgwarner-settlement. You may also inspect the Stipulation during business hours
at the office of the Clerk of the Court, U.S. District Court for the Eastern District of
Michigan, Theodore Levin U.S. Courthouse, 231 W. Lafayette Blvd., Room 599,
Detroit, Michigan 48226. Or you may call the Stockholders' Counsel listed above
from Robbins LLP or Kahn Swick &amp; Foti, LLC, for additional information
concerning the settlement.
</FONT></P>



<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 20 -</FONT></P>

<HR align=center width="100%" noShade size="2">



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>


<P STYLE="text-align: center"><B><FONT size=2 face="Times New Roman">PLEASE DO NOT CONTACT THE COURT OR<BR>BORGWARNER REGARDING THIS NOTICE.</FONT></B></P>
<TABLE style="BORDER-COLLAPSE: collapse; LINE-HEIGHT: 14pt" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD width="49%" noWrap align=left><FONT size=2 face="Times New Roman">DATED: JUNE 22, 2022</FONT> <FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="1%" noWrap align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD width="50%" noWrap align=left>&nbsp;</TD></TR>

<TR>

   <TD width="49%"></TD>

   <TD width="1%">&nbsp;</TD>

   <TD width="50%">&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">BY ORDER OF THE COURT UNITED STATES</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">DISTRICT</FONT> <FONT size=2 face="Times New Roman">COURT</FONT> <FONT size=2 face="Times New Roman">OF</FONT> <FONT size=2 face="Times New Roman">THE</FONT> <FONT size=2 face="Times New Roman">EASTERN</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="49%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="50%" noWrap align=left><FONT size=2 face="Times New Roman">DISTRICT OF MICHIGAN</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">- 21 -</FONT></P>

<HR align=center width="100%" noShade size="2">
</DIV>


</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>bwa4082911-ex9915x4x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bwa4082911-ex9915x4x1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  J /8# 2(  A$! Q$!_\0
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M]UKOQ ^&?@.WLKFZ2U);X@?$3PMX/N]1@8AFN)M TC6=3U\62K_I<>F.C.B
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M(ENXS(H*P>=+B,\IX7^//P@\;^(8?"?A#XC>"O$GB.>RDU%=$TCQ7H%SK/\
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MDGN91+<S00+ ;APJHLD^7E>601JJ;WD9MBJ@P% JRRQ@X\M#D9SM7W]C3**
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@EO;"RF<P(5ZT !G  R23@ 9).23CJ2223W)S10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>bwa4082911-ex9915x4x2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bwa4082911-ex9915x4x2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !% -(# 2(  A$! Q$!_\0
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M[3[WA_V5?^"J_P"SO\1-3^(W[0?[9VM?M0?LM7OQAUZ_O_#'PF^*?[+GQO\
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M_P 0:]-9VEWK.L:WKVIZOX@UG46M].M]2\0:SK6L0:/HZZFVFVWUKO;U_04
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9%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>bwa4082911-ex9915x4x3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 bwa4082911-ex9915x4x3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !, - # 2(  A$! Q$!_\0
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M76OB!X$^$>H^+?V7/V5/#EI);7'DZ'J7A#P%XTT[XN_&O2IGL[;2K;0?C/\
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MIMYK%WX8_9DM(M1T>_\ VF]*_M'3]2\*?$3]H75;*72M<T+X:W;:5;:CX3^
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M#P_X?TG3[1"UU?ZIK>L7%IIUE96<:%KN]N[F."U56-Q+&%./Y_O&?[2_Q?\
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M,,21HJC66-5+''S,VXDEFY'0@,3MQV5< =NM 'Y86?[?'[7FL3P)HW_!'O\
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MMG1U2."^^'WPQ\.ZXMHHM;W6=00N\GZ))&L8PHP, <DDG P,DDDX' YX  '
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M\9_&CXL:Y:/<RV]_XZ\:7=O;RW5GI374T'AOP[I%II/A?PU9,;30M%TZ'*,
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,,\^M+0 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>bwa-20220713.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kw5w7xRiXhun8uFa3VMOaSIGbP9y5B/SYkxvm12bYmKzy0tiiY30CTz9ayGIUkA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:bwa="http://borgwarner.com/20220713" elementFormDefault="qualified" targetNamespace="http://borgwarner.com/20220713">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://borgwarner.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="bwa-20220713_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="bwa-20220713_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="bwa-20220713_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="bwa_CommonStockParValue0.01PerShareMember" name="CommonStockParValue0.01PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="bwa_Sec1.00SeniorNotesDue2031Member" name="Sec1.00SeniorNotesDue2031Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>bwa-20220713_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://borgwarner.com/role/Cover" xlink:href="bwa-20220713.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://borgwarner.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="bwa-20220713.xsd#bwa_CommonStockParValue0.01PerShareMember" xlink:label="loc_bwaCommonStockParValue0.01PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_bwaCommonStockParValue0.01PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="bwa-20220713.xsd#bwa_Sec1.00SeniorNotesDue2031Member" xlink:label="loc_bwaSec1.00SeniorNotesDue2031Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_bwaSec1.00SeniorNotesDue2031Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>bwa-20220713_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="bwa-20220713.xsd#bwa_CommonStockParValue0.01PerShareMember" xlink:label="bwa_CommonStockParValue0.01PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bwa_CommonStockParValue0.01PerShareMember" xlink:to="bwa_CommonStockParValue0.01PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bwa_CommonStockParValue0.01PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.01 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="bwa-20220713.xsd#bwa_Sec1.00SeniorNotesDue2031Member" xlink:label="bwa_Sec1.00SeniorNotesDue2031Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="bwa_Sec1.00SeniorNotesDue2031Member" xlink:to="bwa_Sec1.00SeniorNotesDue2031Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="bwa_Sec1.00SeniorNotesDue2031Member_lbl" xml:lang="en-US">1.00% Senior Notes due 2031</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>bwa-20220713_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.14a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://borgwarner.com/role/Cover" xlink:href="bwa-20220713.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://borgwarner.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="bwa-20220713.xsd#bwa_CommonStockParValue0.01PerShareMember" xlink:label="loc_bwaCommonStockParValue0.01PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_bwaCommonStockParValue0.01PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="bwa-20220713.xsd#bwa_Sec1.00SeniorNotesDue2031Member" xlink:label="loc_bwaSec1.00SeniorNotesDue2031Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_bwaSec1.00SeniorNotesDue2031Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139963097654864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 13, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 13,  2022<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-12162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BORGWARNER INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000908255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3404508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3850 Hamlin Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Auburn Hills<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">48326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">754-9200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bwa_CommonStockParValue0.01PerShareMember', window );">Common Stock, par value $0.01 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BWA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bwa_Sec1.00SeniorNotesDue2031Member', window );">1.00% Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.00% Senior Notes due 2031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BWA31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bwa_CommonStockParValue0.01PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bwa_CommonStockParValue0.01PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bwa_Sec1.00SeniorNotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bwa_Sec1.00SeniorNotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>bwa4082911-8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bwa="http://borgwarner.com/20220713"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bwa-20220713.xsd" xlink:type="simple"/>
    <context id="From2022-07-12to2022-07-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000908255</identifier>
        </entity>
        <period>
            <startDate>2022-07-12</startDate>
            <endDate>2022-07-13</endDate>
        </period>
    </context>
    <context id="From2022-07-122022-07-13_custom_CommonStockParValue0.01PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000908255</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bwa:CommonStockParValue0.01PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-12</startDate>
            <endDate>2022-07-13</endDate>
        </period>
    </context>
    <context id="From2022-07-122022-07-13_custom_Sec1.00SeniorNotesDue2031Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000908255</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bwa:Sec1.00SeniorNotesDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-12</startDate>
            <endDate>2022-07-13</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-07-12to2022-07-13">0000908255</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-07-12to2022-07-13">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-07-12to2022-07-13">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-07-12to2022-07-13">2022-07-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-07-12to2022-07-13">BORGWARNER INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-07-12to2022-07-13">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-07-12to2022-07-13">1-12162</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-07-12to2022-07-13">13-3404508</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-07-12to2022-07-13">3850 Hamlin Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-07-12to2022-07-13">Auburn Hills</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-07-12to2022-07-13">MI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-07-12to2022-07-13">48326</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-07-12to2022-07-13">248</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-07-12to2022-07-13">754-9200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-07-12to2022-07-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-07-12to2022-07-13">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-07-12to2022-07-13">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-07-12to2022-07-13">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-07-122022-07-13_custom_CommonStockParValue0.01PerShareMember">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-122022-07-13_custom_CommonStockParValue0.01PerShareMember">BWA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-122022-07-13_custom_CommonStockParValue0.01PerShareMember">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2022-07-122022-07-13_custom_Sec1.00SeniorNotesDue2031Member">1.00% Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-122022-07-13_custom_Sec1.00SeniorNotesDue2031Member">BWA31</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-122022-07-13_custom_Sec1.00SeniorNotesDue2031Member">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-07-12to2022-07-13">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( +" [50'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ L(#M5&_'
MDPGO    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ L(#M5)E<G",0!@  G"<  !,              ( !S0$
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "P@.U4N[?Z?X,$  #^
M$@  &               @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ L(#M5.#T.HFJ @  , P   T              ( !QPP
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "P@.U4EXJ[',     3 @  "P
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52P4&      D "0 ^ @  %!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="bwa4082911-8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://borgwarner.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="bwa4082911-8k.htm">bwa4082911-8k.htm</File>
    <File>bwa-20220713.xsd</File>
    <File>bwa-20220713_def.xml</File>
    <File>bwa-20220713_lab.xml</File>
    <File>bwa-20220713_pre.xml</File>
    <File>bwa4082911-ex991.htm</File>
    <File>bwa4082911-ex992.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bwa4082911-8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "bwa-20220713_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bwa4082911-8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bwa-20220713_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bwa-20220713_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "bwa-20220713.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "bwa",
   "nsuri": "http://borgwarner.com/20220713",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "bwa4082911-8k.htm",
      "contextRef": "From2022-07-12to2022-07-13",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://borgwarner.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "bwa4082911-8k.htm",
      "contextRef": "From2022-07-12to2022-07-13",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "bwa_CommonStockParValue0.01PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.01 per share"
       }
      }
     },
     "localname": "CommonStockParValue0.01PerShareMember",
     "nsuri": "http://borgwarner.com/20220713",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "bwa_Sec1.00SeniorNotesDue2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "1.00% Senior Notes due 2031"
       }
      }
     },
     "localname": "Sec1.00SeniorNotesDue2031Member",
     "nsuri": "http://borgwarner.com/20220713",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://borgwarner.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001206774-22-001662-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001206774-22-001662-xbrl.zip
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MTT W@BQ(O RUV@ @I 4^E#$'[7"4SL8,I\SGXI%GKG=/>*B/VMV$!Z6G@-+
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M<X. SE4K=]HL6]PJ"J+UNYR9)!1:U!0[QF+.TB1*\H0N/XB+3YY@6ZUL(E=
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MU0M "_F,6%$$^B(+0:H4V_O+ZYLNQ2>QN=PD_EK@C(@M_P=02P,$%     @
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MPE,I0'%HH.KQ3B@PCY)XO6H5!-HF'^RWZV_<#_<?%-@C_P!02P,$%     @
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M&,>5V@51(R&CH]^>C:EP)!PN6IJ'V@DCP7MM$#D-0J?[YVHF72F=I30SE0*
M7NO_CLX7.LR$SR:=WP%^-H&FV IH OZHE<J7I%:J5FJ7;S]_U1..1TV7N!;$
M6QIF7X#GB25(/+VC[Q*K2=PVPT>>X"Z'2*K4T]K4;#&2UUQ\',\F4UN%.W2(
M%@.GJC';$B[9"3XS"MJ .2YA3S V$?(QTW=S4XR7GV"\JC0W)66,9G/@K[/L
M6<N\^G%WU5R; U5&ZUN(]]R<CG8?^K5UVN\#Y,R<Q:%C@(4.?WA&'^BQ1W#4
M;3)M(K4"TTQBM^AC5P6W-=;B#B;T7(S=YXAWRO+2V2[MW;4V(-ZSY@T='E5J
M)]?Y6KE4(Z?E0F1)[+FT83! EV' ]YK,1,="\K--=3WXW+ $6!CYUL<EIC+#
M;1]-<8E-U2BL689!;0>0'+S[0KI<=]O(\K%/(=\^X=PB&.V)"9=KU C(U[!<
M\(U54S2$KAZT]$=*QC_!J&WNLC#"S3"?T174_D)&N<!@33>$.3I]QD@^N*YE
MY\B10;5'$K==XE@&U[\0?_%AX2]0RFHP=V:9N14'#D="6-1 ZZB$G5*/@OY!
M'D!-( :T)]0ACLTT=-YUPH%-78> Q@+%('8'Q)Z)@)50.1 H' O^$?@/\LZ?
MS4;)E=:^,MG^_5=\/_9E*3*L3H7YJTIL;JQ-@K4:L@>,MC:1?4Y2#7+DKYC\
M,RKF;\0&DP8D-F9 3DW-$F#*Y5Z0C)<+:B>C8.ES[,G1PW> YB9S[?%-&&O<
MLL+XUF6VL)Y0R8Q;ZR7@!*^%&;0+=GZ1X=D8MRGAFO?ORUI_"9Y838A>S1,'
M8SQQS T&"&PP,9L!'@^.BY6;A^O*T^8<BN&<H<,XM([O+W3!_A1:OK%\Y\=H
M>4E[IWY^39.R\Q)A,\?/=X_%>JW=;V^,L',  "HGP\E4+)6.998@].MT\1M1
M8D?J)8SG+(CC!'F ,,[1N0KTK.8'M\2K+Q<S\MS!E"M!\25E*[*<U_=^=GWU
M19Y&:I%ZA)0ZMF'U,2G\AS'EF.&4O"E:U.3/\O/;DVLIGGPQ=%H%J&4&VCH!
MQK3?E)#\UX0SZ=B?%<XLPQNI[$>-&K:-[4FO(C/F5>1U73#'\5_.@?'BLSV*
MZ_2S6:7//PZZZR?V)CV*&9.'#I.9=(Q\IQT0 E*SJ#['I]CS7\GK,9*:A9$"
MO*V(2ZMKSL9'D[;J5[QV9SRS3>-C.'7H,.\U/&&2[QQTR/8Q49R%">D+5405
M8CIN:G-"R>SQ;;%@7K)L)OEVH>1L $.'%UQK<["-6X\[E.;9;M2QHN;:< 3I
MH[AJ 3&,.V[/3R;4J^FK]N_&\7=GXPIB;/;082J33.R_5:BQ;?6\XZ\1\[&V
M /[E-C4(ZS'-<_D3IFG!X6#.[D#(/Z2]7'W90$V"Y'S9A=K\KMAPO^/??V42
M\8,O#JS(8';;,ADQ942[1X ,AH<.&J&"46!?'<;<F6=)45_GH=U\V7BP'T_-
MYQ.W=$0W(!NC\X4.$ZEY8??NU(9>(-OG%HA %9?\4A*AW;H^[E2>LZVS_0U
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M=XC-X6-@T.",U(CWX ,\UW?8*46*ZLO(KA+0@) 0O"MC.\_ HB2ANDV,2M'
M*IO*#(Q88;7RP2HUN1QJCA/( ?5@J(!Q&D-OJV_K+K<]8U!(7Y>0(9R;$L;
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M'NPCZ+SGNGW<B$!.GY9:[7%#$$L6Y+D#+_!Q]<4DC$&^C*4E@_M $N =1:N
M%.2GLP0HT)!%9]3_RZA9D.Z6/_^/ZS!U6U$2"[QPR]2C\P/$D-HJK?X%_/N
M LR%7A%1IXV9481NU\K36@%TWW/'75BXXZ/:VTKVJ$D3#:V1M,T@MX*-D+4>
M.'@^V"8$*]IWQ_@"'*4X18X#6_BM4)-J/3HF($P5C2R:#(^_\K?_JKU^\_[X
M^*@"Y^F?*?*^+%M\%1M.U W#;\R%V6*%QQ[Y!O,PK77!$CU$P'?[(?P"RMD@
M(6O$O><^J,;[82]%=A?C*;F'C=U_G'X#NE,=VT)FG4E0FMCH9UNT#*$K(O$2
M?']Q:FHKFPM<&0A[;^Q9_,T29*[ LM2K)+X<'QTN:-"JO3DZ.KS[4!?[N+ '
M4J74NY^W/.J3QJXDQN$]7Q# \5"+(VKG7F$ST&/DCM-NC#LB2/"""/T4E.[(
M8UZ*+?/%FV^;KH8P1>[G_I7V@065L)=GJ0_'._5AISZL3GUXNXUCW3[UX70A
M]6$MHL/YLJ+#E3& 7="%BI9^+RZ*"Y(1:A^1: [0L!UO4(RX"<3O3I"BVG)*
M3JE:F0CZ'RLU!.XP3#QEQK6U-9 ;0-^#ET+T=;RIG!T=P:D;2BW#Z$[1)(Q0
MG=(21U4@S=/ %>\>(;C=G6.;5?MR5V7F[F1?\()[_&F(?9?/D34@M'8[$U14
M(K)'2S%F?Z^PB]F;U_/3/KT,<QO#)3MR03& '<WR%;6)%!DYJ5]4C0PYAOA0
MX 0]5[IW0 'UZ.,DPB'TI%4XGL:).\X352JDO*;0(I%@(/V!L \G(>N!9'L,
M?%PM]]XE99D4-] M(Q<[DR.4*AOJ6* >^6R3Q!]*CG(WI1T>3D!+APV*CXUQ
M2*2"D8Y%C2>XR]Q[/ ^H[9EIK4#=>>1T?"&=K+BI4!=S@Z$SY/FA3IJ2?F=9
M"/1^ ]*BKJR\Q)$[=**^.F43$/?P[U).5_0: @6&CNF0%F$2)K@@L)RQX7_H
M3O#UOK&$ZQ[Y!]=/.CJ:L%^.CTO.9EQV+/^"HY38<U"'<T$A&^Y.4,OP_(4Q
MJQ>H9"()2@]+Y*+^G;7%P%T/>Y=%[05[+>-XG;*50\N5ZQ OM+8.D%8>>R<:
MOXH/??@--I#-+7,[9MYD*H*)P,P%>@B 4T9A"LK9* 0^V8/1\F$'TGI^K-S(
MT$YV^S 5'5^YC%/D&/K+52L")R^F".Q4@1]2%7BWC6/=/E7@;$%/PNIO!Y8)
M,R;Y6>QOQD6H7 ;.,'+EE<>"!EH[$F@1>2K[3>4EJ&\&.Y2,^>4#L&8Q=L<A
M2&[L<<6@!/$)OP$&F(ZQC<\!WES0-+'B_;U/-Y_W#F0LFI+\48[&>+3UWZ\6
M!>7% ..902N0"<<HI/7S]TI.> <F!$K)-'XE!JZ4&MWO(*%@< 0&S6$TAT<7
MI7V7OX([G$4;(!HJ!C D%;6'S7;=P!VP!!0,W A#0^12:7^-B:R;?U>;@"7H
MJOE]Y'6]1-1QX+P9\(J%T>WOW?$+:%)C0O'&DE%_?6@XQO@[?Y&=1CN,/1R5
M&5/4>PZ5)#5=IIB9M#W+TKU83M1X%*8^:5PNB0GS%@D=-J^/SRI'1T>9"#!H
M*TI8.;FWS9WK"^!4LDY.[ /M8>)$+&P-E+_#Z<)*'_:<"9(4C[14Z>DV7L;.
M*T,K9UEYE]&+]YO5"WY?FVNEE5:P<%X(%2R89J6--V>IH%!.5+"D<D6+%G;1
MEV0T;U@MT/'4>JE=9O;*J@6PTQ<2P';"UX\G?)T>;>-8MT_X>KU(.#^=C^T]
M(8^%Z)5<'D\/T%TD0O>)X7B/]][NW#3^^'AS!31NP]U\56]]:E,8;^=C4YPW
MKYN7K4Y[1KI$>2PO[;HU1^AT7=]S40Y6-DVV_@@GCH%0<XQS,J:CQ#$?BY%S
MGY5XQO!,4G1%OL*4BVC*"1=)/D0^9Z_W.+Q11\VS\$36B1$:LO!'EJ;B)$IE
MX BTTE<!KG"CPH\]&69!?T;Z1F5)%X>=1*QAP.,T;+Y;T<@I#6/B8_B ]I"<
MX%*<7$/;\T@<_!>/UNE] W8!O&;(LHVMXD1>_*VBA#6FE]1WR$:%1E6<V<2*
MEPA<G!%J%AP#@\$\T@Q=L.F!H I"1)S,3EPP(BC)ON1J"(%@79\LURZ:=F;,
MD@*.:.71SAWPHCH]L@Q1AVF@H[[2!!0.5V\AG#;9(T'2-Z9W( 2Z/50 "]NM
MW>\R%)O"GYQXQA:LX$\/P,?4(WT/ \LPO%M*Q'U8\"EZ+E 0Y>AO&5&E^J\N
M:N";08_(99J,X<P.C(5>]PB+!61E[=.%H]+UO1C#UH36(-%P;*9F4T913B\.
MA;%++<P^QM+V./<4%\FW?OF_G&:T?3#]).TA[S&F3^-A49S!"1Q_&GNQY2>I
M+*$(D(,#Y5=G"9&?XPE-=$LFFFU"=N&(LVQ@6),4%K2'BYD0 X.OVLV&BA-4
M=E4K+!_GDP QV,L2*T74B\.('NABJ(6E%,L,+#,<%:HX!M;@F&9*W\N\6.96
M6]C!QYJ)^UR?9-AWG^25Q-G<XV1BUXEZ='Z 40'E'3P6H'"Q_B63\>8?#QG6
MLJA=GYBC\JR8 \@F!A@7#(NU6?;"%)R*^(B7>08SNCA.U.;=R/> Q,E^?$"O
M8$PKGQ%ZTAG3FO$&<F,9='K/V6S*>$'7'%ZPYD(ENM@Y:\;A:%.SU-R2=;-1
MC]FN,(*/#"RK5D3/=IZ G3*Z2F6TMHUCW3YE],V+>0+.*6L5N&:IS/ *.6[(
M0JL5%Z'$ W65Z0 !3#[$V]=.&52\NZ+27S'D@=@P/N1C>'70P[S >)8)MJ!&
M67PV8Y(N:#D>!;%'&&#BQ&& MU9%7OV<'* '-2"O>)D=.9U 0T88J0HF&7T]
MBVA #3^5TF1&CR$9K(^)YF.ZULNFY.DX;;H(2#IP98YB)G2IS\TI WDX)R&9
MAYO-1,ZE*/\ B<G+V$.>EZV\>FO(PDG,K6NX,UL7F,=\T;QL7E_4KSOM5_#W
M=:M^13:0+W<WUQ\N;EK7'\A$<M6JG[>N6IVOCV8WK\T;,4,?EJ<A\-R^9@ZH
MA%/8M0OZ*D7ZDXL%:(D@"SK0J2?S[/$5%!)9+<63;7B/!)\P:OF8D18P18J<
M.M0_Y2P7GUQ2J:LH3Q J*AC;C<-'RPD#!M#AM2+68!PFP]GNEZ-7RLG%9B/-
M,Z;2% 3CB ?>[/0M)Z&!:":=X.I4)._H23/4, S[R"L3IO>B#$AG(4D&)YLE
MVPYH5ACZ8BO/67ZIUE G,/V5]H?,U=GIUG4U;(B,E2=!'JE:,+F,6>0VT?)Y
M0BZH>-CTUD:7.7NT+#6NDD^<Y^FU,X2R4RI@.^0IJ>Q\@P'/GQ21BM[ R[5%
M#G;8B&,#B"&5G"<;,>;L4[93C=(X"_I"UYQU.<>A3PE@H7#N0Z^O1H74I67N
M\W4$;6N;'4@*87"/BQ'TY-T-&R.)5,K*@$4 2QFDO67W@.:PK&4*O\74O%19
M457F!5HW$PZUA,,\Z_0^P'+$(3*H56MCKW<)&CM=;'6ZV&HUG1]6%WN[<PPN
M)PO_^9*.P4[S[A,[_BS8-)1ZZQ_NFN0'S'H%Q?7-EPIZ#>^(^55$JR-:;8&?
MS[_J1IH7IHV%0(%*^/S"\G$!#"VE2#>.BE9AZRHGH! >Q1I:A:4"BFB6Z#/J
M#171+R]=K=J!5AT^5$J51?;Y==TY04QBGU5(E,_55UVWA_A>0\X!QSB;.:!:
ME'0!C\>8L<J*:]]"V**D$)CH/U,O'N$GMHKS.(V+1AJ5U8"ME,JL-%AA!;A$
M[2U%YE*"A"6ND-.+8>I6X<%Y?&?7ELW6ND 4&IY 2=[5&D(@8Y'&2G+,$RL+
MZL=$EG(AJ@=.0/Y5<D&B[K(H,AUMVI]7+&>]>;Z<M6S@U?\\/!2W];N..#H6
MAX>[4*P?4^(ZV<:Q;I_$]6XQ9-4EV1>\4QC''@U$P$@$#64/N&S-A)8B7^*(
M!H(5F0F-0'?M@\=7SL!.L_L,#!C#BA."O;E W=3K)?+N5#=RTXG1X6M^ANEC
MJ"OHK(N%W1:G\:S0VV)S=OAM]K);WSH<B[F8J')QYB&(PA5MPH"59U5'=*!1
M1*,5,D(GR$6>$Q'([ 113C'8)XSHMY[^FV2S&,6Q>%.D.,%IPXY1DW[VKMK4
MP$]AX#)IU#(49I!TY930HG(+GQ'H8A2*\ &%7>L=S)E P8X1CK2GJ2]3"O%O
M]SM&8]EVGWR F[+5D>T1!R!-I,OU8[EF/KH42X!19,J;/S/:BV6@&9!;.4B5
M,<'?J-YAA-Z8XDP2S.@=PY9UM9D4?V7'6>2BL1F&1;P)3:_P6V[S(D@G[UVY
MD=&H#D1)*.B+LV_F&/%"B:N9<=LI>_"F-M59!N^7]P\:_FT XKG PDI9*)WH
MIF;QVIZ%]A6JX]#VQA,\"QVX67IH2/Z;,X9[]AR4/!^VG[BZNIT[T(R(L.B@
M#L7;G.2+<F\0QB3=LOR[)YO,"I#<[F_:MBB'@O%-AX@F]^VPBP$J[B[EX#]"
MSCW=QK%NGYQ;.UH3]LNB/.A-$?1J89GW26+I\Y"_BNUET;\L6"^$[O*K!SJA
M%&[R<J2M1U"UUD?[MZ7):!;YI2G+1/YG%FI3PWPG]IJ#@:RL< $"B#W$ <@7
M"<M&W:DD-4EB]X1 EX>W5\8=%#7^-G$BY_UKT+;*A#7+$8_[0D6VA#V"(.EO
M:O)P0/?(=FE/FJ9+UD,S81]D;0VYHJU<;(6D09?&Q?ZNW-ML,35AH[;AS(I!
MXLA\[B.B'&B5<]O,Y]QR\#1+Q1,O<HQ8[)*_7R=\.IC*X3%@#.<<,,JJ/3X9
M^^P-*,6#']+H[J3N2@<W_.03R$>/-!%\QO7(#XZ*%GF;,_-F'':->><DJG6U
MZ6FH T*6GU(,M&VZAJ\'T TUKWN646G8]03C(_KO\3F.P<8)"-!_1B3GJQ$.
M(Z N]#^KK8J.$)DS)3+1^X14;\\N\PRWH.G\"D,A>A[EQ_!S2GTHH8_ZB5^M
MBLM<QBKM&SQ2,)O)"&5[L<?/[ED9.Q*'A*@I*2WG1NDY,4,*4=Y$'*>\)^;F
M-TM<(F>J06Y$[$;W!.X*S*I?%75&E)(9-/@&R6"LB9AAX'3<A).X:;W%@\P&
MPC06#Q3WR(,G(I67:V(%)%4P!MV\G1LT?+7XF"L9@K&KWYER"@N-$_8A43&S
M5'1HL@Z/=0CH[YXGH.^$\YUP?K:-8]U"X;SVPL(Y#&!&"24IC*RZ&M3C99XV
M)G<=BSW%66W1ZP8Y!(^.K#N:^W)Z:H2YJI$):2-[Z#P)*@]4 I>[EJ@V-M<3
M48)(:$T:[3WH<21A\W% 156.+0O$R&]+6$4[SGPUJ(H;(]:IV+LF>=6FT+66
M8&]Q!P0]#J"X+8*Z4.4Z2ZTM 2Y]TFYI;(P 9V*/S>3&<&Y5HJMDW1R^-_:X
M<)$*3NRI30(K..#D; O,<\9+6'8J@$Y'WJ22_:">S7P)8G?8\V1KC"*(^F :
MN>HC6]?U6%Q*VZR4FK%!^HZ 2!60L#'84V;'];.=<*Z<%KI1Y PQYK.'*'II
M%ZFCDM*!M>/^H+S!<&",X!RNV\7B%9A9&BJC.AO'930W1I]KDWP\"=/8,K//
M]A@5#//:"N\^BIKY1#D1-->=H+@3%)\E*.[JP"XF*"Y8"'9=-\)KN!$P- X=
M7M%4U%7T'0E+>XC5AIY$J2EKH#,Z0XL9E\[S-Y^-S\R&IHDU@-DP6?.3\Z25
M*?\Z7[W ?6&^5&9P("M;H$AB;%>YGC ^<;[CV2Y#ZK!1+Q-3F7'PVDQ:K'D]
MWX@]58^%;WHM\%OWC[!]AQ.R/I)E@J1!O./0W^R.)WXX=>G&D6[GBO$YTU7.
M#V9#']1UB2YB*SY"&U4J"FB$O=I.VO>X/8F?0,GM,5:G)+?LH?F D:GJ;WU]
MYES;4^7\UA<K^_5YQ$20,E\WRQ T"-B'E /"KY#XL&A !UW-+ IP5\8KCD*"
M)CK9 <N]X):H(-//C,A@%2FF-2-0 [EHI2MDK:!:5'M)%EC )RY:^9HM1<OG
M!\4N?&3>TI&Q0Y:5U=.."J!3)!0&N)4UAN<>&9@[ 'Z@81D^!P@=%,@&#RI\
M/U ",ZIH-'$//X\=5-"0;$XJS;$*,M%*#**5X1;AVY0;KQCH)_I2?9(V9^,&
M(3BE;(KBXZ!188F"0T6SLLEB\$4N7XPBT*>/<- Y]:[M6 N9D9<]/M"'7C!F
M<D")R",S-WKC$(,1AF$2J^DFX&1R.-E![*@L2W8U591K"!&G<*O3.G%I,H2_
MKV2084()4L7'74/D$X*23*>D!+DRHC^6'5=*<VWMEANN6/.M8DTV3PIZ.P\.
M:P.5(G"_"4"R^H%G72QKUG.7NHFK6+*6 <NU+P@CMDM.&>,N^3IU4YT19*.Z
M\FX^451>L^5Q1@9='3G$F-&Z^#01N_6ZJ3Y;Q)D((D6?02>'2LM^QK/JJ<V.
M5J1CY>NMKE?'VFE9/Z26M:NRNIB6M5B9U34*&>\L]K>08&X%:.8$^HV%4!^I
M,5L98K;E-"L(D*Q*PN\CNM,,8!86_VQHE%SO4QVM:4R6G <V5>0K#'=CM*J)
M/7-!VD32D/85SEO2&#$JL 7O)4<5_"Y&<+ ]_I,S%36VQQ^; '27=>S-S?+8
MGJ52;^T@[!%_1:&^_"<A1IA8%XXRIVP'%8_!&7T+ V2O<7HG<GK%_9Z/$+;/
M; %:M/Q ;VP6IS"+DACY"Q0S'3@V0J9W?$+0?*&#ZLCI@5A"LM+DQL9[EAUO
M(9KY#V<4B/:#U_LFXY@OPP3&>W75H#'?A=TNB'+K"FJNY0M;[FSA.REM22EM
M5\QR,2EM7=4L%V9%KX$5I>,Q&J*+CN+L+R_I,+[8&&]^(_:REBS[LL\(74JM
MWX\/BM$&.5"A1P5$LH-H2;@?4C@=#D/:=N)4A\)B% N%VHT\,OH:S**!<T_1
M?"86U (8=&*W,'XI7]OHJM(40A.J8 @HTZ(+DHXWMKNKB#%N>HF#13'/N'3Y
M,>F839P0EDNTT ,RD*]5\247\VN;'G.6E!FU;F(I1THP<Q1$!1>^T5:Q;'3V
MK';(&&K0R!X<BN3/23J/+*J%JH#R,.$H(;%8\ ""AA,W&VG\N\'OPC?YX=PH
M9.PP^72D48Z-2-QJL5A1=\JV4CR.#3@6<-0"D((:H$_XC&P<2\-:[>ST6(6^
MR&KH\<_Y<R=OZ%($E-OZQ47K^L/A5?.R@Z?QMF.^N^/+'+]<]#36Q8?F=?.N
M?B7NFE?->KLI+FZ:;7%]TQ'-?W2:6+W@1M4R^/*QU?A(U0P:=\V+5N?F3L#_
M^3T$\D.P@*_F_3^N;[[@ ^W/[=MFHX,--?_1:G=$ZUI\;+7QIX_-.W%9_Q/^
MJG>HX4[K4Q/!4)K_:#8^=[!1_%8-C8LIU#L5T;JDYJ_%^5=HZY-LJR*^W'R^
MNA ?ZW\VQ:=ZIWG7JE]=?17URTL80//"[M:"6_G2ZO"T+IKGF4G!&S2G-<5#
MY&L:[F3 G0RXI RXJV*XF RX2!G#=0D\GV==BP45WY).2F_'0LC7"UV/&:FA
M>$M6YER35.'#>5#%/OY*(R_N>SV5/(/?D5N,'#+P%GJ$M4R8Q1B0CR.W@V7)
M-%7AT ,)VLRU4RB''KK6!7"!.M[8\YVHPF%_$4,O8V+&/U.0J'T5M%%ZH;>M
M"[V:$S3M!'LDQ6.K-':FPI3^11\A%60@YR+E>TB829+M(BIEPLB0TA6&M6EX
M4B/$PQJY4C+$TT2R)1%+0E2KJH-8(Z<T!4R!3['_JEP>C\G#-T?DHTUJ>V8S
M^[NPO24JM 6@9>WU1WR^J]GC\W# )/17 =]KCNA<]*I+[4*YU?7'BH2 &,I0
MT2 ,S!=JL^)"DDY282,HZFXX.M8,Z!?EEN9JF:X\-G36>$<G4].,M*;*U"""
M/N5&T'&I],64XV.M\BKHU44=0\788MR5 FG5IRIPA\ G:?"> C[&,&#::V&D
MTUM!V""+(:56=2/%UG#\_13C6^FPHI\YQ7.I7F-GK+598PS\PEK@\MQ,.;=*
MS0::) @X<VJP0P/<2J=L1D%NJU23P7-;EN?.W8)RL]H]J4@+J;.[0XIT)\X;
M4=9PC.5"X)3!N>DZT9#-_)R1V,<%<,0W=RI<8RW(.=H1YEF:SCU=L(9?Q*#I
MM=@[\^4CGXKB\"3\LI,=?MF/*@&?[4I)+B8!+U1+<AT8D<?+8D1V[(K<AFUM
M!"_RN%K3\!&?'WVZH2LC?3"5D639(SW<QYNIVE<)WQY./YS@_8D%[]C-R^'&
M'GEUI4#&!:]+JF:4ELF86PX;+U>J9PX7E1?VD?JUXR/1QPIY+)46A3R^,^_F
MU]TFGVSDXL@)^95:D.G4IJ\@!)86$P0]9DNGD=@_/1!3UXEB&Z%SQA!4OAB*
MT0Y0BR0L&?R=<&8Y566(Q!A%)BW0SATXI9U[_*BU/.<A"A_0Q(7&R=K?HR^Q
MT+LJFL)2NUVPP/WN1CV/S<.H%.FL'EU/@+$&*$NHQ\E0/;=/ I@,Z65)2=>R
MI^@W71/33IQ[%6>+(LC"EP-H&'I^X/H)4Z.X*:DK6S;--E@KV8OD/@L]M6W*
MU]49S:WV[N2$(MYH(5"6T0'L^M&F@O\U[YP6WB%T!1#\8HXT',K0!2RS%XY3
M?^APRB!,D,RN5='"K'E>5"2+7O\^+WR?8#XJ<CUQ$?FDR9T?>]]!/MY_?71@
MEH9VOS'VTUNO4+[]GL@11:BZX#E*?2J[YR8D)M/I%52!SX?C3LMEJ,T+W:.J
M;@@<'.?<-236.NA8(#T,]OI[92J&\8]4[5%J!@X.";?E/058<P=KI.)X,!1D
M4%%;Q10;LG=I<5<2%L'8^2N,4'\(!QE*(,.=D+<JL2/$/5VK5?<R-84JL28%
MC#KD(R(S*"AJ P7VQ%1+ISV(?Q0K?&1R2U5X_ ,<+P9WX.T5*P$<%%F7JIE*
MG4'Q"YV2RQ^UW,Z%$[GD%$5G!Q@/VG5B4_7(G+0Z_WI'[^ ;E[@!:T>'?TA_
M$^$= [^ZC<+O4[9=,&7EHQ?-R]IIG2T682R[S?;QX'9CD!!67;NAMBNEMQ/&
M5RJ,[TKI+2:,+U)+;Q7";5$5/ZX>9U(AC-DA-O[<V!@@"MD$%5&"_&6,([FR
M-K&Q.H#H1^5H*8W!KF+'DJUDT6B-0:&JP&>UCQN8N!:+,X*<2I53M>9 /EI'
M&>,RFIYD*P'3_6C+3\JVY2692Q,Q08-#@P=JWZ%SY,?"+5VAW*]<R3X#MZ4(
MQ(9XQ!8JUA#,EQ LK9RE\Q,/"OD>9J[XRZ7+MMPF(QR)^IB*@'MR8J02D/D3
MOB@O?CBSN)=]8Y>-<2-U#TZ6U6EU!BP.F4-]UJ3/%K?G">BT7UC*': @LG^6
MEW%9PYN+55PILW$26EMB< &UZ$;QN-4R?Q87IV=C)JVGPKF22RM;0B%_DO@2
M%('&)V-7&#^NYT[42+F$-N)O95N2=90S[9;. @55-Q@B8Y;86C830P%<0A%;
MXW/04,KN%_D$*C:J_C:5N72_R5+4"\4?KV_QC]7B@W0M]FM%!6>@2#6+3J;*
M*1,,V >H@84M M,>NA2J3_O #B4WDC?59PF4\H4:)WGP$-."'19.(// ]_&%
M>6GD!PL"$>YRQ8?/U1Q*3?J[TF\[W6&%NL.N]-MBNL,BM=_6=YN<J$#EQSF4
M3G<GTPY;DE88Y2SV%>R6AE266*(<6#T$P39"HT^Y.^&1JMQ*GWFLR,+3H+G(
MVOG@X@V(7M<UQ( #=7(QYW.OR\7#PM>WM4ZUE(I2@DO2RFFYJ$I"H)(8\,-L
M,2$;(X[UYU"/>,"#A=$4<H\B2H),NS)[ &EL*&XD=QE PT5U5%3#((T"*@.G
ML^&;#;0P&L4(L3DF4UKQ0$E&%(*M#U+.B/CV\ \I!<%?N'[95$8Y]DG:13-R
M:3)!($/4Y5('CBI6*^.)8(;+@:6W")(O1)GP7*W+A>/YTR5!TMEQ@Q,DHP/M
M/D)"4((AEC4&&C]B$16@57I^-J*" &^A-\:[G9D5FL@T6'L;4*_8Y>);@4>6
MQ5&1@XO9)V$B3:2T1S$7_TR](BHD_,D3Q4$Q90QRC%)WJ)QAH5%5Z:F+T"I9
M^(P9L2TR'$SV1X$Z.3F5M@PU7\0PR(,[(Y=/O"3%P#P0\OZ9J@0!R]$0+'QS
M3-(H3AV6@[->*:Y1D[KL'XN!QK>1AW)O'H+"L.B2DB:V_II56B6<N,&2' R\
MOG/O,?"UV_,=N13YR#FI0Q%\3L@!5HG!@<2OLX=S+2+Y"JH$[D3RG4BN1/)=
M;<#%1/)%B@.N3VXZFQ&[R)E9H3)V" M?E\H&8*TQIX1CYDQ=#THHBY+I(1L0
M3\\.0&3RD:M&MEAVK2^X(3R', -LF9N?J$\<7=FNX5FV(=EW^E,K3N"]3F!)
M71(7$8>9[3UV<0MWIH: Q71+C=/J@K/LX59-A&Q5WXS54 )/S4OA7Y/%^G19
MBW6IW/0*DPEU\.FU.X0%)XMGW50WN%0E&:3Q?UV%?HM'X;1:$W7:B($<F5IA
MF0HP6QNL/%K$FA"\\+,LA9V,HC =CHK27T^)F%:8;F H11ZJ>04L; ?' ^U>
MJ9VP0.QXI&&4VV<9L"M40J2*3AN:Z+22K(R\YT?*I';6J!UEQ8>7AE0^"&N@
MZ00__??KX[/*T=$1F=?G3#U3RMM4[+9$9*D.E;N7]@[6(E/EZ\_M9*J=3/4,
MF6I7AVXAF>IX777H%KM(CHGES7!CZT QXG&4/(,6G;@7A0\*TE3CL+*27\XI
M'QZW=\F;"OV*J)-;-;0*#C.-B\BLTOBT$, V*_$8WJY*41U8ULZ@!&K!#%IE
MK>>BZ4 TT-.*O 2=C:J>$9+PP8O0#!4G42HQ/TF0$H0XWQ=?#M\A*C1A(9&I
M##@_7G3.=V@$YN;ANFK811&D",=K(CXDS6DIC+ Y,PI!7E%]%S1US&/:C(7S
MM'JRT*[2X,/^5";GD/%#QWEG]T*,:*-B_\W!_&#M>>ML]@QQD]ALJ>RNF3'P
M?8+.P  7$MP=_M;AM,:N+,UQGS-V'; Z(N-$K7O?+GG&1;BXY%E5M'CZA*YJ
ME)GL-$4_=+E)+G$G-PC/3O\F1_38I.1C\;SG.$P\H,2I@\IC+9(L&D:R0#N5
M>Z"H^.\]*O P,(.%XT25OPX>W1<*1=V9AM$L(LT^"2J=<8Y,F299 RN"T\HC
MA)966?>& I &"G'N;_]5>WO\GJH5XC2]0!HWYX45=%W:S!&I>!*IE0<VSE=X
M 5:1!GT9&B[93)RAA(YIGR=J3W!KA2DFH!(K5_S8&TAV7(B4(1X;N3W7N[?\
M]_1MF9D1,^URS+#  X''P9>HRSK%LC4KDF'S)=IV,NQ.AGV&#+LKU[:8#+NN
M<FV+21NG,[@M7LL8GI8M,4G7C]3765NGL*Q9B)26DB_!T6??,QF]7GI9I':O
M//>%2$&ZPB?H]D9/MAQHG09:JN>OA8)L6;7*<LZY2VV7%=]^_-_3:JTB0*%@
MRR'*@/+>-]$1[#=3@*64OX<!SHGI&I=BED&N[(93@C'<O.,N#$S'#.BKC[O!
MF-H<JK\7<#WC"J?J2]%#?UF$B2\/$Y=X#WG4^1G^6.U_]<.>JO8V@\X@7K(X
M.H;W[MV9+1I@,D84\.().2<-ECMI#MRCE9G_:+>6^L=E,EA&8<@3(44T@H?H
M$[9;0%4IG,B 2U L>U_C2<2A+Z5C1XS3A/"'#VGX)-]QBRC1Y-,\K5/%1D[R
MB,K%U?F#MN-62N"J23;LJ4^PE_0&XJVAJAR3=,^/R=B8G_"7J.LIQ[2F"?N?
M92G<F8JOA,V@Q>Y+VLZ0/J=6RB/5*+.HJ./=\_/:$']X/4>?RX;X !&S3*Q"
M90IR*YB/'25>^=Y.^7-E!BVZ5RR5P0Y5,/RSZYI,8+MHA6&^5$DF]%TN7$!*
M3"73.?$,3SMD9BE!RF1NSW =@NQQOH3<3I#=";+/$&1WY>06$V07*2>W)L?E
MV;*.2PG%M#FWXUFU)F9BO-G!AQD!>E^Z$W4 &2' <KDB]H@_7LGH8'E N'UY
M-7LE<6L]!WD3!P_$=.D?; !<RP!JH<$Z^&=*493\#$(ZC9QH*/VF.92MC#\]
MC[<K5!757&&MV=6T"B6.K/I&LK1/J>Q+^7L(6&8E.Y)A"DB=VJ19N#*3RO87
M,L<?K5)#:4B3=)692G!+83:DXT6RRR3R>DP0B5@K[6"VQ]N.$LF58[+<X[F
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MD7(#: 5D@S16:SZ[^%2^WE0A)23"/&8N!\-%VZ%EN*\9!:D0A&387[FZJHF
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M:;JLBM: ??!89+7T'K!]:;.&[PBV5<:N>BMKSU1CC;%,JMA_L^PH-W-IGW)
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MDH3S3\K"++)S\[/-]PP_SXYI7O_OWN4&H!-.9#NJN6S"2O[A!0=<O[H2-U]
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M':G#OA#$,5>JNNR( +G'P#DR:Q##! FM%"T-A9U!R*!#O/O4CL"."06T=$&
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MJ\ONT4X9O<EUYM -:RVXBW488Q*PH_&K^-"'WV#9[3LXM\[S1JEFQY%,T$,
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M1;KLJK#O9.9MD4/+9>9W1]LXUBV4F5^_H,Q<SAB)^<,MU4\I:<\8!8U'2XD
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M,\8?0;"3H<3MT2(=(7D5PO/$^F-LZV--R40CQ:%8J1+1&4XH*F.*%6.'0-8
M=%]30]!J)QFAV*^%3WH[D0&;/##4#?5DIQM8^;95DM'6X/P.T:C _.1(E5Z-
MJ*"%>E&:AQW?7P@[:O8*?&B/Q!6F]!D%YH([?(=X!?2SZB8P1"1WQ#T25^V:
M*62]-G.&$FX0/9MVB&:V"#&IP](SD_^QM<[X[$_>E?IF1A5(G_S+M_6O*J/8
M'DYVOQ_-?HTOXM7%^?KYO/^U._NWO:8:_AC76\*_&:_-AC[:K(NB)Z=<Y3$Y
ML#9=8 J(DF\8S.VCV+']J@N\9#@0>2EKW%!3#RUWXDE;[A(+IW+Y5#;^KKAX
M<&F7/LSQNA83:BT4KZ4)59I0:$*5E*[%3*@BE*ZE";5%=]-RY"V^F9J<0(6W
M$5TKEY*QD[QHQ%CAW/"L'\3A($0,U]DU1F>;$X&,;10<?ZJ;JR6"ULWK_,#?
M-W>.26#9,P9#CR\JX9GYO/ MHAE2@5V?@"4EF;7"/3-I\9(/Y0U,R6H*E,7$
MDQP-O)(Y7O3'3AD%)]U"B#B7OEK,]N?!/EW&U#FA@\%[E!K*-XO$RPIW,,$'
M"@2^_MTN:)/'$V?PA=#7:31[6OQ@26+Z$9:DAYQV1@EAW@@T41_ZL%L[FH\1
M&]*D#4WPUIX&/H/6D"->@C05M@UL%8/>PEE1$<?87'6S@%&Q0<)ERMC'VD'_
M:+^F9A-!__$IFY\GRC*'3: &R5<%/ ASLRB8&%22CF.:D1W)]>($[ Z&!^UW
M$7^7Y-+QKR@FA\O/C^.[2S_KNQSW24> 4VLI5G,PS?M^?X2%$[NOCTB@G"4W
MO"6%2]!Q<,IT03MYNN, 3[3HDX$P-%L2UO0HT*0*:'C05/:3,RWUOQQ;T!$Y
MO26T!BBIC(Y "&@T75,&G\1QT+*/!<^[7>J=!P)3*[\5 (2AP-?"&UQO9KB5
MDH_!<X[ 43'($%$])N'2S2^,^<<1N7BE$'*0-$,%+]26@2-(FM2:V5?<-6Y<
MOYSU&IVGEVR#05>A(0T$L&<@D QVD(V08:I@5KU$9U/*)G"DJ[MPNTXX3"14
ME^HGF$HXF,^#FY_V=)QNIY?>A3ACC"E/@6Q;8\<(,=+7!7 <B66J*Z7P82MC
MU9RSZ=B-E7X8>U3L99!TJ."V"STJS\*E*E*2JV1'0EL[)\%,'&=6,UI29M#F
M)K'R;'%?(&"PKW;?2@(M1]Z,C%&85B#M@<N*-XI=\M67,!DY4_(K+2)WD$@5
M,->H%$Q(%W:6#DUIG'XU#:(Y;1Q8*+FW*7D2'#LE%#U<BK&<'2O'A?"M.)=T
M4X&KEZ*C+JVN']#J*LFHBUE=1<BH2ZMKBZRN+(^@]@#'815*:&-JQI@9,S(>
MN1@@2I>KQ'EM<0X:EYZ0\IH12EIJO9*EA$OIB*[GF\+%@]EMK M*NHZS0, ?
M[W]T[>PL=B9:M)YI[LKEP@H)=N"UK1V3Q QJZV$"^R@U*'82VP2+<YD]BY5#
M^^6Z2ZMP<A*5"C&OJAF['J8EZK0,X[A"5G2(1QDGNYGQBEFGA89U+%XXC8U-
M_1V;D&8(.:4PV4[6[R!B4,8-"L8-J'XJ&7;5+I'8'V_!%U 8=;@8)&J.>37:
MZ=.HX<:>$&T"6L5J[+B!+QQ"_<MJ'7>8KH#"]F* "5#S!Y&=%&W,?#RFW*\.
M'F45=7*/J<X,QG>OL[Y"U/(7KDW54,D&0HN1P4@ 23RUBNJV_ZK8<6.T50FN
MUXH-4C(L)[N1&R8S7XUAPC&#;G*_3P8]QQ<=WR/8LKF<;":U>#,Z>$FE6VKA
M:]3"2RK=8EKXLU'I%LI@@B.W%<P]3FO DS=*XBW8U<$IQO14];.4MCY<05U5
M9U36//&B-"U71_,_S0A-$*EE5C+>;(A[*'H B,/&,(K!W07Z%044Q?I8#J]9
M)L\J>=.3"#46N97+O*/L7+2A)#E/2'*5$"(3*[&7]+ZA.^#RX43ENCW?>NKT
M'(/>7%5QD1%Z%Q/X('1KV7$>\OU+0;>E;5<H(C/4,$")FN(59>%+5<L56H$I
M=,LXI5P/@]$VN9P@#;>91MO,Q*"R\L23*SD9TW+5F23 -1B%2-6)! F>DI%1
M^0IY1.&#;*#0(A9&9B>W 5+H";!"F2?L-V -+>_>E7!#EB(.;_\$;Q>%!U];
M] VGS>Y%L]NMGQ.07J=QWJAW&]T'H8:>LZHU">]J (<TCBPNI@"+.4)71V.$
MF0&5Y7F:@"^_=&/D8;5A/J--['5 ,*+8'O;YSH&CYX0ZD;A7EE@U4FU^=!F:
MF:#ZT.T_C^-KUKDL<25^-5.22/]^-P=([.%(O4, PS1$7!(*CBUT.:@-!MB=
MF%.#(&+#"[=J@E7M'JD]!BY?D\;26;Y1=*AKYMQK2R/_>.$76RE7.%Y]9$FT
M=>;P,#3[)1H^M!!XFFV9P-&#<:E(G='4<@%H0Q<>J5/XZ?.P"==*.N'2_EBC
M_5'2"1>S/UZ23OA*7T;) R8)4YFX#G8=1MCGWV$YP1TF6XR=R4C<NQI_<H)(
M1_JK!)3=GF"KBG9*A^8#M]"N0%!Z^K6BQQ$7@(/;GI%1F99H+TYH'2(:$=E'
MB'7)+X:#.IBY<3EYXOCE7_+#HP4IV73)3L2QC%YS=/ +0P51R<,%\^\%!9H-
MTB6CQ Y%$4YBL]LD4.:[2RK9%IM%=$P+&-5*I[KRT<3QI;6]5)R^8H?Q&6.4
MTJI\-Y55)3"NE01),PDVF"QLT2P#C<)C&?QDJX:U&4,Q=SG;2VU)XENS5@R.
MLF61)]%C,\$=D[LU]?MU;RS*T7C6=8EKR)LOYAJ0B_C4V"0GN&3Z,[)LP&]:
MM&)BI[;HL^A7:Z&V?3*Z)=8FE^B6/ZRV51+=%M.V7I+HMA60Z6X5E46N8;HR
MH7N&L,88VW1&*"ETO,U#;R!EJSAR<DD]HLAHV13FQ&BXH<2<MOCK4Z0Z<D3J
M6V\;'%TOA9W]YT8((U*DM^VK5K=Q_E-7U7N]=J?5N(8/SQH-YL%M_'79:!7Q
M=CV3:YZ2%],T5\;1>YM85TG7K?FW7I(<?&7SHJ\Q780,=4DUT:J/3EH'%4;W
M0K3NE53WG R:!8G/K/<#9Q&9+%+'&RYS'1BR*DVHQ>G"F;Q@PBS%CO!0.P$M
ME4P[SZP8S5)Z,'<INQ-61Q<S_-<_WAP>50X.#N@\62&(BLT*9=R(":<A>Z"R
M?5\[>]#1@/Q9>61>&"+P \Z.]6Y=-FZT8VUD,,Q L[LEVC36"C61VV-4.3AM
M- .BYA&C"FUOVE^$D>0<B]&ZF.\'H_T9=-B=QZL"=%E4EX<L_?3B7.8EBQ93
M&WXXLLN%0T*YP?#:JG5HER<,4-P:/R?RIM[$"=7 "P>+*6?MDW"L>)0^K.?W
M,[>:R-$"@\(U#ERL=@[F@@E&M3L(E"-0].R=-&Y.LCSO!$9X5<\W8]!E3<-/
M%L:P;+L<QRPZR#$M/T3#BC8IXBAQNC5:2.1--X&ZG(.*PWLRRR8.93<;>]4Q
M<+;/@3-S)#X3YV^M)/TM[8>UV0^'!R7I;S'[8?M(?PEI?C:+ 1AUK,]<JGRB
MT]DFV@'K!I2[9WG&DKXF.BT3B@6<MD)J(HI"19/VZ&=,!4_.B>SY=AH@OC<Y
MIAD>\0-O%N=;<)*%CM%9[J!\1T\>#5++]>C$MRY*7ZH+I:ULC=#X!ZUKDY28
M(#39Q C6D!#V=V@EK3L5(&TZK;2=GI (D"(<2O ,J8^->J?9^O!"9E$J!4 '
MS'4=W-@E+C1*P,=U]S& -4!K*T'*4U&R8A$CF$P<]IH*W"RGH8SB3Y2HI5?5
M;A4A)]EG$!\'Y!EW(J2ECK^&U7OA#<:PAZ!%Z'<PQ%Z=N[?0+#5$OQ\'"PP5
M'+ZJJ4]5=>Z,G'L8GJN.)[?#:@6&#?L>.WSJSL, V;ETF^KUN\/#-V)$+(L$
MT;20D<B$P;FW)"B36,2I#KI (.6L2#&5&9XYHUD[#W$"2YZ"W;ZDY)%//\G'
ME\PDAAY0Y?'AJVHMSA(84H4Q?0&?G<"1,D&0%BGLT D5Z8:&"Y?+/Z)(YQ_H
M+N'Y\Z@@4BP&'@*3:/L"ML0/2[FM/6S6<O?A0,]+=4""*3GGZGRI+$L\KK&E
M6@ZC9L_)&HFL:<:K"X,N-CJ-97LE-X\ :.L2SV2^A5JF59;?,2L)U\DZP\_P
M,&;A8!(Y@\&!=H],CI)$HK&[.#_F613WD@:Y5-S7J+B7-,C%%/<B-,A_1Q+D
M/S?$@HSZ&15XJ5Y;M8]_;YSTT(']<[NCCANDKIVJ>H_H(E]6=T,:@=51<[J*
M G:;"A8@7& :[Q NQ#MQUH)R-L8$B[$K9*^<LN_?BRX"EV_:\:OO4X%.*:[%
MT!MT>[^G>'>E-4WRRK>>G_B)PS=\CMO/>%&UH]!X,+/[6P6=5@BT%CX5H1GN
M*$6K/G5_5]1]L!!+BPQ/1K)CQ@!$CYQ/V,E*.:>B]J337E<Q?'83"0,5G!K=
MUTI29&S.ID252E2-G*EF^'VZY/)""D9D*!).+M%; 79"LUB\+X:U >FB'WRW
M]GH/EN4$K=J0T6T2;'/+FI/9?TW>@P5>6\DA035XJ9)W#&+@_2,0]7.I>YPG
M"I8M'/LE^I]GV?JUJKI&ICV?IA<YH1$;:8C HN+J -UY-D8"/W^!="J_;J1;
MAZP3#U!?P:Y15[@#:E?WH-BZN 2;#_.AD$VZJFZK9*<YD?G$GO,"S>TVJJ?<
M1G5/D3Z%&HHQ8/<V(Y]7532O:*/#NL==PR&W@4<&3W"'&G^ZA!U/5#L=6U,\
M?$WYEQ*1<%]=P-%?>P^6\,'A8<6NTZ5H(6YEMGHH!!-M9OROJZI.' GQ&2->
M/?ZOV6E]EPVIH;N9CAU5M26-)I88FC@_6%DC=-]R<>:9;VH7G]<Q++&9K5_N
MD;7Y'';:6LB(2SNMM-/83BOIAXO9:2])/_P&O9T:T8SS%-"SFCJR&.<O$6V!
MFV 2Z#(E_!2O:=,*?(IUD[MNM)=J:H#Z+C;D4B]7'(/::RCI&DCUQA>4%_*O
MIX%_OYF@?'-$H[@C\+- &T(B#@/D:"O<^#A1\J%V2(]I?3"^FYBBH8^F3A^T
M\K0*R7EHXC/7[G&\A.'N QDNM2>L1(N91H"0J=3,@&D]=>*&7^(R3YK2];K1
M'Y&L5]CC?O3^?:[+79B3W!!D^8AWD_*B<R($M A6)6?X8,J@%2^,-?7E' W)
MP5E-VYFXU%HO5A4K/WV=$WLJI@KK<"RN$-NL^R5A1F4&O6K?\MZ'FS\Z6->X
MXJ#HTJALG*)GEO13!5H NFC=PGL6*15X[P66F0P=50<%'$Z%8!(%?@XJTNHU
M^)@Q/DI^!1K^/? =@BX"F]R_N0N"X9)2L %1_E'_V%+=3\V3/]0_G>D,H?9Z
MS8HZ/S_Y[@3:;5Y<=MLMU?M8/_G8Z+R$-&MP/JO+X'X8.IAD'KHN7%S=!:B5
MZM52$M*SBW0%C)IHM2#M@HD1Q70G7D+']4[OO-'KP2JZ?(E9P#_;X<1U_ A6
M<EV]/:B]>?7=+>?7AT>@8'V%F9N#=E@GE+&7D*8<ME5?G[2_?8E&HO]4!\'T
MNQ,L_GD=A%\JJG6M8,/6WJY=K(^2Q=H'^/E>WRB_1?/^Q+E+3].FEDX]&D_<
M>]6IJHXW^N)MV1V]24ETVL?'S58W?2+^O81P=/#Z0'7'8#F.G:FZG,!3?U]A
M=!TTK]V;H*).ZNK]82WMH/H["<,)Z7SX+0SZ?<^/)I/9]MTL&W757;>O.NI3
MI]GK-5J23M!LP_EQ<=7M84+!9;O;NZAW_FB<JG9'@=)[UCQOJ$_-WD=*,3@Y
M;W3^4.TS_@>TU5.M-JA"O48'U>.62N9ALJ.IC8'I1&W-W9BQ L2=Q  8$^^6
M0L>W,"[^3)@LDT'0*!D%U;FA=K#;!,'S_8(2*K8<92'US(3;GR6'[7T9&REC
M(^N+C;S:QKYN86SD_4M"!15+XW$>SI["0W,8N%P6.D7"FS$"-(XQ68BRI"+K
M6)3"#^@"-F,PVS KQ_/SH%O4G4.EIIQ_;-KB["S\A09F@5_V':K(U7 M@PE%
M+ZB01;A^J4#$-")Q#DS&\BDO)$[(XG]C-ACE9 WNLY./*&ABQ*C/^(K5O<2W
M?;!5C)1SLI3BG'(!$^"O;T *RQBMVWIV;JH2I?G7LQ:B-/ZJ7S1;=51'4,&X
MK%\V.ERKWVS][ZMFI_EBQ?H]8CY&FCN#(6OG6&$FRT#8WE+:AG/K>!,J4,F"
MWQ6LRLAZ#*,%2'HF4&$)F%HA5J*ZC[N[JJUIH5++&P%^E)D<]_#O*8>+J^(F
M$;*3"056*I=GN"#]R8#:CN'\BK2B%1#CNXD'/GMP<"T1/U!0.;L&Q\Z1Y7$>
M8 !B/YM0*QUV';8LT #',^H/9PPS<.<-OFBW-RBMY/9FS/]B2RB&:7JD&EHL
MW?"2D%[5:1N4]QX<4JU>_:1GJ?3M#JJ+]FXKUBZ<?Q\^U3LM, 8ZC0_U#K)3
M0+/-+KZG>=)(GA_KTZL/#TJ]NM2KUZ=7O][&OFZ?7OWVH)A>S9OCI'%^WKVL
MG\"9\+]V#G;HW\)@0__F#4)_RA"02G5_[+*X]#[B/;"/9)'.+(*QZ;_BT>%>
M260PY-#S\+;9^5<!&I_BP:R"O$ OU^"CF(B>0?O,)$DJ!%=>[S5.?\GQL26[
M<_3N&_N3G=N0?,GK30SZ\=&55?N_:,=RQKW^)C,7\I,5]>-K18=(TD%YU6K"
MPH$WPOKIJM-FM]=IGO2TJL-/@C[4:W1:\;?P^47SY&/S0[WUL-O@VQ686JG
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MS-- -[1 :@\N$#>\18<LB2Q*KA5:) EGH:V767S?I'_E+9^\2?:)=_+&]TQ
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MI@PMR\_'[=-K;N/GC[V+<_KS_P-02P,$%     @ L(#M5# [_][>+   I-<
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MH2JB1KHBZG;G 4/<T<=:!ATV\I/N#N3R3>[HZ 0&'8PSG!K,+GG)DJ@<Q@_
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M]+;T'4"1$WFW)0[$$2;YJ?*UM4ZN)%0^A./BIS\[R^]A:M[1 XKYG,P\=#6
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MTB724)BM,EU%07U\6'VF6ECZ,W7TM:\B6J4.%X[H@PB0'9J=?7,"!.S,F59
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MLU;CM/7!V]SBAF_@Z^7=/;27S8FPY\?=Y@6/\_QT>-:F/_\_4$L! A0#%
M  @ L(#M5+RPY6[+ P  >@X  !               ( !     &)W82TR,#(R
M,#<Q,RYX<V102P$"% ,4    " "P@.U45$>^N/L(  !8:   %
M    @ 'Y P  8G=A+3(P,C(P-S$S7V1E9BYX;6Q02P$"% ,4    " "P@.U4
MW.7T5>X+  "PCP  %               @ $F#0  8G=A+3(P,C(P-S$S7VQA
M8BYX;6Q02P$"% ,4    " "P@.U4XN>?KCX(  #R8@  %
M@ %&&0  8G=A+3(P,C(P-S$S7W!R92YX;6Q02P$"% ,4    " "P@.U4:S@$
M=O07  !NA@  $0              @ &V(0  8G=A-# X,CDQ,2TX:RYH=&U0
M2P$"% ,4    " "P@.U4 0DBSJ2B   @A 0 %               @ '9.0
M8G=A-# X,CDQ,2UE>#DY,2YH=&U02P$"% ,4    " "P@.U4,#O_WMXL  "D
MUP  %               @ &OW   8G=A-# X,CDQ,2UE>#DY,BYH=&U02P4&
2      < !P#' 0  OPD!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
